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Down syndrome (DS) is the most common cause of intellectual disability in humans and is 
associated with intellectual and physical complications, including Alzheimer’s disease 
(AD). Ophthalmic problems are common in DS often resulting in mild-moderate visual 
impairment. Cataract (reported prevalence 4-72%) has also been reported, but morphology 
and type are not well understood. Recently, researchers have described ‘supranuclear’ 
cataract in the eyes of typically developed adults with AD and those with DS, linking this 
with beta-amyloid (Ab) peptide accumulation, pathognomonic of AD.  However, this 
assertion seems precipitous, given the lack of characterisation of lens opacities in DS.   
 
This study has established a method of objectively grading any morphology of cataract 
using Optical Coherence Tomography (OCT).  In a cohort of 90 typically developed adults 
aged 50 years and older, this newly-developed method was validated by comparing its 
measures of lens opacity to the commonly used, slit-lamp based Lens Opacities 
Classification System III.  OCT subsequently characterised the morphology of lens opacity 
in a group of individuals with DS aged 6-55 years. Lens opacities were common in DS 
(prevalence 77.8%). Their presence was unrelated to age or visual acuity. The most 
common presentation was dot-like opacities scattered throughout the crystalline lens 
cortex and, occasionally, nucleus. These opacities were not supranuclear and do not appear 
to be consistent with Ab accumulation. There was little evidence of early onset of age-
related nuclear, cortical and posterior-subcapsular cataract types.   Retinal structure was 
examined using posterior-segment OCT in DS. Increased macular and nerve fibre layer 
thickness was found, in opposition to the neural thinning found in AD.   
 
In summary, this work has developed and validated a novel technique of assessing 
crystalline lens structure, provided original, detailed quantitative data on typical DS cataract 
morphology, and shown that the DS eye does not exhibit the characteristic features 
reported in AD.    
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Chapter 1: Introduction 
This literature review initially provides a background on the development, prevalence, and 
current systems of assessing opacities of the crystalline lens known as cataract.  This is 
followed on by descriptions of Alzheimer’s disease and Down syndrome, and their 
interface in exploring the potential of the eye, including cataract, as a possible biomarker.  
The purpose and aims of this thesis will then be described in the context of this review.         
 
1.1 The Human Crystalline Lens and Cataract 
1.1.1 Anatomy and Physiology of the Crystalline Lens 
The human crystalline lens is a transparent, biconvex refractive structure located in the 
posterior chamber of the eye, situated anterior to the vitreous chamber and posterior to 
the iris.  Anteriorly, the lens is surrounded by aqueous humor and is attached to the ciliary 
body and muscle by zonules of Zinn.  Contraction of the ciliary muscle causes a change in 
tension of the zonules and subsequent steepening in the curvature of, primarily, the 
anterior surface of the lens; this yields an increase in dioptric power and is known as 
accommodation.  Accommodation allows an emmetropic eye to have a sharply focused 
image on the retina when objects are not at optical infinity.  In its relaxed, 
unaccommodated state the lens still acts as a refractive medium, aiding the cornea in 
forming sharp images of distant objects on the retina (for the emmetropic eye). The 
dioptric power of the normal lens is approximately 15D; it has the ability to produce a 
further 15-16D of accommodation in early life that decreases to less than 2D after the age 
of 50 years due to presbyopia (Bron et al. 1997). 
 
The crystalline lens consists of four main structures: the capsule, epithelium, cortex and 
nucleus (Figure 1.1.1).  Apart from a single layer of cuboidal epithelial cells forming the 
epithelium, the other structures of the lens are composed primarily of fibre cells.  The 
capsule is a protective basement membrane that surrounds the entire lens. The epithelium 
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only exists between the capsule and anterior cortex; it progresses from the central pole of 
the lens to the equator, a peripheral area that runs circumferentially at the midpoint of the 
lens. There is no epithelium running from the equator of the lens to the posterior pole 
because, during embryology, these cells become the primary fibres of the fetal nucleus.  
The epithelial cells located at the equator constantly produce new fibrils throughout life 
(Andley 2007).  The apical portions of the new fibres progress anteriorly towards the 
anterior pole, whereas the basal portions progress backwards to the posterior pole.   The 
new fibres are developed at the outermost layer of the cortex and form a suture where they 
meet at the poles (Augusteyn 2010).  This constant production of new fibres results in a 
steepening of curvature and thickening of the crystalline lens throughout life (as seen in 
Figure 1).  The axial sagittal width of the lens is approximately 3.5-4.0 mm at birth and 
slowly increases to 4.75-5.0mm in the elderly; in contrast, the equatorial diameter of 6.5 
mm at birth increases to 9-10mm in the second decade and stays mostly constant 






Figure 1.1.1: Slit images of the crystalline lens.  (a) Layers of the lens at 20 years with Ca 
representing the capsule, C1 through C4 representing the cortex and N representing the 
nucleus. (b) The lens at 50 years. (c) The lens at 80 years.  Image taken from Bron et al. (1997). 
(a) (b) (c) 
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1.1.2 Refractive Index and Transparency of the Crystalline Lens 
The refractive properties of the lens are primarily due to the presence of a water-soluble 
protein called crystallin, that resides in the cytosol of cortex and nucleus fibres.  The 
crystallins account for 90% of the protein content in the lens (Sharma and Santhoshkumar 
2009).  The lens is said to have a ‘gradient’ refractive index due to the crystallin content in 
the fibres increasing from 15% in the outermost layer of the cortex to 70% in the nucleus, 
and then steadily decreasing again posteriorly (Remington 2012).  
 
The lens maintains its transparency in many ways. Firstly, it is an avascular structure that 
receives its nutrients from the aqueous humor (Wormstone et al. 2006).  The fibres in the 
cortex and nucleus have a very regular and tightly packed structure.  They take on a 
hexagonal shape with their broad surfaces parallel to the vertical plane of the lens.  This 
results in spacing that is smaller than the shortest wavelength of visible light.  As a result, 
there is no scattering as light passes through the lens (Remington 2012).   The cortex and 
nucleus fibres also maintain transparency due to a complete lack of organelles in the light 
path (Tholozan and Quinlan 2007).  The organelles of the germinal epithelial cells that 
produce new fibres tend to reside in the periphery of the lens at the equator; this way they 
are behind the iris at normal pupil sizes where they cannot scatter light.   
 
1.1.3 Cataract and its Development 
The crystalline lens does not stay completely transparent throughout life. Often, certain 
areas within the crystalline lens lose their transparency to the point where they scatter light. 
This is generally caused by oxidative stress damaging the crystallin proteins in the cortex 
and nucleus; they then become insoluble, bind and clump together.  Once the bound 
proteins become larger than the wavelength of visible light, they begin to scatter it; this 
occurrence is known as a cataract.  The primary and most common cause of cataract is 
age: typically, above 50 years all human crystalline lenses will have some early cataractous 
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changes.  There are three main types of age-related cataract, and these are classified 
according to their location: cortical cataract forms in the cortex (usually anteriorly), nuclear 
cataract forms in the nucleus, and posterior subcapsular cataract forms between the 
posterior capsule and cortex (Michael and Bron 2011).  Cataract is the leading cause of 
blindness worldwide (Leske et al. 1997; Tan et al. 2011; Koo et al. 2013) but is amenable to 
treatment with surgery.  This generally involves the creation of a hole in the anterior 
capsule and epithelium, and then breaking up and removing the entire cortex and nucleus 
(phacoemulsification).  Subsequently, an artificial intraocular lens implant is suspended 
within the remaining capsule. Ocular biometry helps calculate an appropriately powered 
IOL implant to optimise vision.    
 
There are other risk factors and causes of cataract; these include trauma or a congenital 
condition.  Certain medications such as systemic steroids, environmental factors such as 
UV light exposure, lifestyle factors such as malnutrition, and smoking as well as systemic 
diseases such as diabetes, can all cause and/or accelerate the occurrence of cataract 
(Andley 2007).  
 
1.1.4 Prevalence of Age-Related Cataract  
Cataract is a multifactorial condition whose prevalence has been heavily studied 
throughout the world.  Various large-scale studies have been conducted looking at factors 
causing vision loss and blindness in population-based cohorts.  However, these studies 
often differ in their methodologies, definitions of cataract, grading systems used and age-
ranges. 
 
In developed nations, a variety of studies on the epidemiology of eye diseases causing 
visual impairment have been conducted.  Of these, age-related cataract is often the most 
common cause.  These studies all involve older populations but some have broader age 
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ranges than others.  One of the earliest studies, the Framingham Eye Study (Kahn et al. 
1977) conducted in Massachusetts, examined 2477 adults aged 52 to 85 years, and reported 
an increasing prevalence of cataract causing visual impairment (VA below 20/30) with 
increasing age; prevalence was: 5% in those aged 52-64 years, 18% in those aged 65-74 
years and 46% in those aged 75-85 years.   
 
One of the most well known studies of eye disease causing visual impairment in the US is 
the Beaver Dam Eye Study (BDES) (Klein et al. 1992).  This study was conducted in the 
Wisconsin area and involved 4926 participants aged 43-84 years. The BDES measured 
cataract prevalence by morphology as well as employing a grading system to measure 
severity of opacification. The Wisconsin grading scale used was developed specifically for 
the study and involved five grades of increasing opacification (Klein et al. 1990). The 
prevalence of cataract in the BDES was determined to be 17.3% for nuclear cataract, 
16.3% for cortical cataract and 6.0% for posterior subcapsular cataract (Klein et al. 1992).  
 
A similar study to the BDES was conducted in an Australian population using a similar 
methodology.  The Blue Mountains Eye Study carried out eye examinations on 3654 
people aged 49-96 years who resided in a locality just outside of Sydney (Mitchell et al. 
1997).  The same Wisconsin grading scale for cataract that was used in the BDES was used 
to grade the severity of opacification. The presence of cataract was detected in the 
following amounts: nuclear in 53.3% of women and 49.7% of men; cortical cataract in 
25.9% of women and 21.1% of men; posterior subcapsular in 6.2% of women and 6.5% of 
men.  Although women showed a higher prevalence in all subgroups, this was only 
significantly higher for cortical cataract (Mitchell et al. 1997).  The age-related increase in 




A second large-scale study was carried out in the Australian state of Victoria.  McCarty, 
Mukesh et al. (1999) used data from the Visual Impairment Study to estimate the 
prevalence of cataract in Australia. The cohort included 3271 urban residents, 403 nursing 
home residents and 1473 rural residents with ages ranging from 40 to 103 years old.  The 
Wilmer system was used to grade opacification and cut-offs were set to define cataract 
independent of VA. Total age standardised prevalence of nuclear, cortical and posterior 
subcapsular cataract were 11.6%, 11.3% and 4.08% respectively (McCarty et al. 1999).  
 
Studies have also been conducted in single geographic areas looking at race and cataract 
prevalence.  One such is the Salisbury Eye Evaluation Project that took place in Maryland, 
USA (West et al. 1998). A cohort of 2520 people aged 65-84 years, of which 26.4% were 
African-American, were graded for presence of nuclear, cortical and posterior subcapsular 
cataract using the Wilmer grading scheme.  The presence of lens opacity was solely used to 
define cataract and VA was not considered as a factor. The total prevalence of lens 
opacities was 66% for African-Americans and 55% for Whites in the cohort. (West et al. 
1998). Cataract prevalence for African-Americans and Whites respectively was 33.5% and 
50.7% for nuclear, 54.2% and 24.2% for cortical, and 5.5% and 13.0% for posterior 
subcapsular morphologies (West et al. 1998). African-American participants were 4 times 
more likely to have a cortical opacity while Caucasians were more likely to have nuclear or 
posterior subcapsular opacities (West et al. 1998). 
 
The Baltimore Eye Survey examined visual impairment in a population of Caucasians and 
African-Americans in the Baltimore region of the USA (Rahmani et al. 1996).  Out of a 
cohort of 5308 subjects aged 40 years and older who were initially assessed in community 
screenings, a total of 120 individuals with VAs between 20/40 and 20/200 were identified 
for subsequent detailed ophthalmic examinations to be carried out; in this group, 33% of 
the visual impairment was due to cataract. Stratified into age groups, 0% of visual 
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impairment in Whites under 65 years old was due to cataract whereas 27.1% was due to 
cataract in African-Americans under 65 years old. In Whites over 65 years old, 44% of 
visual impairment was due to cataract whereby 36.6% of visual impairment was due to 
cataract in African-Americans of this age range. The authors stated that this disparity was 
very likely due to Whites taking advantage of cataract surgery at a greater level compared 
to African-Americans (Rahmani et al. 1996).     
 
Studies of visual impairment have also taken place in Europe.  One such is the Rotterdam 
Study from the Netherlands (Klaver et al. 1998).  This study involved 6775 subjects aged 
55 years and higher.  After using two different classification systems for blindness and 
visual impairment (World Health Organization and commonly used criteria in the United 
States), it was determined that 6% of blindness and 36% of visual impairment was caused 
by cataract.  The prevalence of cataract causing visual impairment by stratified age group 
was: 18% in those aged 55 – 74; 26% in those aged 75 – 84; 42% in those aged 85 and 
higher (Klaver et al. 1998).  
 
In the UK, a study of visual impairment was carried out in a North London population on 
1547 individuals aged 65 years and higher (Reidy et al. 1998).  Using a criterion of a VA of 
worse than 6/12, the prevalence of cataract causing visual impairment was determined to 
be 30%.  Broken down into stratified age ranges cataract prevalence was: 16.3% in those 
aged 65-69; 24.4% in those aged 70-74; 41.5% in those aged 75-79; 58.5% in those aged 
80-84; 70.6% in those aged 85-100 (Reidy et al. 1998).   
 
While the above studies all have used slightly different methodologies, they demonstrate 
that cataract is a common age-related condition that occurs throughout the world.  
Different methods of clinically assessing the morphology of age-related cataract exist and 
are discussed below.   
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1.1.5 Clinical Grading of Cataract 
While cataract could be considered to be a structural/anatomical problem, clinically it is 
often evaluated by its impact on vision and visual function.  Thus, visual acuity is a 
common method to indicate the severity or impact of cataract in clinical practice. 
However, in considering cataract in terms of its structural nature, there have been many 
systems developed to quantify its severity.  Perhaps the simplest method has been 
described by Mehra and Minassian (1988), who used an ophthalmoscope to visualise the 
red reflex through an undilated pupil and assigned a grade from 1 to 5 based upon the area 
of lenticular opacification seen.  However, more sophisticated systems were required for 
epidemiological studies and a host of them have been developed that utilise the slit-lamp 
biomicroscope (Chylack et al. 1983; Sparrow et al. 1986; Chylack et al. 1988; West et al. 
1988; Chylack et al. 1989; Taylor and West 1989; Klein et al. 1990; Chylack et al. 1993; Hall 
et al. 1999; Thylefors et al. 2002). These methods came about after the American 
Cooperative Cataract Research Group developed a system of describing cataractous 
changes in extracted crystalline lenses (Chylack et al. 1983). 
 
Of these, there are a number of grading systems that have gone on to be used in 
subsequent research and epidemiological studies and are worth describing in further detail:  
these are the Oxford Clinical Cataract Grading System, the Wisconsin and Wilmer grading 
systems, and the Lens Opacities Classification Grading System III (LOCS III).  The LOCS 
III is the a widely used and well-known method.  
 
1.1.5.1 Oxford Clinical Cataract Classification and Grading System 
The most comprehensive slit-lamp based grading system is the Oxford Clinical Cataract 
Classification and Grading System (OCCCGS) (Sparrow et al. 1986). In this system, 11 
features of the lens are graded at the slit-lamp by comparison to a set of standard images 
and colour samples at scale ranging from zero to five in severity.  These features are 
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categorised into two broad groups: cortical features and nuclear features.  Cortical features 
include: Anterior subcapsular opacity: those opacities just posterior of the anterior capsule 
visible with either retro or focal-illumination; Posterior subcapsular opacity: opacities lying 
just anterior to the posterior capsule visible with either retro or focal-illumination; Cortical 
spoke (cuneiform) opacities: base out wedge-like opacities visible as shadows with 
retroillumination; Waterclefts: base out, wedge shaped features that are optically empty 
when seen by slit-beam illumination; Vacuoles: small, round cystic spaces that appear as 
diverging lenses and are found in the anterior or posterior cortex; Retro-dots: rounded 
features that are similar to vacuoles but are larger in size and behave as converging lenses 
that produce a reversed illumination pattern; Focal dots: grey to white punctate opacities 
lying in the peripheral cortex; Thickness of the anterior clear zone: a measure of the most 
anterior stratified layer of the cortex.  Nuclear features include: Nuclear brunescence: the 
colour of the nucleus graded against Munsell colour scales; White nuclear scatter: the 
degree of opalescence in the anterior nucleus graded against Munsell neutral density scales.    
In the year 2000 the OCCCGS was modified and decimalized (Sparrow et al. 2000) to gain 
smaller scale intervals and increase accuracy (Bailey et al. 1991).  
 
While the OCCCGS uniquely provides a grading system for many subtypes of cataract, it 
requires the use of numerous standard diagrams, images and colour scales.  The system 
requires a high level of training and grading is time-intensive with experienced graders 
averaging five minutes to grade each cataract (Sparrow et al. 1986). 
 
1.1.5.2 The Wilmer Cataract Grading System 
The Wilmer system was created to allow live grading of cataract at the slit-lamp specifically 
for clinical and epidemiological studies of cataract (Taylor and West 1989).  Observers are 
to compare optic sections of the nucleus to four standard images and then assign a grade 
of 0, 1, 2, 3 or 4 based upon whether what is seen is clearer or the same than the standard 
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image, without respect to brunescence.  Cortical cataract is graded by obtaining 
retroillumination of the crystalline lens, and then assigning the same range of grades as the 
nuclear values but based upon estimation of the total circumference that the opacities 
cover; these correspond to no opacity, less than 1/8, less than 1/4, less than 1/2, or 
greater than 1/2 of the circumference for grades 0, 1, 2, 3, and 4 respectively.  PSC 
opacities are simply measured for maximum horizontal and vertical length by adjusting the 
height of the slit beam; the height and width are then multiplied to obtain an area however, 
this does not represent true PSC as these opacities are usually irregular in shape (Taylor 
and West 1989). 
 
1.1.5.3 The Wisconsin Cataract Grading System 
The Wisconsin system was used in the Beaver Dam Eye Study and relies on slit-lamp 
photography.  Optic sections of the nucleus and retroillumination images of the crystalline 
lens are captured and compared to a set of four standard photographs of cataract.  In 
grading the nucleus, observers are to disregard colour and assign a value from 1 to 5 if 
images are gradable or 8 if this is not the case (Klein et al. 1990).  As with the Wilmer 
system, grades are assigned based upon the observer’s opinion as to whether the image 
they are grading is the same or clearer than the closest standard image.  Unlike the Wilmer 
system, retroillumination images are graded for cortical or PSC by overlaying a grid of 9 
equal sized areas to estimate the area of the lens that each opacity occupies (Klein et al. 
1990).       
 
1.1.5.4 The Lens Opacities Classification System III 
A cataract grading system that has established itself is the Lens Opacities Classification 
System III (LOCS III) (Chylack et al. 1993).  The LOCS III has evolved from a lineage of 
earlier systems.  In 1988, the Lens Opacities Classification System described a simple 
method of grading cataract based upon black and white retro-illumination photos of 
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cortical and posterior subcapsular cataract, as well as a single colour slit-lamp photograph 
for the grading of nuclear colour and opalescence (Chylack et al. 1988).  A second iteration 
of the system was then developed that used updated colour transparencies to grade cortical 
and posterior subcapsular cataract as well as nuclear colour and opalescence; this system 
was named the Lens Opacities Classification System II (LOCS II) (Chylack et al. 1989).  
While LOCS II was used in various clinical and epidemiological studies of cataract, it had 
limitations (Chylack et al. 1993). These included: a small scale for nuclear colour grading 
that was too coarse, unequal scaling systems, as well as underrepresentation of the early 
stages nuclear opalescence and posterior subcapsular opacification.  
 
To address the above limitations of the LOCS II system, Chylack et al. (1993) updated it to 
the current LOCS III version.  The grading system was decimalised as opposed to the 
previous integer based version, the scale for nuclear colour was expanded from three to six 
steps, the nuclear opalescence and posterior subcapsular cataract scales were expanded to 
represent earlier opacification, and objective bases for the selection of interval steps to 
grade cataract features were determined (Chylack et al. 1993).   
 
The LOCS III system consists of three sets of standard images on a transparency; they are 
used to grade nuclear opacification (NO), nuclear colour (NC), cortical (C) and posterior 
subcapsular (P) opacification.  NO and NC are each graded using six standard slit-beam 
images of increasing severity while C and P are each graded using five standard retro-
illumination images of increasing severity.  Grades of 0.1 to 6.9 are assigned to NO and 
NC and grades of 0.1 to 5.9 are assigned to C and P; 0.1 represents complete clarity, or 
zero opacification, while 6.9 or 5.9 represent the most severe cataract for their respective 
categories.  Graders must use their intuition to imagine ten distinct levels of opacification 
between each standard image (Chylack et al. 1993).  This tighter, decimalised grading 
system produced 95% tolerance limits of 0.7 for NO, 0.7 for NC, 0.5 for C and 1.0 for P 
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Figure 1.1.2: The set of standard images used for grading in the Lens Opacities Classification 
System III.  Image taken from Chylack et al. (1993). 
which significantly outperformed the LOCS II system (with 95% tolerance limits of 2.0 for 
each category) (Chylack et al. 1993).  Figure 1.1.2 shows the standard images used for 





A unique aspect of the LOCS methods when compared to other slit-lamp based grading 
systems, is the ability to grade from photographs taken at the slit-lamp or by directly 
comparing the status of the lens to the standard images while at the slit-lamp.  Karbassi et 
al. (1993) evaluated LOCS III photo-grading and grading at the slit-lamp. Two sets of 
participants (n = 205 eyes and 51 eyes respectively) were graded independently by two 
graders using both methods.  The 95% tolerance limits for grading at the slit-lamp were 
slightly worse than photo-grading, ranging from 0.9 to 1.8 for the first set and 0.6 to 1.2 
for the second set; the 95% tolerance levels for the first photo-graded set were 0.3 to 0.6 
between observers and 0.6 to 0.8 for the same observer at two different sessions; the levels 
were similar for the second set of images (Karbassi et al. 1993).       
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While the LOCS III is a robust system for grading age-related cataract, it is, like all slit-
lamp based systems, subjective. Changes to slit-lamp settings can have an influence on the 
appearance and therefore, grade assigned to cataract (Kirwan et al. 2003).    
 
1.1.6 The Advent of OCT – Potential for objective grading of cataract? 
In order to examine cataract in any area of the crystalline lens, it will be useful to have an 
objective method of grading severity and location using more modern imaging techniques.  
A potential method of doing so is that of using optical coherence tomography (OCT).  
OCT was developed and first described by Huang et. al (1991) and is a way of imaging 
transparent and semi-transparent biological tissues.  In OCT, near infrared light is 
generated by a laser or superluminescent light emitting diode and then split into two 
separate beams: the reference arm (reflected by a mirror) and the measurement arm 
(reflected by ocular structures). Upon striking ocular tissues, incident light from the 
measurement arm is reflected and this is then recombined with the reflected reference arm 
to form an interference pattern.  Through low coherence interferometry, A-Scan (axial) 
measurements of the targeted structures are formed.  Joining a series of adjacent A-Scans 
creates B-Scan images, which can be thought of as 2D slices through the imaged area. 
OCT provides micron resolution cross-sectional images in a fast, non-invasive manner.  In 
the eye, various layers of the cornea, crystalline lens and retina can be imaged.  The ability 
of OCT to differentiate the layers within these structures is due to their different 
reflectivity profiles (Swanson et al. 1993). 
 
The first use of OCT was in imaging the retina (Swanson et al. 1993).  By providing high 
resolution cross-sectional images through the structure, its various layers can be examined.  
This has allowed visualisation of a tremendous amount of retinal pathology.  For instance, 
conditions such as central serous retinopathy, other various maculopathies, 
neovascularisation and retinoschisis can all be detected, often before they are visible using 
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fundus biomicroscopy and standard fundus photography. There are also age-matched 
normalised databases that have been generated to provide standard values for 
measurements such as retinal nerve fibre layer thickness and neuro-retinal rim thickness.  
Other physical dimensions that are measured are optic nerve head size and cup-to-disc 
ratio.  It is safe to say that OCT has revolutionised ophthalmic practice.    
  
Aside from posterior segment imaging, OCT has also been found to be useful in imaging 
the anterior segment of the eye (Izatt et al. 1994). Manufacturers have developed OCT 
equipment specifically for imaging the anterior segment or have adapted their existing 
posterior segment OCT devices to add the facility.  By using longer wavelengths of light 
than posterior segment OCT devices, dedicated anterior segment OCT devices have the 
ability to penetrate tissues more easily and provide a larger field of view.  
 
While anterior segment OCT is primarily used to image the cornea and irido-corneal angle, 
there have been a few in vivo studies where cataract has been examined using the technique.  
Wong et al. (2009) used a Zeiss Visante Anterior Segment OCT to image and objectively 
grade nuclear cataract by measuring pixel intensity in 55 cataract patients.  The authors 
found that the intensity grades correlated with LOCS III scores for nuclear colour and 
opalescence after performing Spearman analysis (Wong et al. 2009).   
 
Two other studies have examined posterior-polar cataract using anterior segment OCT 
(Kymionis et al. 2014; Chan et al. 2014). Kymionis et al. (2014) used anterior segment OCT 
to preoperatively detect a capsular defect not visible with a slit-lamp in two of three 
patients who had posterior-polar cataract. Chan et al. (2014) assessed 37 eyes to develop a 
grading system for anterior segment OCT images of posterior-polar cataract based upon 
an observer’s subjective opinion of the opacity’s location when viewing a B-Scan; the 
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grading system was found to significantly detect risk for posterior capsular rupture during 
cataract surgery.     
 
The most recent study of cataract grading with OCT has compared the CATALYS laser-
assisted femtosecond surgery system with integrated spectral domain OCT, against LOCS 
III nuclear grading (Kim et al. 2016).  Forty-seven eyes were imaged with the CATALYS 
system while patients were undergoing cataract surgery, and nuclear densities for each were 
calculated; a positive linear correlation was observed between the OCT grades and 
preoperative LOCS III nuclear opalescence scores (Kim et al. 2016). While this OCT 
system provides high resolution 3D scans of the entire lens, it is limited because it must 
come into physical contact with the eye through the use a liquid interface, and the scans 
are performed while patients are undergoing surgery.  
 
The above studies show that there is very real potential for OCT to be a useful tool in the 
detection, localisation and measurement of cataract at any location in the crystalline lens 













1.2 Alzheimer’s Disease 
Dementia, a group of diseases caused by neurodegeneration and reduced cognitive 
functioning, is a condition affecting over 40 million adults over the age of 60 years 
worldwide; the number of those with the condition is predicted to double every 20 years to 
at least the year 2050 (Prince et al. 2013).  Of all the forms of dementia, Alzheimer’s 
disease (AD) is the most common (Scheltens et al. 2016).  It is a disease that has been 
heavily researched but about which little is known and no cure available.  The disease 
develops over decades including a lengthy preclinical stage.  The hallmarks of AD are the 
cerebral deposition of amyloid-beta (Aβ) plaques and neurofibrillary tangles of tau (NFT).  
The classic signs of the disease are impaired memory and subsequent executive 
dysfunction however, impaired vision, language and executive problems can appear before 
memory impairment in atypical presentations (Scheltens et al. 2016).  In the past, a 
diagnosis of AD was only possible based solely upon clinical symptoms. While definitive 
confirmation is still only possible after death and subsequent autopsy, the ability to detect 
the signs pathognomonic of AD through the use of magnetic resonance imaging (MRI), 
cerebrospinal fluid (CSF) biomarkers and positron emission tomography (PET) has 
become possible.  Based upon these, the U.S. National Institute of Ageing has now 
devised suggested criteria for the preclinical, mild and full diagnoses of AD which is also 
preferred by the National Institute for Health Care and Excellence in the UK (Albert et al. 
2011; Sperling et al. 2011; McKhann et al. 2011; NICE 2016).  As current methods of 
assessing biomarkers for AD are invasive and expensive, the search for alternatives is 
underway.   
 
1.2.1 Pathophysiology of Alzheimer’s Disease 
As mentioned above, the concrete diagnosis of AD requires both the presence of 
irregularly folded senile Aβ plaques and NFTs of hyperphosphorylated tau protein in the 
brain.  The leading causal theory of AD development is that of the Amyloid Cascade 
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Hypothesis (Hardy and Selkoe 2002; Karran et al. 2011).  This theory, which has been 
established for over two decades, states that Aβ deposition in the brain is the first step in 
the development of AD (Hardy and Selkoe 2002; Normando et al. 2009; Karran et al. 
2011).  These deposits subsequently lead to synaptic and neuritic injury, oxidative 
stress/injury, NFTs and finally dementia (Hardy and Selkoe 2002).  The genes involved in 
the production of Aβ are those that encode for the Amyloid Precursor Protein (APP), 
Presenelin-1 (PSEN1) and Presenelin-2 (PSEN2) proteins.   
 
Beta-amyloid is a polypeptide consisting of 38 to 43 (commonly 38, 40 & 42) amino acid 
residues (Walsh and Selkoe 2007; Normando et al. 2009).  Aβ derives from the APP whose 
gene exists on the 21st chromosome (Webb and Murphy 2012).  Despite some uncertainty 
about the function of APP, it is hypothesized that it plays a role in processes such as 
neuronal survival, formation of synapses, and dendritic integrity (De Strooper and Annaert 
2000; Tyan et al. 2012).  APP is initially cleaved into smaller proteins by either α-secretase 
or β-secretase (BACE1) enzymes; the latter is responsible for the formation of Aβ. Firstly, 
BACE1 cleaves the protein into soluble APP (s-APPβ) and C99 membrane bound protein; 
C99 is then cleaved by γ-secretase to form Aβ (Walsh and Selkoe 2007; Normando et al. 
2009; Karran et al. 2011). The specific amino acid length of Aβ depends on where C99 is 
cleaved.  It is important to note that although Aβ production is normal (Haass et al. 1992; 
Seubert et al. 1992; Shoji et al. 1992), it is an overproduction of the polypeptide that leads 
to detrimental effects (Walsh and Selkoe 2007).  It should also be noted that while all Aβ 
lengths are capable of binding to one another, Aβ42 is the most damaging as it is more 
prone to forming oligomers, and subsequently senile plaques, in AD (Burdick et al. 1992; 
Jarrett et al. 1993; Walsh and Selkoe 2007).  Figure 1.2.1 outlines the cleavage of APP to 





 The genetics of AD are complex with over 20 genetic loci that have been associated with 
increased risk of developing the disease (Scheltens et al. 2016).  The major genetic risk 
factor is for those homozygous with the E4 allele of Apolipoprotein (APOE4); lifetime 
risk is increased to 51% for males and 60% for females, whereas risk without reference to 
the APOE genotype at 85 years of age is only 11% in males and 14% in females (Genin et 
al. 2011).  Those heterozygous for APOE4 and APOE3 have a risk of AD increase 
ranging from 20-30% (Genin et al. 2011).  Amongst other effects, APOE4 reduces Aβ 
clearance from the brain and is broken down into neurotoxic fragments (Scheltens et al. 
2016).  In familial AD, that which occurs before the age of 65 years and with a hereditary 
link, mutations in APP, PSEN1 and PSEN2 are risk factors (Bertram and Tanzi 2008).  
PSEN1 and 2 are genes that encode the proteins at the catalytic centres of γ-secretase 
Figure 1.2.1 The processing of APP.  The left side of the figure shows the non-
amyloidogenic pathway where Aβ is not generated (APP cleaved by α-secretase).  The 
right side shows the amyloidogenic pathway where Aβ is generated (APP cleaved by β-
secretase). Image taken from Normando et al. (2009). 
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enzymes and mutations, along with those in APP, are thought to increase production and 
aggregation as well as reduce clearance of Aβ (Bertram and Tanzi 2008; Scheltens et al. 
2016).   
 
1.2.2 Biomarkers in Alzheimer’s Disease 
Although a definitive diagnosis of AD can only be made post-mortem, there are various 
biomarkers that are currently used to aid in the diagnosis of the disease.  These consist of 
bodily fluids as well as brain imaging.  Cerebrospinal fluid can be extracted through a 
lumbar puncture and measured for Aβ42, total tau and phosphorylated tau (Blennow et al. 
2010; Scheltens et al. 2016).  Aβ42 levels represent cortical amyloid deposition, whereas 
total tau is a measure of the intensity of neurodegeneration, and phosphorylated tau 
correlates with NFTs (Blennow et al. 2010). CSF biomarkers are highly accurate with a 
sensitivity and specificity of 85-90% at mild AD stages, and can virtually exclude the 
diagnosis of AD when at normal levels in patients with mild cognitive impairment 
(Scheltens et al. 2016).  Until recently, the measurement of CSF biomarkers varied across 
laboratories and therefore, normal values were not available.  This has been rectified by the 
use of mass-spectrometry to determine validated and standardised values (Leinenbach et al. 
2014).   
 
Brain imaging using either computed tomography (CT) or magnetic resonance imaging 
(MRI) is commonly conducted at least once in dementia diagnosis to rule out other causes 
of cognitive impairment (Scheltens et al. 2016).  These imaging technologies can also show 
diagnostic changes that help identify AD, including medial temporal atrophy in typical AD 
and parietal atrophy in those with posterior cortical atrophy, an atypical presentation of the 
disease (Frisoni et al. 2010; Lehmann et al. 2012).  Positron emission tomography (PET) is 
also used to aid in the diagnosis of AD.  Specifically, a radioactive tracer 18F-
fluorodeoxyglucose used with PET can assesses glucose uptake of neurons and glial cells 
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to measure synaptic dysfunction; this will signal AD if positive results are found in 
diagnostic areas of the brain and exclude dementia if results are negative (Scheltens et al. 
2016; Yang et al. 2012).   
1.2.3 The Eye as a Biomarker for Alzheimer’s Disease 
The above-mentioned methods of biomarker detection are invasive (CSF and PET) or 
expensive to perform and therefore, are not effective as tools for disease screening (Yang 
et al. 2012; Kerbage et al. 2014).  The eye has been suggested as a site where AD 
biomarkers could possibly be measured in a non-invasive and simple manner.  A variety of 
studies have been conducted to visualise Aβ in the retina and crystalline lens; these are 
discussed below. 
1.2.3.1 Aβ and the Retina 
As the retina is an extension of the central nervous system, various studies in both animals 
and humans have queried as to whether Aβ is detectable in this structure.  Animal studies 
have mainly focused on the presence of Aβ in various layers of the retina. In a rat model 
of ocular hypertension (OHT), raised intraocular pressure (IOP) was associated with Aβ 
accumulation in retinal ganglion cells (McKinnon et al. 2002).  Through similar research 
with rats, Guo et al. (2007) also noted increased Aβ deposition in the same area. Similar 
studies of AD and Aβ have also been conducted in mice.  Ning et al. (2008) studied retinal 
degeneration in two transgenic mice strains that over-produced APP; Aβ was detected in 
the retinal nerve fibre layer (RNFL), ganglion cell layer (GCL) as well as the 
microvasculature of the retina and choriocapillaris. Another study in transgenic mice that 
overexpressed APP also found the presence of Aβ in the eye - specifically in the outer 
plexiform and inner nuclear layers of the retina (Perez et al. 2009).  Building on the above 
study, Liu et al. (2009) investigated Aβ in the eyes of yet another mutant mouse model of 
AD; the polypeptide was detected in the optic nerve head, GCL, inner plexiform layer, 
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outer nuclear layer and photoreceptor outer segment.  More recently, Ito et al. (2012) 
carried out a study investigating Aβ in the eye using non-human primates.  The researchers 
induced monocular OHT, and subsequent glaucoma, in seven cynomolgus monkeys to 
study any associated deposition of Aβ42 in the retina.  After enucleation of the eyes and 
histological examination, Aβ42 was found in the NFL, GCL and ONH of the eyes with 
induced glaucoma. 
Results from studies that have been carried out in humans are not so clear compared to 
those achieved in animal models.  Ho et al. (2014) conducted a post-mortem study 
examining 11 eyes using immunohistochemistry to detect the presence of AD biomarkers, 
and found no trace of Aβ in the retina.  Similar research by another group also found no 
presence of Aβ in post-mortem AD retinas however, only two eyes were analysed in the 
study (Leger et al. 2011).  A recent study, differing from the above two by analysing whole 
rather than partial retinal mounts, found the presence of Aβ plaques in the inner retinal 
layers of eight AD and five AD suspects (Koronyo-Hamaoui et al. 2011).  Studies have also 
found subretinal Aβ plaques contained in drusen of AD eyes (Dentchev et al. 2003; Isas et 
al. 2010).  The most recent post-mortem study examining Aβ presence in the AD retina 
found no traces in any of the 30 eyes analysed (Williams et al. 2017).  The above summary 
demonstrates the complex nature of AD and much work needs to be done to determine 
whether the retina can be used as a biomarker for the disease. 
1.2.3.2 Aβ and the Crystalline Lens 
As outlined in section 1.1 the crystalline lens in subject to oxidation, protein aggregation 
and age-related changes leading to cataract.  This has naturally led to the structure being 
investigated in relation to AD and Aβ accumulation.  Studies conducted in humans, 
monkeys and rodents have shown the presence of Aβ in the lens.  In an in-vitro study, 
Frederikse et al. (1996) exposed monkey, rodent and human lenses to oxidative stress in 
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Figure 1.2.2 Stereoscopic slit-lamp images showing supranuclear cataract from an 80-
year-old participant with AD (left) and a control lens from an 80-year-old participant 
showing no supranuclear cataract.  Image taken from Goldstein et al. (2003). 
the form of UV radiation and hydrogen peroxide.  Immunohistochemical analysis revealed 
low baseline levels of Aβ that subsequently increased after exposure to oxidative stress 
(Frederikse et al. 1996); in human lenses, Aβ was detected in the cataractous cortical area of 
the lens although the authors failed to state how many lenses were analysed.   
Spurred on by the findings of the above study Goldstein et al. (2003) conducted post-
mortem examinations on nine crystalline lenses and brains from individuals diagnosed 
with AD, and compared the results to eight non-AD controls. After immunohistochemical 
analysis, the authors found similar concentrations of Aβ in the lenses as compared to the 
brain.   By comparing an additional four lenses from AD donors to four control lenses, 
histology revealed that Aβ was exclusively located in the cytoplasm of deep cortical lens 
fibres.  A surgical microscope was used to image all lenses and the authors found that deep 
cortical cataracts were consistently present in the AD lenses but not in those from control 
eyes.  Goldstein et al. (2003) termed these cataracts ‘supranuclear’ and claimed them to be 
distinguishable from age-related cataract and therefore, pathognomonic of AD. The 
supranuclear area has been described as the interface between the deep cortical layers and 
superficial nucleus of the crystalline lens (Chylack et al. 1983). Figure 1.2.2 shows an 
example of the supranuclear opacities found by Goldstein et al. (2003).         






Other authors report contradictory findings to the above study.  Michael et al. (2013) used 
similar immunohistochemical techniques in a post-mortem study of 39 AD crystalline 
lenses and 15 controls, and failed to identify Aβ in any lens.  The authors noted a 
limitation in their study was that many of the AD donors had been diagnosed by general 
practitioners instead of specialists and did not have their diagnosis confirmed post-mortem 
in contrast to Goldstein et al. (2003)’s protocol. The group also highlighted other variations 
in study protocol that may have led to differences in the results compared with those of 
Goldstein’s group (Michael et al. 2013).  To further their work, Michael’s group used 
confocal Raman microspectroscopy on seven post-mortem lenses and matching 
hippocampal tissues from AD donors (Michael et al. 2014). Raman microspectroscopy is 
sensitive to the beta-sheets of Aβ fibrils and the authors detected fibrils in all the 
hippocampal tissues but none of the crystalline lenses (Michael et al. 2014).  The 
researchers note that this technique is not definitive for the absence of Aβ but conclude 
that this evidence, combined with the findings from their previous study, demonstrates 
that Aβ is not present in the AD crystalline lens (Michael et al. 2014).   One more study 
that failed to find Aβ in the AD lens was carried out by Ho et al. (2014).  This group used 
similar immunostaining procedures to Goldstein et al. (2003) and Michael et al. (2013) on 
11 AD donor lenses, six Parkinson’s disease donor lenses and six controls, as well as 
corresponding brain tissues (Ho et al. 2014). 
 
In contrast to the studies not supporting Aβ accumulation in the AD lens, Kerbage et al. 
(2014) developed a new technique to detect lens Aβ in-vivo, and claim to detect its 
presence in the supranuclear region of lenses in AD subjects.  Aftobetin hydrochloride 
(AH) ointment was administered topically to the eyes of 20 probable AD subjects and 20 
healthy volunteers. AH binds to Aβ and fluoresces when stimulated by light with a 
wavelength of 473nm (Kerbage et al. 2014).  The team developed a Fluorescent Ligand Eye 
Scanning Device (FLESD) with a pulsed laser source peaking at 473nm to illuminate the 
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eye, and scan the supranuclear region of the crystalline lens (Kerbage et al. 2014).  After 
excitation with light, fluorescent emission was recorded as a function of time delay 
(Kerbage et al. 2014).  Upon analysis, the FLESD technique correctly predicted a clinical 
diagnosis of AD with 85% sensitivity and 95% specificity (Kerbage et al. 2014); positron 
emission tomography was also conducted on the brains of all subjects and it was 
determined that FLESD was the more accurate technique at predicting AD (Kerbage et al. 
2014).  It is noteworthy that this group, a private company, developed the technology and 
also conducted the research. 
 
An in-vivo study conducted by Bei et al. (2015) again contradicts the findings obtained by 
the studies supporting supranuclear cataract associated with AD.  In this novel study, the 
authors sought to determine whether cataract grade or lens opacity was related to the risk 
of AD in a pre-clinical population.  Forty participants aged 45-years and over with no 
evidence of dementia and two with mild evidence of dementia took part in the study; the 
status of AD biomarkers was determined in each participant through PET and Aβ42 CSF 
analysis (Bei et al. 2015).  The participants then had their lenses graded using the LOCS III 
and densitometry  measured with Scheimpflug imaging (Bei et al. 2015).  Twenty-seven 
participants were negative for AD biomarkers and 15 were positive.  There was no 
statistical significance between biomarker status, cataract or densitometry; furthermore the 
authors did not note any supranuclear cataract morphology (Bei et al. 2015). 
 
As evidenced by the contradictory findings and small sample sizes of the above studies, it 
is obvious that further research is required to determine the exact interface between 
cataract, Aβ and AD.  Despite this, a link between supranuclear cataract and Down 
Syndrome has been suggested (Moncaster et al. 2010).  The following sections will outline 




1.3 Down Syndrome 
1.3.1 General Overview of Down Syndrome 
Down Syndrome is the most common form of chromosomal abnormality and a leading 
cause of intellectual disability in humans. The condition was first described by John 
Langdon H. Down, a British physician, in 1866 however, it would be almost 100 years 
until Lejeune and colleagues used karyotyping to discover that DS is caused by the 
presence of an extra chromosome (Catalano 1990).   
 
1.3.2 Genetics of Down Syndrome 
It is now well known that DS is caused by a third full or partial copy of the 21st 
chromosome. It is a congenital condition for which there is no cure.  There are three 
genetic sub-types of DS: I. Trisomy 21, II. Translocation and III. Mosaicism: 
I. In trisomy 21, all cells in the body contain an extra full copy of the 21st 
chromosome meaning there are a total of 47 chromosomes instead of the normal 
46.  During meiosis, non-disjunction of the 21st chromosome occurs resulting in an 
extra copy of the chromosome in the gamete.  Trisomy 21 is the most common 
form of DS, occurring in 95% of cases (Selikowitz 2008; Bull 2011).  
II. Translocation occurs in 4% of DS cases (Selikowitz 2008; Bull 2011).  In this form 
of DS all cells in the body have a partial extra copy of the 21st chromosome. In this 
form of DS, a Robertsonian translocation occurs between the long arms of 
chromosomes 21 and 13, 14, 15, 21 and 22.  This can either happen in meiosis or 
can be inherited from a phenotypically normal parent with a balanced 
translocation.  
III. The Mosaicism form of DS occurs when some, but not all, cells in the body 
contain an extra copy of chromosome 21.  This is the rarest form of DS, occurring 
in approximately 1% of cases (Selikowitz 2008; Bull 2011).  Unlike the other two 
26 
 
forms of DS, mosaicism is caused after the egg is fertilised and during mitosis 
rather than meiosis.  Mosaicism can occur during early cell division after the 
formation of a normal diploid zygote when a non-disjunction of chromosome 21 
occurs, or can happen from a non-disjunction during mitosis of an embryo that 
was formed from a DS zygote; both of these occurrences will result in a mixture of 
normal diploid cells and cells with trisomy.  
While the trisomy and translocation forms of DS affect individuals with the condition by 
the same degree, the form of mosaicism can have less of an effect on individuals due to 
the presence of normally developed cells mitigating developmental changes (Bull 2011).  
 
1.3.3 Epidemiology of Down Syndrome 
As previously mentioned, DS is the foremost genetic cause of intellectual disability in 
humans (Bell et al. 2003; Stoll et al. 2015).  Recent estimates of the prevalence of DS in the 
United Kingdom have found rates of 6.6 and 6.3 per 10000 people respectively (Wu and 
Morris 2013; Alexander et al. 2016).    
 
Various epidemiological studies on DS throughout the world have all found similar 
incidence levels of approximately 1 to 1.6 per 1000 live-births (Krivchenia et al. 1993; 
Olsen et al. 1996; Forrester and Merz 2002; Lai et al. 2002; Métneki and Czeizel 2005; 
Tagliabue et al. 2007; Loane et al. 2013; Wu and Morris 2013). It should be noted that birth 
prevalence of DS would naturally occur at a higher rate, but prenatal screening and 
abortion have a mitigating effect on live-births (Loane et al. 2013; Alexander et al. 2016).  
For instance, Wu & Morris (2013) noted that although the instance of DS in England and 
Wales from 1989 to 2010 remained relatively constant at 1 per 1000 births, the expected 
live-birth rate should have been over 2 per 1000.  An example of the expected live-birth 
rate can be seen in Ireland, where prenatal screening and termination are not conducted; 
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analysis of DS birth rates from 1981-1990 of four counties in Ireland showed an instance 
of over 1.8 per 1000 births (Johnson et al. 1996).  Similarly, a retrospective study estimating 
the incidence of DS in Northern Ireland showed a minimum rate of approximately 1.7 in 
1000 births (Devlin and Morrison 2004).    
 
1.3.4 Physical Characteristics of Down Syndrome 
There are many differences in physical appearance when comparing an individual with DS 
to a typically developed counterpart.  These phenotypic features can be used by clinicians 
to suspect DS however, definitive diagnosis is determined by chromosome analysis 
(Roizen and Patterson 2003).  Bull (2011) notes that those with DS commonly exhibit 
facial features such as a small brachycephalic head, small mouth and ears, a flat nasal 
bridge and excessive skin at the nape of the neck. The eyes take on a characteristic 
appearance which is described in section 1.4.  Common features of the body include 
hypotonia, a single palmar crease and short fifth finger, and a deep plantar grove located 
between the first and second toes (Bull 2011).  It should be noted that not all phenotypic 
features are present in every individual with DS.   
 
1.3.5 Health Characteristics of Down Syndrome 
There are a variety of systemic and general health conditions associated with DS that vary 
in prevalence and seriousness.  Cardiac defects are common congenital malformations in 
DS with studies reporting a prevalence ranging from 26 to 50% (Selikowitz 1992; Kallen et 
al. 1996; Freeman et al. 1998; Roizen and Patterson 2003; Marder et al. 2015; Stoll et al. 
2015).  These cardiac problems are a major cause of death in the DS population (Marder et 
al. 2015). High prevalence of gastrointestinal disorders at levels greater than 70% are 
present as well as significant levels of obstructive sleep apnoea (30 to 50%) and epilepsy 
(12 to 46%) (Malt et al. 2013).  Individuals with DS are at risk of higher levels of type 1 
diabetes with a prevalence rate ranging from 1.0 to 10.6% (Anwar et al. 1998; Roizen and 
28 
 
Patterson 2003; Esbensen 2010).  Cancer is also more common in DS including a higher 
incidence of leukaemia as well as, amongst others, increased rates of skin cancers, 
gastrointestinal cancers and brain tumours (Sullivan et al. 2007; Malt et al. 2013). Thyroid 
dysfunction, with hypothyroidism being most common, also has a higher incidence in 
people with DS (Roizen and Patterson 2003; Esbensen 2010; Malt et al. 2013). The 
immune system is thought to be deficient in DS causing increased susceptibility to 
infection in those with the condition (Kusters et al. 2009).  Malt, Dahl et al. (2013) 
estimated the prevalence of this tendency of infection to be 100%.     
     
There are high rates of sensory deficits in down syndrome including a prevalence of 
hearing loss ranging from 38-78% (Roizen and Patterson 2003; Malt et al. 2013) and a 
multitude of ophthalmic and vision deficits which will be detailed in later sections.         
 
Life expectancy in those with DS has been steadily increasing from decade to decade.  
After analysing the mortality rates of 17897 people with DS living the USA, Yang et al. 
(2002) determined that the median age at death increased from 25 years in 1983 to 49 years 
in 1997; this amounted to an average increase of 1.7 years annually.  An Australian study 
examining a cohort of 1332 people with DS who had registered with ID services from 
1953 to 2000 showed that life expectancy had increased to 58.6 years with 25% of subjects 
living to the age of 62.9 years (Glasson et al. 2002).  Four distinct age ranges, each with 
common causes for mortality, where revealed by the Australian study: prenatal, childhood 
and early adulthood (0-18 years), adulthood (18-40 years), and senescence (>40 years) 
(Bittles et al. 2007).  While pneumonia and respiratory infection remained as the most 
common cause of death across the entire life span, a shift in comorbidities from congenital 
heart defects in childhood and early adulthood to coronary artery disease and failure of the 
cardiac renal or respiratory systems in senescence occurred (Bittles et al. 2007).  With the 
relatively full lives those with DS now live, coupled with evidence suggesting accelerated 
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aging in the integumentary, immune, sensory, endocrine, musculoskeletal and neurological 
systems, the healthcare focus has shifted from maintaining quality of life to the 
management of treatable illness (Roth et al. 1996; Bittles et al. 2007; Zigman 2013). 
 
1.3.6 Cognitive Characteristics of Down Syndrome 
As DS is the most common genetic cause of intellectual disability, much has been studied 
regarding the cognitive development process in this population.  A variety of traits have 
emerged that are phenotypic of the syndrome however, they occur in varying levels across 
individuals (Chapman and Hesketh 2000; Silverman 2007).  In specific regard to 
intellectual disability (ID), the mean IQ in DS has been shown to be 50, with a wide range 
from 30-70 representing a large to borderline deficit (Vicari et al. 2005; Contestabile et al. 
2010; Grieco et al. 2015).  A decline is seen in both IQ and learning rate with age and 
cognitive testing shifts from assessing development to monitoring decline from middle-
adulthood onwards (Patterson et al. 2013; Grieco et al. 2015).  The ability to interpret visual 
rather than verbal information has been shown to be stronger in DS  (Contestabile et al. 
2010; Grieco et al. 2015).  While non-verbal abilities continue to develop throughout 
childhood and into adolescence, the development of verbal ability tends to decline during 
the same period (Grieco et al. 2015).  Studies have shown that syntactic development is 
impaired in DS from early childhood onwards (Silverman 2007).   
 
Both short- and long-term memory problems are also characteristic of DS. Verbal short-
term memory has been shown to be significantly reduced compared to visual-spatial short-
term memory (Jarrold et al. 2009; Patterson et al. 2013).  Individuals with DS display a 
disability in explicit long-term memory: that which requires conscious recollection (Jarrold 
et al. 2009).  Vicari et al. (2005) showed that subjects with DS show much better long-term 




In relation to cognitive characteristics, the anatomical properties of the brain are different 
in those with DS.  Initially comparable in size to typically developing infants up to the age 
of six months, brain size becomes relatively smaller in DS thereafter (Nadel 2003).  Nadel 
(2003) suggests that brain size does not affect intelligence and a smaller brain size may 
simply be due to allometry as individuals with DS are physically smaller.  A more 
significant aspect of the brain in regard to intellectual disability is that certain areas are 
disproportionately smaller than typically developed peers when allometry is accounted for 
(Nadel 2003).  Volumetric MRI studies in DS have shown that the hippocampus and 
cerebellum are the most disproportionally reduced in size, although multiple areas of the 
brain are also smaller, compared to typically developed controls (Beacher and Murphy 
2006).  The diminished hippocampal volume is constant from childhood to adulthood and 
may explain the various deficits in memory performance that occur in DS (Beacher and 
Murphy 2006).  While the cerebellum is associated with motor function, a comprehensive 
understanding of its roles remains to be determined; the reduced volume of this structure 
in DS may explain the degraded motor, language, spatial and other higher cognitive 
functions present in this population (Beacher and Murphy 2006).   
 
It is clear to see that many cognitive and brain changes are present in DS. Further unique 
sequellae to DS are the dementia and Alzheimer’s like brain pathology that occur almost 
invariably.  These are explained below.    
 
1.3.6.1 Alzheimer’s Disease in Down Syndrome 
Coinciding with the above cognitive aspects that occur in DS, a high rate of AD also 
occurs in this population.  As the gene for APP is located on chromosome 21, because of 
its triplication, those with DS produce more of the protein (Prasher 2006; Lee et al. 2017).  
Consequently, studies have detected the presence of senile Ab plaques and NFT in the 
brain of DS adults aged 35 to 40 years and older (Wisniewski et al. 1985; Zana et al. 2007; 
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Lee et al. 2017).  While AD neuropathology is detected in all individuals with DS by the age 
of 40 years, prevalence of dementia ranges from 8% in those aged 35-49, to 55% in those 
aged 50-59 and finally 75% in those above the age of 60 years (Zana et al. 2007).  There are 
several other genes located on chromosome 21 that have also been suggested to play a role 
in the onset of AD in DS. Although the gene for APP is directly related to the 
accumulation of senile Ab plaques, there are genes that contribute to the oxidative stress, 
hyperphosphorylation of tau and neuroinflammation that are also seen in AD (Prasher 
2006; Zana et al. 2007; Hartley et al. 2015; Head et al. 2016; Lee et al. 2017).   
 
While the above evidence shows the close relationship between DS and AD, the actual 
diagnosis of dementia in this population remains very difficult.  The main challenge to 
diagnosis is the pre-existing intellectual disability masking initial symptoms as well as the 
inability to apply tests of cognitive ability and memory traditionally used in typically 
developed adults (Prasher 2006; Prasher et al. 2015; Lee et al. 2017).    As AD diagnosis is 
complex in typically developed adults, the even greater difficulty in those with DS stresses 
the need for reliable biomarkers that would provide objective judgements on the presence 
of the disease.  To this end, as explained in section 1.2.3.2 investigating cataract in AD, the 
crystalline lens has also been examined in DS as a potential site for Ab accumulation.  
There are a variety of ophthalmic conditions, including cataract, that have been 









1.4 Ophthalmic Characteristics of Down Syndrome 
1.4.1 External Eye 
There have been many findings in regard to the exterior eye in DS.  Most notably is the 
upward and outward slanting of the palpebral fissure and associated smaller width of the 
palpebral aperture (Lowe 1949; Jaeger 1980; Catalano 1990).  It has also been noted that 
individuals with DS have epicanthal folds at a higher prevalence than their typically 
developing peers (Catalano 1990; daCunha and Moreira 1996; Fong et al. 2013). Catalano 
(1990) stated that epicanthal folds in DS may differ structurally from typically developing 
individuals. There are fairly frequent reports of higher rates of blepharitis in DS (Jaeger 
1980; Shapiro and France 1985; Catalano 1990; daCunha and Moreira 1996; Fong et al. 
2013), which may be connected with atopic tendencies, and Catalano (1990) surmised that 
the blepharitis may be due to decreased ability to fight infection. Additionally, Filipello, 
Cascone et al. (1997) have concluded that the reduced density of conjunctival goblet cells 
found in individuals with DS may also increase susceptibility to anterior segment eye 
infections.    
 
Specific to spectacle fitting, the above-mentioned facial features have been shown to 
require careful frame selection when dispensing eyewear to those with DS.  Woodhouse et 
al. (1994) determined that DS children above the age of 14 years had a significantly smaller 
pupillary distance than controls; accounting for facial morphology, the following frame 
measurements were also different compared to controls: a smaller apical radius, larger 
splay angle, lower crest height and shorter front-to-bend (Woodhouse et al. 1994).   
 
1.4.2 The Cornea 
The cornea is the transparent and avascular primary refractive surface of the eye. It is 
comprised mostly of collagen whose fibrils are arranged in a highly ordered pattern.  Until 
recently, the cornea was thought to consist of five distinct layers: the epithelium, 
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Bowman’s layer, the stroma, Descemet’s membrane and the endothelium; however, in 
2013 Dua, Faraj et al. described a sixth layer resting between the stroma and Descemet’s 
membrane.  The cornea is a prolate ellipsoid in shape with an average central thickness of 
530 microns and approximate anterior horizontal and vertical diameters of 12mm and 
11mm respectively (Remington 2012). Compared to typical values, increased steepness in 
corneal curvature, a thinner cornea and higher levels of astigmatism have also been 
reported in the DS eye (Haugen, Hovding and Eide 2001; Evereklioglu et al. 2002; Vincent 
et al. 2005; Little, Woodhouse and Saunders 2009).   
 
A higher prevalence of keratoconus, a disease that results in progressive thinning and 
steepening of the cornea, has been reported in DS (Cullen and Butler 1963; Jaeger 1980; 
Catalano 1990; Doyle et al. 1998; Woodhouse, Griffiths, et al. 2000). After this initial 
discovery, it was later found that corneal hydrops also exist at a higher rate in those DS 
individuals with keratoconus (Catalano, 1990).  Catalano (1990) suggested that excessive 
eye rubbing, a risk factor for keratoconus, may also play a role in this population; it was 
also suggested that irritation from blepharitis can cause increased eye rubbing.     
  
1.4.3 The Iris 
There have been many reports of Brushfield spots which are defined as speckles of 
condensed collagen in the anterior iris stroma (Jaeger 1980; Catalano 1990).  Jager (1980) 
reported a prevalence of these phenomena at 59% in DS compared to 10% in controls and 
noted a decreased likelihood of them occurring with increasing iris pigment. Berk et al. 
(1996) also noted less prevalence of these spots in darker coloured irides but found a lower 
overall prevalence of 36%.   It has been noted in various studies that the presence of 
Brushfield spots is more prevalent in Caucasian DS populations compared to Asian 




1.4.4 The Crystalline Lens 
In their study of young adults with DS, Haugen et al. (2001) noted decreased levels of 
crystalline lens thickness (3.27+/-0.29 mm) and mean calculated lens power (17.70+/-2.36 
D) when compared to typically developed controls, whose values were 3.49+/-0.20 mm 
and 19.48+/-1.24 D respectively; the authors also found significantly higher axial density 
of the lens in their DS cohort.   
 
Opacities of the crystalline lens have been reported at a prevalence ranging from 4-72% 
and at an earlier age in DS when compared to a typical population (Jaeger 1980; Catalano 
1990; Hestnes et al. 1991; Berk et al. 1996; daCunha and Moreira 1996; Woodhouse, 
Griffiths, et al. 2000; Kim et al. 2002; Liza-Sharmini et al. 2006; Wong and Ho 1997; 
Fimiani et al. 2007; Krinsky-McHale et al. 2012; Fong et al. 2013) (Table 1.4.1).  This wide 
range of reported values is conflicting and results from cursory and qualitative evaluation 
of lens opacities in this population. Perhaps as the range of serious sensory, neurologic, 
systemic and physical conditions is so great in DS, the study of cataract has been given less 
importance. It has also been reported that DS individuals are prone to congenital cataracts 
of a cerulean (blue-dot) type (Jaeger 1980; Catalano 1990; Fong et al. 2013). Although most 
studies on the ocular manifestations of DS have reported increased cataract prevalence, 
they do not often detail its type and location/severity.  Furthermore, the definition of 
cataract varies by study with some only reporting cataracts when vision was affected and 









Table 1.4.1: Studies of Lens Opacity in DS. 
Authors Date Number of Participants 
Age Range 
(Years) Prevalence 
Jaeger 1980 74 15-64  55% 
Hestnes et al. 1991 30 21-72 50% 
Berk et al. 1996 55 0.17-25 20% 
daCunha et al. 1996 152 0.17-18 13% 
Wong & Ho 1997 140 0.25-13 4% 





Kim et al. 2002 123 0.5-14 13% 
Liza-Sharmini et al. 2006 60 0.08-17 13% 
Fimiani et al. 2007 157 0.08-18 11% 
Krinsky-McHale et 
al. 
2012 455 30-80+ 42% 
Fong et al. 2013 91 30-56 73% 
 
 
1.4.4.1 Beta-Amyloid and Cataract in Down Syndrome 
Due to the previously mentioned link between AD and DS, the blue-dot cataract type 
reported in DS, and the exploration of cataract as a potential biomarker for AD, the same 
group who detected the presence of Ab in supranuclear lens opacities conducted a study in 
a cohort of DS subjects.  Following on from their study in AD [(Goldstein et al. 2003)], 
Moncaster et al. (2010) obtained crystalline lenses from DS patients who underwent 
cataract surgery (n=3), post-mortem DS specimens (n=12), and post-mortem non-DS 
controls (n=34).  Lenses were visually assessed for cataract using slit-lamp biomicroscopy 
and then underwent a battery of immunohistochemical analyses to detect the presence of 
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Figure 1.4.1 Slit-lamp images showing no cataract in a lens from a 2-year-old (E) and 
progressively worse supranuclear cataract in 42-year-old (F), 61-year-old (G) and 64-year-old 
(H) adults with DS.  Images taken from Moncaster et al. (2010). 
Ab (Moncaster et al. 2010).  Slit-lamp biomicroscopy revealed the supranuclear cataract 
phenotype in all surgical and post-mortem adult DS lenses; furthermore, the authors claim 
that the severity of supranuclear opacification increased with age (see figure 1.4.1); 






Amyloid histochemical analysis of the DS lenses showed positive Congo red staining and 
intense apple-green birefringence suggesting Ab pathology; none of the control lenses 
were positive for staining (Moncaster et al. 2010).  The amyloid pathology present in the 
histochemically stained lenses was co-localised with the supranuclear cataract in the deep 
cortical layers (Moncaster et al. 2010).  Immunogold electron microscopy and mass 
spectrometry supported these findings in DS and control lenses (Moncaster et al. 2010).  
Moncaster et al. suggest that their data align with their previous findings of Ab 
accumulation in the lens of AD participants and that supranuclear cataract may suggest the 
earliest signs of AD pathology.  This is in contrast to the studies (mentioned in section 
1.2.3.2) conducted by unrelated groups that refute these findings. 
 
Although increased prevalence of cataract has been reported in DS individuals, as 
previously stated, little research has been conducted on its morphology and severity.  The 
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conflicting evidence of the presence of Aβ in the crystalline lenses of those with AD and 
DS has not addressed this.  The studies that are positive for the presence of Aβ in the 
crystalline lens report its existence in a specific supranuclear area (Kerbage et al. 2014, 
Goldstein et al. 2003, Moncaster et al. 2010), but it is unknown whether cataracts exist in 
this location in the DS eye in the absence of AD. 
 
1.4.5 The Retina in Down Syndrome 
The retina consists of light sensitive neural tissue lining the interior surface of the eye, its 
supporting structures and blood vessels.  It is formed of ten distinct layers.  Nerve fibres 
from the retina congregate at the optic nerve head, enter the brain through the optic nerve, 
are split through partial decussation at the optic chiasm, travel to the lateral geniculate 
nucleus and finally divide into optic radiations which proceed to the occipital cortex. 
Adding to the battery of conditions reported in the DS eye, retinal changes have also been 
noted. The properties of the retina in DS have also had limited attention in the literature 
but include reports of increased vascularisation at the optic nerve head (Williams et al. 
1973; Sherk and Williams 1979; Jaeger 1980; Berk et al. 1996; Kim et al. 2002), optic disk 
elevation (Al-Hemidan et al. 1999; Catalano and Simon 1990) and case reports of macular 
coloboma (Yamaguchi and Tamai 1990; Hayasaka and Hayasaka 2004).  Recently, Stirn 
(2012) noted that, out of a cohort of 65 children with DS, 16.9% had retinal vessel 
abnormalities, 9.2% had a hypoplastic fovea and 6.1% had optic disc pallor. 
 
Modern imaging techniques such as OCT have been seldom used to examine the retina in 
DS.  Recently Laguna et al. (2013) investigated retinal thickness in five eyes from three 
individuals with DS and reported an increased thickness especially in the foveomacular 
region.  Fong et. al. (2013) measured retinal nerve fibre layer thickness by scanning the 
optic nerve head with OCT in three DS eyes and found it to be normal.  Most recently, 
O’Brien et al. (2015) performed macular OCT scans on 17 children with DS aged 6-16; 
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when compared to controls, the central subfield thickness as well as inner and outer retinal 
layer thickness were significantly greater in DS. Beyond these three aforementioned 
studies, there are no detailed analyses of retinal structure using OCT in the DS eye.   
 
1.4.6 Strabismus in Down Syndrome 
Strabismus, or heterotropia, is an involuntary misalignment of the visual axes of the two 
eyes when a person is fixating on an object.  Deviations of the eyes can be medial 
(esotropias), lateral (exotropias) or vertical (hyper/hypotropias) in orientation. There are 
many reports of strabismus in DS with prevalence ranging from 19-42% (Jaeger 1980; 
Berk et al. 1996; daCunha and Moreira 1996; Haugen and Hovding 2001; Cregg et al. 2003; 
Liza-Sharmini et al. 2006; Yurdakul et al. 2006; Fimiani et al. 2007; Kim and Hwang 2009; 
Ljubic et al. 2011; Krinsky-McHale et al. 2012; Fong et al. 2013).  All studies agree that 
esotropia is more common than exotropia and vertical deviations in those with DS; Kim 
and Hwang (2009) had an unusually high prevalence of exotropia in their cohort at 10.5% 
however, this was still well below the prevalence of esotropia (22.1%).  In contrast to 
typically developing children, Cregg et al. (2003) as well as Kim and Hwang (2009) did not 
find strabismus to be related to refractive error.   
 
1.4.7 Nystagmus in Down Syndrome 
Nystagmus is an involuntary pendular or oscillating movement of the eyes that often 
results in reduced vision. It has also been shown that the prevalence of nystagmus is 
increased in DS with values ranging from 6% to over 33% (Jaeger 1980; Berk et al. 1996; 
daCunha and Moreira 1996; Liza-Sharmini et al. 2006; Fimiani et al. 2007; Kim and Hwang 
2009; Ljubic et al. 2011; Krinsky-McHale et al. 2012; Fong et al. 2013).   Wagner et al. (1990) 
characterised nystagmus in 188 DS participants, found a 29.8% prevalence and noted that 




1.5 Vision in Down Syndrome 
1.5.1 Visual Function in Down Syndrome 
Aside from the many ophthalmic features of DS, there are many differences in visual 
function.  Studies have been carried out to analyse visual acuity, refractive error and 
amblyopia in this population.  Of the studies of visual acuity in DS, they have all found 
reduced VA levels in those with DS when compared to controls.  Courage et al. (1994) 
evaluated visual acuity using Teller acuity cards in children with DS aged two months to 18 
years and found it to be reduced compared to age matched controls; this reduction was 
still present when ocular abnormalities were accounted for.  Woodhouse et al. (1996) 
found reduced VA in a cohort of 53 children with DS and found that although normal 
visual development occurred before the age of two years, it was reduced from then on; the 
authors surmised that the reduction in VA in DS could very well be due to physiological 
changes in the visual cortex.  In a study examining amblyopia, Tsiaras et al. (1999) 
examined visual acuity in 68 children with DS aged between five and 19 years; 47% of 
these participants had VAs between 20/30 to 20/40 while 31% and 24% had less than 
20/50 in one or both eyes respectively. In a study designed to determine whether the 
reduced VA detected in DS was due to cognitive or behavioural deficits masking true 
levels, John et al. (2004) utilised visually evoked potential (VEP) to measure visual 
function; it was found that DS subjects exhibited poorer measures of VEP acuity than 
those obtained with behavioural techniques.  This finding provides additional confirmation 
that a physiological deficit contributes to reduced VA in the DS population and that poor 
visual performance cannot be attributed solely to attentional and motivation issues in DS.  
  
While the above studies demonstrate a true reduction of visual acuity in DS compared to 
age matched controls, they did not clarify whether the differing optics of the eye in DS 
play a role in this.  To test this, Little et al. (2007) used grating resolution acuity and 
interferometric acuity analyses to measure VA in a cohort with DS.  The authors found a 
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larger difference in grating acuity compared to interferometric acuity in those with DS 
when compared to age-matched controls.  This suggests that the optics of the eye in DS 
do not wholly account for but do play a large role in the reduced VA that is found in this 
population.  To add further confirmation of the sensory deficit that contributes to VA 
reduction in DS, Little et al. (2009) measured Vernier acuity in 25 children with DS and 
found it to be reduced by a factor of 2.7 when compared to 65 age-matched controls.  
Reduced Vernier acuity was also found in a small study (n=5) of Adult participants with 
DS (Krinsky-McHale et al. 2014).   
 
Another important measure of visual function is contrast sensitivity.  In contrast to the 
above studies of VA, there have been few studies of CS in DS populations.  Courage et al. 
(1997) first assessed contrast sensitivity in children with DS and found it to be reduced 
compared to age-matched normals; furthermore, the reduction increased with increasing 
spatial frequency.  There was also little improvement in CS with age.  In a more thorough 
assessment of CS, John et al. (2004) assessed CS with behavioural and VEP tests.  This 
study demonstrated reduced CS in both VEP and behavioural measures for the DS group 
of participants when compared to controls; the deficit remained after ocular abnormalities 
were accounted for.  Finally, Krinsky-McHale et al. (2014) measured spatiotemporal CS in 
seven adults with DS and found a generalised reduction when compared to younger and 
older adults without intellectual disability.  These studies of CS in DS all suggest a sensory 
component to the reduced visual function observed in DS.  
 
1.5.2 Refractive Error in Down Syndrome 
Like the differences in visual function that are present in DS, there are many reports of 
increased refractive error (Shapiro and France 1985; Caputo et al. 1989; Hestnes et al. 1991; 
Berk et al. 1996; daCunha and Moreira 1996; Woodhouse et al. 1997; Haugen, Hovding and 
Lundstrom 2001; Kim et al. 2002; Cregg et al. 2003; Liza-Sharmini et al. 2006; Fimiani et al. 
41 
 
2007; Kim and Hwang 2009; Ljubic et al. 2011; Fong et al. 2013).  While most studies 
report a higher prevalence of hyperopia, there are some reports of similar prevalences of 
myopia and hyperopia (Shapiro and France 1985; Caputo et al. 1989; Liza-Sharmini et al. 
2006; Kim and Hwang 2009).  Interestingly, Fong et al. (2013) reported a higher incidence 
of myopia (59.3%) compared to hyperopia (30.2%) in a cohort of individuals with DS aged 
30 years and older; this contrasts with most studies that have been conducted in younger 
populations. All studies also report high prevalence of astigmatism. The varying prevalence 
between studies may be due to the different criteria used to define refractive error, varying 
age-ranges between cohorts as well as differing techniques used to measure refractive 
error. 
 
1.5.3 Accommodation in Down Syndrome 
There have been various reports of reduced accommodative ability in DS.  Woodhouse 
and colleagues used modified Nott retinoscopy as an objective technique of assessing 
accommodation in a group of 24 children with DS and found it to be significantly reduced 
compared to controls (Woodhouse et al. 1993).  Following on from this, Woodhouse et al. 
(2000) found a similarly large level of under-accommodation in a group of 77 children with 
DS with a mean reduction of at least 50% at all testing distances when compared to 
controls; increasing under-accommodation with increasing age was also found to be 
significant.  The authors did not determine the aetiology of under-accommodation in DS 
but postulated that it may be due to a sensory or motor deficit.  Following on from the 
previous study, it was discovered that under-accommodation was present in DS regardless 
of refractive status however, increasing under-accommodation occurred with increasing 
hyperopia (Cregg et al. 2001); interestingly, spectacle correction of hyperopia did not 
improve accommodation.  In a later study, it was found that bifocal spectacles improved 
accommodative responses in DS (Stewart et al. 2005). Surprisingly, the reduced lag of 
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accommodation remained when the participants viewed objects through the distance 
portion of their bifocal spectacles. 
   
To try and understand the aetiology behind the lag in accommodation that occurs in DS, 
Doyle et al. (2016) recently examined the near triad using a photorefraction system in a 
cohort of 24 children with DS and 75 controls.  Participants with DS had a significantly 
lower mean accommodative response to accommodative demand; however, they 
demonstrated a very similar mean vergence response compared with typically developing 
controls.  There was a significant difference in pupillary response to accommodative 
demand at 5D between the DS and control groups with controls showing greater 
constriction but baseline diameters were similar between groups.  These data add 
additional support to the assertion made previously that the under-accommodation found 
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1.6 Summary of Introduction and Aims of Thesis 
 
The above literature review has shown the complexity of AD, its relation to DS and the 
need for simple non-invasive biomarkers for its diagnosis.  While supranuclear cataract has 
been suggested as a site for Aβ accumulation, there is conflicting evidence that precludes it 
as a definitive biomarker for AD.  This is further weakened by the presumption of 
supranuclear cataract being characteristic of DS. While the above literature review 
discusses the numerous ophthalmic and visual sequalae that occur in DS, and shows that 
many have been studied in detail, there is a specific paucity of comprehensive analyses of 
lens opacity, with widely varying and vague reports of its morphology and presence in the 
population.  This is most likely due to current methods of cataract grading being only 
applicable to age-related forms of the condition, as well as their unsuitability for use in 
those with intellectual disability.  There is a need to undertake a detailed structural analysis 
of cataract in DS, but this requires an objective method of examining and quantifying 
opacity at any location within the crystalline lens.   
 
The aim of this thesis is to profile, for the first time, presence, severity type and location of 
cataract in the DS eye.  In order to accomplish this, an objective method of imaging and 
quantifying opacity within any location of the crystalline lens will be developed using in-vivo 
anterior-segment optical coherence tomography in typically developed adults and validated 
against the slit-lamp based LOCS III. By then applying this new technique to a cohort of 
children and adults with DS, a detailed structural profile of cataract can be obtained.  
Finally, as an adjunct to the above, posterior-segment optical coherence tomography will 





Chapter 2: General Imaging Methods 
 
The following chapter discusses two techniques used to image the eye throughout this 
thesis. Firstly, the development and current state of optical coherence tomography will be 
outlined and followed on by the specific instruments used in this study.  Secondly, a 
method developed to modify a slit-lamp biomicroscope that was used for the traditional 
assessment and grading of cataract will be described.   
 
2.1 Optical Coherence Tomography 
Optical coherence tomography is a non-invasive and non-contact in-vivo medical imaging 
technique that can be thought of as analogous to B-scan ultrasound.  Instead of using 
acoustics to image transparent and near-transparent biological tissue, OCT creates 
tomograms through the measurement of backscattered light produced from a coherent, 
broadband light source.  These cross-sectional images are micron resolution and quick to 
obtain.  As a result, OCT has evolved to become the standard of care in diagnosis and 
management of many ocular diseases.  The following sections will outline this technology 
and its current use in the ophthalmic and vision sciences.   
 
2.1.1 History of Optical Coherence Tomography 
The origins of this technique came about through the development of femtosecond optics 
and its application to compute ex-vivo A-scan measurements of a bovine eye through 
analysing optical echo (Fujimoto and Swanson 2016).  A team of researchers from the 
Massachusetts Institute of Technology (MIT) then, as a means of reducing cost and 
simplifying manufacturing, replaced femtosecond optics with interferometry based on 
earlier studies by other groups using the technique to image biological tissue (Fercher et al. 
1988; Fujimoto and Swanson 2016).  Ongoing work led to the first published B-Scans of 
the ex-vivo eye and coronary artery (Huang et al. 1991).  It was then that this technology 
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became officially coined as Optical Coherence Tomography.  At this point, the technology 
was slow, taking minutes to complete a scan and therefore, not yet feasible as an in-vivo 
technique (Huang et al. 1991).  OCT was then refined by the MIT team using fibre optics 
and other sophisticated techniques to derive a slit-lamp based imaging system capable of 
capturing in-vivo images (Fujimoto and Swanson 2016). This faster system produced the 
first reports of in-vivo retinal and anterior segment images (Swanson et al. 1993; Izatt et al. 
1994).  Following this, a series of studies were conducted to image and characterise many 
retinal diseases over the mid to late 1990s (for a review see Fujimoto and Swanson 2016).  
Eventually, the spinoff company formed by MIT was purchased by Humphrey Zeiss and 
the first commercial OCT instrument was released in 1996.  After some time, OCT has 
evolved to become critical in the management of many retinal and anterior segment 
ophthalmic conditions.  There are a variety of manufacturers producing instruments and 
the technology has continued to improve in resolution and scan acquisition time.  The 
following sections will outline the development of OCT technology and its clinical use.     
 
2.1.2 Methods of Optical Coherence Tomography 
All versions of OCT make use of an interferometer and low coherence light source.  The 
interferometer splits the beam of light into a reference arm, which is reflected by a mirror, 
and a sample arm, which is focussed through the tissue structure to be imaged. 
Transparent and semi-transparent tissues can cause backscatter from the sample arm and 
when this is recombined with the reference arm through the interferometer, an 
interference pattern forms; processing the signal of the interference pattern from a 
detector yields a one-dimensional A-scan of the tissue.  Using an optical system to focus 
and move the sample arm laterally, a transverse series of A-scans is taken to form a two-
dimensional B-scan of the desired ocular structure. More recently, OCT instruments have 
gained the facility to combine multiple adjacent B-scans to form three-dimensional images 
of tissue structures.  See the figure below for a schematic of a basic OCT system (figure 
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Figure 2.1.1 Schematic of a generic OCT device.  Image taken from Drexler and Fujimoto 
(2008) 





OCT technology has undergone a series of design evolutions with each producing 
significant improvements in resolution and scan times.  These can be divided into two 
classes of instrument: Time Domain OCT (TD-OCT) and Fourier Domain OCT (FD-
OCT).  FD-OCT can be further classified into Spectral Domain OCT (SD-OCT) and 
Swept Source (SS-OCT) subgroups.  
 
2.1.2.1 Time Domain OCT 
The first instances of OCT were of the time domain type.  TD-OCT generally makes use 
of a Michelson interferometer and a broadband light source.  As mentioned previously, the 
light is split into reference and sample arms.  In TD-OCT, the reference arm is reflected 
by a mirror that moves axially, whereas the sample arm is moved laterally and focused 
through imaged tissue by an optical system.  Back reflected sample arm light from various 
scattering areas of the imaged tissue is recombined with the reference arm; an interference 
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Figure 2.1.2 Schematic of a TD-OCT device showing the oscillating scanning reference 
mirror.  Image adapted from Drexler et al. (2014) 
pattern is generated when the reflected sample arm matches a specific axial location of the 
reference mirror; this provides the depth information for A-scans.  A photodetector then 
sends this interference data to be analysed and processed by a computer. The scanning 
speed of TD-OCT instruments is limited by the maximum oscillating speed of the 
reference mirror (Gabriele et al. 2010). Figure 2.1.2 shows the basic design of a TD-OCT 





2.1.2.2 Fourier Domain OCT 
FD-OCT was developed after TD-OCT as a means of improving resolution and scan 
speed.  FD-OCT differs from TD-OCT in that there is no mechanical movement of the 
reference mirror.  The first FD-OCTs were of spectral domain design and swept source 
technology then followed. 
SD-OCT again makes use of a broadband light source and interferometer however a CCD 
camera and spectrometer take the place of the photodetector that is used in TD-OCT.  All 
depth information is extracted simultaneously by separating the spectrum of the back 
reflected sample and reference arms using a diffraction grating and then processing the 
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Figure 2.1.3 Schematics of FD-OCT devices. The left schematic shows a typical SD-OCT 
system while the right schematic outlines a SS-OCT.  Image adapted from Drexler et al. (2014) 
various spectral interference patterns (Gabriele et al. 2010; Drexler and Fujimoto 2008).  
SS-OCT differs from SD-OCT in that it uses a narrow width laser light source that can 
sweep at high-speed across multiple wavelengths.  A photo-diode then detects the 
interference signal produced by the two optical arms as the light source sweeps across its 
various frequencies over time (Gabriele et al. 2010; Drexler et al. 2014).  In both forms of 
FD-OCT, A-scans are generated through Fourier analysis of the signal from either the 
CCD camera or photo-detector.  It is important to note that the acquisition time of SD-
OCT is limited by the CCD camera’s speed whereas the wavelength-tuning speed of the 
laser is the determining factor in SS-OCT (Drexler et al. 2014).  Figure 2.1.3 demonstrates a 
schematic of SD-OCT and SS-OCT systems.  As TD-OCT acquires A-scans sequentially 
through the sample tissue depth via mechanical movement of the reference mirror, the 
acquisition speed is much slower than FD-OCT where all depths are imaged 
simultaneously (Kiernan et al. 2010).  This means FD-OCT systems are less susceptible to 










2.1.3 Light Source Properties for Effective OCT Imaging 
The wavelength, bandwidth and intensity of light used in the design of various OCT 
instruments are all dependent on intended use.  Most commercial OCTs designed for 
retinal imaging make use of light source centre wavelengths in the 800nm range (Wolfgang 
Drexler and Fujimoto 2008; Gabriele et al. 2010). Typical bandwidths have been 
approximately 25nm in magnitude (Gabriele et al. 2010).  Axial resolution is dependent on 
bandwidth; more specifically, the coherence length of the light source in relation to the 
optical path length of the sample arm is inversely proportional to axial resolution (Drexler 
et al. 2014).  Theoretical axial resolutions of 1µm are possible with ~800nm wavelengths 
however, to achieve this, wide bandwidths of 280nm are required making manufacture of 
the instruments impractical (Drexler 2004).  For light sources with another common 
wavelength of ~1300nm, bandwidths are needed to be even wider to achieve similar axial 
resolutions; for instance, a 180nm bandwidth centred at 800nm would achieve a resolution 
on 1.6µm but this would drop to 4.1µm if the centre wavelength was 1300nm (Drexler 
2004).  It is important to note that these resolutions are theoretical and the dispersion of 
light within, as well as its scattering and absorption by, the imaged tissue all have 
detrimental effects.   
 
Transverse resolution and depth of focus are dependent on an OCT instrument’s imaging 
optics and numerical aperture size rather than light source. Altering the optics to improve 
transverse resolution decreases depth of focus and therefore, these two properties must be 
balanced in the design of OCT instruments (Drexler et al. 2014).  
   
Imaging depth of various OCT instruments depends on whether they are of a TD or FD 
design.  In TD-OCT, depth is dependent on the reference arm travel range whereas the 
light source centre wavelength and spectral resolution are the important factors in FD-
OCT (Drexler et al. 2014). The properties of imaged tissues also have effects on imaging 
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depth.  For instance, due to the melanin content of the retinal pigment epithelium having 
high scattering and absorption properties, many ~800nm OCTs have poor penetration 
past this layer (Wolfgang Drexler and Fujimoto 2008).  Along with melanin, haemoglobin 
content causes most biological tissues to absorb in the visible and near-infrared 
wavelength range (Drexler 2004).  While absorption has a detrimental effect on imaging 
depth, the scattering properties of imaged tissues play an even greater role in affecting this 
property.  At 800 to 1800nm wavelengths, which includes those used in OCT, increased 
scattering from tissue becomes the prominent limiting factor of imaging depth (Drexler 
2004).  Because longer wavelengths of light are scattered less, studies have shown that 
OCT imaging depths of one to two millimetres in most biological tissues are possible at 
optimal centre wavelengths ranging from 1300 to 1500nm (Drexler 2004).  This is not the 
case for the retina where, due to water absorption from the ocular media, the ideal centre 
wavelengths are between 750 and 850nm or ~1060nm (Drexler et al. 2014). As soft tissue 
is comprised of 50 to 90% water, wavelengths greater than 1800nm as well as circa 
1430nm are inefficient for OCT imaging due to strong water absorption at these values 
(Drexler et al. 2014).   
 
Specific to posterior segment imaging of the eye with OCT, light scatter due to cataract 
can have a detrimental effect on imaging (van Velthoven et al. 2006).  As a means of 
improving image quality, Povazay et al. (2007) found that a device operating at a centre 
wavelength of 1050nm was significantly better at imaging the retina through cataract when 
compared to a 800nm instrument.  Esmaeelpour et al. (2010) also compared a 1060nm 
OCT to a commercial 800nm instrument in obtaining choroidal scans of eyes with 
moderate to severe cataract; the authors found that reduced signal strength occurred in 
65% of 800nm images in comparison to only 10% of 1060nm scans.  Although useful in 
eyes with cataract, it is important to note that the increased centre wavelength results in a 
decrease in axial resolution (Esmaeelpour et al. 2010).       
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2.1.4 Recent Advances in OCT  
Since the advent of FD-OCT, continued development of the technology has led to even 
greater utility.  Namely, these have been in the form of OCT angiography (OCT-A) and 
whole-eye OCT.  Blood flow in the eye has been measured using either doppler shift or 
speckle variance techniques to interpret OCT scans of vasculature (Gao et al. 2016).  OCT-
A commonly uses speckle variance as a means of imaging retinal and choroidal 
microvasculature (Gao et al. 2016); the technique relies on a series of B-Scans acquired in 
quick succession which are then analysed by removing the static overlap of tomographs to 
detect the motion of cells within blood vessels (Wang et al. 2007; Gao et al. 2016).  This in-
vivo and non-invasive method of angiography holds many advantages over traditional 
intravenous fluorescein and indocyanine green modalities in the assessment and 
management of age-related macular degeneration and diabetic retinopathy, with its primary 
disadvantage being the inability to measure stationary blood leakage and flow over a time 
course (Gao et al. 2016; Cicinelli et al. 2017).   
 
Lately, efforts have been made to image the entire eye proceeding from the anterior 
chamber through to the retina and choroid. There are various methods that have been 
employed to carry out this whole-eye OCT imaging technique including combining two 
SD-OCT systems, creating customized systems by integrating three separate reference 
arms, and also using two separate beams of light from a single source that are orthogonally 
polarized (Kim et al. 2016; Grulkowski et al. 2018).  Most recently, a whole-eye OCT 
system has been developed using swept-source illumination and a tuneable lens allowing 
variable focal distances to facilitate simultaneous imaging of the cornea, crystalline lens and 
retina (Grulkowski et al. 2018).  While whole-eye OCT systems are, unlike OCT-A, not 
commercially available, their continued development will eventually supplement or replace 
current systems for assessing ocular biometry as well as methods of imaging the entire 
globe, including ultrasound, CT and MRI, which are necessary in the management of 
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conditions such as penetrating foreign bodies and tumours.   
 
2.1.5 OCT Methods to be Used in This Study  
This study will seek to image the crystalline lens and retina using two separate OCT 
systems: the Visante anterior-segment OCT (AS-OCT) (Carl Zeiss Meditec, Germany) and 
the Spectralis posterior-segment OCT (PS-OCT) (Heidelberg Engineering, Germany).  
The following subsections will outline the specifications of each instrument. 
 
2.1.5.1 The Visante Anterior-Segment OCT 
The Visante by Carl Zeiss Meditec was the first anterior segment OCT device to be made 
commercially available.  The instrument is of the time-domain modality and uses a 
superluminescent diode as a light source with its wavelength centred at 1310nm.  The 
Visante AS-OCT is capable of performing B-scans at resolutions of 18µm axially and 
60µm transversely at a frequency of 2000 A-scans per second (Carl Zeiss Meditec n.d.).  
While the instrument has been designed to image the cornea and anterior chamber where 
automated segmentation and calliper tools are available for analysis, a ‘Raw Image Mode’ 
exists for imaging in their absence.  This raw image mode has been shown to effectively 
capture B-scans of the crystalline lens (Richdale et al. 2008; Lehman et al. 2009; Wong et al. 
2009; Doyle et al. 2013; Richdale et al. 2013; Chan et al. 2014; Kymionis et al. 2014).  There 
are two options for capturing B-scans in raw image mode: low-resolution consisting of 256 
A-scans with a length of 16mm and tissue depth of 6mm, and high-resolution consisting 
of 512 A-scans across a 10mm length with a tissue depth of 3mm (Carl Zeiss Meditec 
n.d.).  This thesis used the Visante’s raw image modes to capture B-scans of the crystalline 
lens in all participants; development of custom software enabling the processing, 
subsequent segmentation and analysis of opacification of the instrument’s raw sensor data 
is described in Chapter 3.  Figure 2.1.4 shows the Visante OCT.   
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Figure 2.1.4 The Visante AS-OCT instrument showing its height adjustable table and 
moveable chin and head rests.   
 




2.1.5.2 The Spectralis Posterior-Segment OCT 
A Spectralis (Heidelberg Engineering, Germany) instrument was used in this study to carry 
out PS-OCT imaging on all participants with DS.  This instrument consists of a SD-OCT 
coupled with a confocal scanning laser ophthalmoscope (cSLO).  The cSLO allows en-face 
imaging of the fundus in order to cross reference the location of captured posterior-
segment tomographs.  The Spectralis SD-OCT makes use of a superluminescent diode as a 
light source with a centre wavelength of 870nm.  The Fourier-domain modality of the 
Spectralis allows high speed acquisition times with 40000 A-scans per second and excellent 
resolutions up to 3.9µm axially and 6µm laterally (Heidelberg Engineering 2013).  As the 
light source wavelength is shorter than that of the Visante AS-OCT, the Spectralis PS-
OCT is only able to obtain a scanning depth of 1.9mm in tissue.  Through its TruTrack 
technology, the Heidelberg instrument tracks eye movement in real-time thereby avoiding 
motion artifact and allowing repositioning of the scan to the exact anatomical position on 
the retina should participants blink or move during imaging; this feature is helpful in 
imaging paediatric populations and those with intellectual disability.  Figure 2.1.5 shows 
the Heidelberg Spectralis instrument. 
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Figure 2.1.5 The Spectralis PS-OCT instrument sitting on its height adjustable table with a 
fixed forehead and moveable chin rest. 















2.2 The Modification and Digitisation of a Slit-Lamp Photo-Biomicroscope 
for Imaging the Crystalline Lens 
 
2.2.1 Introduction 
Slit-lamp biomicroscopy is a pivotal tool in ophthalmic practice. A slit-lamp is an upright 
visible light biomicroscope with an adjustable slit-beam that can be varied for width, 
height, intensity, and angle of illumination to the objectives; the instrument provides three-
dimensional cross-sections of the anterior eye structures and, with the use of a condensing 
lens, a stereoscopic view of the retina. Although recent developments in ophthalmic 
imaging technology such as OCT can provide important information for the treatment and 
management of ocular disease, slit-lamp biomicroscopy and photography are, 
comparatively, simple and cost-effective methods of viewing and documenting anterior 
segment pathology.  Slit-lamp biomicroscopy is the primary technique used to diagnose 
and monitor cataract, including grading with the LOCS III (Chylack et al. 1993).  In this 
thesis, the LOCS III method was used to grade cataract as a validation method for the 
development of crystalline lens opacity assessment with OCT.  This required the need for 
a slit-lamp photo-biomicroscope capable of capturing images of high quality and 
resolution. While most slit-lamp biomicroscopes are well made, often consumables such as 
light bulbs fail and, occasionally, replacements have become obsolete rendering the 
instruments useless.  Furthermore, replacing older analog slit-lamps that were capable of 
photography with modern digital versions is an expensive proposition.  The following 
chapter discusses the modification and digitisation of an analogue Nikon FS-3 slit-lamp 
photo-biomicroscope (Tokyo, Japan) used for crystalline lens imaging and LOCS III 
grading in this study.  
 
The Vision Science Research Laboratory at Ulster University was in possession of a Nikon 
FS-3 slit-lamp, which included a Nikon 35mm single lens reflex (SLR) film camera 
connected to a beamsplitter, xenon flashtube and flash controller, thereby facilitating 
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analog ophthalmic photography. Due to the high-quality optics of the slit-lamp, it was an 
ideal instrument for photographing the crystalline lens and performing LOCS III grading 
however, the xenon flashtube had failed and replacements were no longer available from 
the manufacturer or third parties. Successful digitisation of this slit-lamp was achieved by 
replacing the incandescent illumination and xenon flash sources with a single high-
powered LED array, and using an Arduino microcontroller to interface with it, a new 
digital SLR camera and the existing slit-lamp controls/beamsplitter. 
 
2.2.2 Methods 
The existing system setup was comprised of, in brief: a beamsplitter containing a mirror 
connected to a solenoid in front of the right eyepiece that, when actuated, diverted 100% 
of the light downwards, through lens system and another mirror, to focus light onto the 
film of a 35mm camera mounted below the eyepieces (see figure 2.2.1).  The entire process 
of capturing a photograph was automated by pressing a trigger on top of the joystick: the 
beamsplitter’s solenoid-mirror momentarily actuated, the camera shutter fired, its hot shoe 
then triggered the flash controller, which subsequently fired the xenon flash tube for the 
correct exposure.  This design provided high image quality to go along with the superb 






The methods to investigate and develop a digitised photographic system were undertaken 
in four parts. 2.2.2.1: Physical modification of the illumination system. 2.2.2.2: Selection of 
a microcontroller, LED driver and overall system design. 2.2.2.3: Integration of the 
microcontroller, digital camera and illumination system components with the slit-lamp’s 
existing trigger and beamsplitter. 2.2.2.4: Final installation of the components. 
 
Prior to commencement of the study, the choice of digital camera had to be considered.  
The mount on the FS-3 slit-lamp’s beamsplitter was the same as a Nikon F-mount; thus, 
current Nikon digital SLR cameras fit this without any modification and a Nikon D3300 
digital SLR camera was purchased for this task.  The D3300 was mounted onto the 
beamsplitter without any issue and did not interfere with the eyepieces. 
 
2.2.2.1 Physical modification of the illumination system 
The Nikon FS-3 was designed with a dual system of illumination: a dimmable incandescent 
bulb for use by the practitioner, and the previously mentioned xenon flashtube that fired 
Figure 2.2.1 A. Beamsplitter attached to slit-lamp between objective and eyepieces with 
original film camera mounted. B. Unmounted beamsplitter attachment showing the camera 
mount. C. Inside view of the beamsplitter with solenoid/mirror (upper left-hand side) in the up 
position.  D. Mirror in the down position covering the right eyepiece and diverting light 
through the lens/mirror system to the camera mount. 
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for an instant when a photograph was taken.  The incandescent bulb sat atop of a 
condensing lens that focused its element to a point at the centre of the xenon flashtube 
located below. This created a single compact conjugate source for both bulbs.  As the 
flashtube was no longer available, it was decided that a high-powered LED would be used 
to replace both it and the incandescent bulb. The metal housing for the incandescent bulb 
was physically modified to allow a XLamp XHP70 LED array (Cree, Inc., Durham, USA), 
affixed to a fan cooled copper heatsink, to be mounted on top at the plane where the 
element of the incandescent bulb would have been; this allowed the optics of the slit lamp 
to remain unchanged (see figure 2.2.2).  The fused xenon flash tube was removed from the 
slit lamp and the holes where it previously resided were plugged with rubber fittings.   
 
 
Figure 2.2.2 A. Illumination tower showing: (I) Incandescent bulb in its mount; (II) location where 
mount was cut in order to allow the LED/heatsink combination to rest in the correct location; (III) 
Xenon flashtube. B. Xenon flashtube removed showing holes that were plugged with rubber 
fittings. C. Transverse view of illumination tower showing the incandescent bulb mounted above 
its condensing lens. D. LED array mounted to the copper heatsink and fan casing.  E. The 
incandescent bulb mount removed from the illumination tower. The dashed line shows where it 
was cut in order for the assembly in D to be mounted. 
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The decision to use a XHP70 LED array was made upon studying Nikon’s original 
specifications for the FS-3 slit lamp.  Nikon specified the power of the xenon flash to be 
500Ws.  The XHP70 was selected to be powered a by a maximum of 15V DC at 2100mA.  
This would provide a package that was physically small enough to fit above the condensing 
lens while, when fired at full power for 1/60s, delivering a similar brightness to the xenon 
flash fired at 1/1000s through a 0.2mm optic section. Compared to the film speed of the 
original camera, the ISO speed of the D3300 would also be increased to exhibit similar 
exposure levels; this was acceptable due to the low noise generated by modern digital 
camera sensors. 1/60s was considered an acceptable maximum flash speed as it was felt 
that saccades or blink reflexes would cause minimal motion blur during photographic 
capture.  
 
2.2.2.2 Selection of a microcontroller, LED driver and overall system design  
An Arduino microcontroller is an open source hardware device that can be programmed 
using the open source Processing computer language.  The devices are inexpensive, available 
in many configurations and consist of analog and digital pins that can be assigned input or 
output (I/O) functions. Depending on the Arduino model, the I/O pins operate at either 
5V or 3.3V (common logic levels for digital devices) and then interface with other 
electronic components, including sensors and actuators. The Arduino runs two sets of 
code: an initial portion that runs once to assign variables and defines the roles of I/O pins 
when the device is first turned on, and a second code that runs continuously in a loop until 
the device is switched off. This second portion of the code comprises a collection of tasks 
that the Arduino is to perform.  The code is written in a compiler that is freely available 
and then uploaded to the Arduino via USB.     
 
An Arduino Pro Mini device operating at 5V and 16MHz was chosen to act as the main 
control unit for this study. This device had enough I/O pins to interface with an LED 
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driver optocoupler (to initiate maximum LED brightness during photograph capture and 
then return control to an analog potentiometer), solid state relay (acting as a failsafe and to 
turn the LED off during the remainder of the exposure during short flash intervals), slit-
lamp joystick trigger (to initiate the process of shutter release on the camera), beamsplitter 
solenoid, as well as to control the D3300’s remote shutter release (to start the photograph) 
and receive the hot shoe signal (to initiate maximum brightness of the LED, i.e. the flash).  
These processes are described in more detail below. 
 
In order to power and drive the XHP70 LED at the required levels, a BuckBlock A009-D-
V-2100 LED driver (LEDdynamics, Inc., Randolph, USA) and 30V 2.17A DC power 
supply (generic) were purchased.  This combination was capable of driving the XHP70 at 
the maximum output during a brief flash period (maximum 1/60s) without damaging the 
LED or driver. As an analog method of controlling and limiting the LED’s brightness to 
standard slit-lamp levels during normal, non-photographic use of the instrument, a 210Ω 
resistor and 1kΩ linear potentiometer were connected in series with the BuckBlock’s 
dimming circuit. An optocoupler was also wired in series with the BuckBlock’s dimming 
circuit to be controlled by the Arduino microprocessor; this would act as a switch to 
initiate an open dimming circuit, causing the BuckBlock to enter a default mode of 
running the LED at full brightness and therefore act as the flash during photography.  
 
In the above configuration, if the Arduino device failed, the LED would stay on at full 
brightness due to the design of the BuckBlock. This could potentially cause damaging 
levels of brightness if a patient was sitting at the slit-lamp when it occurred, and would 
definitely cause failure of the LED if power was not interrupted swiftly.  To prevent this 
from happening, an AQY410EH photoMOS normally closed solid state relay (Panasonic 
Corp., Osaka, Japan) was wired in parallel with the dim circuit; this acted as a failsafe by 
shorting the BuckBlock’s dimming circuit and causing the LED to turn off if the Arduino 
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microprocessor failed (see figure 2.2.3 for flowcharts depicting the above scenarios).  This 
failsafe, combined with the resistor and potentiometer described above, ensured that the 
intensity of light emitted by the LED would be safe for exposure to the eye and adnexa.  
The photoMOS was also used to turn the LED off for the remainder of the exposure at 
shorter than 1/60s flash times, such as when photographing the eye during diffuse 
illumination; this method of controlling exposure eliminated the need to change shutter 
speeds on the D3300 camera and therefore, it could be simply left set at 1/60s. The 
Arduino was programmed with predefined, user selectable flash times, which are explained 
in more detail below and shown in figure 2.2.4.     
 
The original FS-3 flash controller consisted of a large, heavy (approximately 9.6kg) 
apparatus, and this was used to receive the trigger signal from the slit-lamp’s joystick, 
trigger the remote shutter release on the 35mm SLR camera and then fire the xenon 
flashtube after receiving a signal from the SLR’s hot shoe.  The control box also contained 
controls to set the flash brightness either manually or automatically. The manual brightness 
control consisted of 9 levels that were selected by pushing up/down buttons.  In order to 
imitate this, the Arduino microprocessor was programmed with 9 brightness levels, each 
increasing the time that the LED was at maximum brightness, which could be selected 
using a momentary up/down toggle switch.  These brightness levels allowed correct 
exposure at different slit widths and heights during photography. I/O pins on the Arduino 
were available to receive input from the switch and the device was programmed to show 








Figure 2.2.3 Flowcharts demonstrating the BuckBlock and Arduino control of the LED 
array’s brightness.  The chart on the left shows the undesired scenario where the LED defaults 
to full brightness if the signal is lost from the Arduino (highlighted).  The chart on the right 
shows the failsafe and post-flash control scenario (highlighted) after the addition of a 
photoMOS solid state relay. 
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2.2.2.3 Integration of the microcontroller, digital camera and illumination system 
components with the slit-lamp’s existing trigger and beamsplitter 
 
In order to control the D3300’s shutter with the Arduino microprocessor, a generic male 
2.5mm to DC-2 shutter release cable was obtained.  As the Nikon DSLR’s shutter was 
triggered by creating a short between the focus, shutter and ground pins on the shutter 
release cable, an optocoupler controlled by the Arduino was used for this purpose.  The 
corresponding shutter and focus terminals on a female 2.5mm audio connector were 
permanently shorted together and then connected to the ground pin through the 
optocoupler.  When the Arduino microprocessor sent a HIGH signal to the optocoupler, 
the circuit would close causing the D3300’s shutter to fire.  The optocoupler eliminated 
any chance of damaging the camera’s circuitry as it electrically isolated it from the Arduino. 
The shutter and focus pins of the shutter release cable were permanently shorted because 
the shutter would not activate unless both were grounded at the same time.   
 
The existing trigger located in the joystick of the slit lamp was used to initiate the shutter 
release on the camera. One digital pin on the Arduino was programmed as an input with 
its internal pullup resistor activated, forcing its value to stay HIGH at 5V. This was then 
connected to a terminal on the joystick trigger while its other terminal was connected to 
the common ground.  When the joystick trigger was pushed, this digital input pin would be 
grounded and its value would drop to LOW from HIGH.  The Arduino microprocessor 
was programmed to set the output pin controlling the shutter optocoupler to HIGH when 
this occurred.  As a result, the above-mentioned shutter release pins on the camera would 
be shorted, causing a photograph to be taken.   
 
In terms of simplicity, it would have been convenient to program the LED to flash at 
maximum brightness by using the same signal from the slit lamp’s joystick button as a 
trigger. Theoretically, the camera shutter and flash would fire at the same time.  This was 
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attempted by programming the Arduino microprocessor to, upon the joystick button 
being pressed, change the value of its pin controlling the optocoupler on the BuckBlock’s 
dimming circuit from HIGH to LOW for the user selected time period (causing it to enter 
its default mode of full brightness and creating a flash). In actuality, there was a variable 
delay that occurred within the camera between it receiving the signal from the remote 
shutter release and its subsequent opening of the shutter curtain.  Consequently, in most 
cases, the flash fired before the photograph was taken.  To rectify this situation, the 
camera’s hot shoe was utilised to synchronise the shutter release and LED flash.  A hot 
shoe adapter with one of its terminals connected to a pin on the Arduino and the other to 
the common ground was used for this purpose.  The Arduino’s pin was defined as a digital 
input with its internal pullup resistor activated.  The configuration worked in a similar way 
to the shutter release signal from the joystick triggering the Arduino. When the camera 
opened its shutter curtain, it synchronised a temporary short between the central pin and 
ground rail of its hot shoe; this caused the value of the Arduino’s hot shoe input pin to 
drop to LOW from HIGH.  Upon this occurring, in order to create the flash, the Arduino 
was programmed to change the signal feeding the optocoupler on the BuckBlock’s 
dimming circuit from HIGH to LOW for the time specified by the user selected flash 
brightness level. 
 
The final step to this project was developing a method to control the solenoid-mirror 
fixture in the beamsplitter. The mirror was required to, in a synchronised fashion, divert 
incident light to the camera before a photograph was taken and then return to its original 
position in order to restore the view through the slit-lamp’s right eyepiece.  It was 
determined that 10V DC was adequate to activate the solenoid.  In order to control the 
polarity so that the solenoid could be moved down and then back up, an H-bridge 
integrated circuit was utilised.  The H-bridge was digitally controlled with two of the 
Arduino’s output pins.  Upon receiving the trigger signal from the slit-lamp’s joystick 
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button, the Arduino was programmed to move the solenoid to the down position and then 
delay for 500ms before firing the camera’s shutter.  This delay allowed any vibration of the 
mirror to dissipate before the photograph was captured. Another delay for 500ms was 
initiated before the Arduino instructed the H-Bridge to move the solenoid back to the up 





Figure 2.2.4 A flowchart depicting how the Arduino was programmed to run the system.  The 
shaded top portion (demarcated by the dashed line) runs only once when the Arduino is turned 










2.2.2.4 Final installation of the components 
Due to their compact sizes, the BuckBlock, flash intensity adjustment switch, 16x2 backlit 
LCD display and Arduino, with associated circuitry, were able to be installed under the slit-
lamp table in the original incandescent bulb’s power supply housing.  The 30V DC 2.17A 
power supply was mounted to the slit-lamp table and connected to the original switch of 
the power supply unit.  This power supply was sufficient enough to provide electricity to 
the LED, heat sink fan, beamsplitter solenoid and Arduino microprocessor.  Connections 
were made from the power switch directly to the BuckBlock and to voltage regulators for 
the Arduino, H-Bridge and heatsink fan.  The values of these voltage regulators were 6V, 
10V and 12V respectively.  The Arduino, H-Bridge, optocouplers, LCD display, flash 
intensity switch, various resistors, capacitors and voltage regulators were all soldered in the 
appropriate configuration to a stripboard. Removable connections were made between the 
stripboard and camera shutter release cable, hot shoe adapter, slit-lamp joystick trigger and 
BuckBlock dim circuit.  Wires for the dim circuit potentiometer, LED, heatsink fan, 
shutter release cable, hot shoe cable, joystick trigger and beamsplitter solenoid were all run 
from the new control box, through the base of the slit-lamp and exited out of the existing 
slit-lamp ports.  The potentiometer was mounted in the slit-lamp’s original rheostat 
location and the voltage regulator for the heat sink fan was soldered to a small piece of 
stripboard and mounted to the top of the illumination system cover.  Detachable 
connections were then made to the heat sink fan, and holes were drilled into the 
illumination housing cover to increase ventilation. The LED wire was connected with 
detachable connections to the BuckBlock LED circuit and XHP70 LED array.  Finally, the 
new control box was mounted in its original position under slit-lamp table.  Figure 2.2.5 
gives a visual depiction of the above installation while figure 2.2.6 provides an electrical 
schematic for the entire design.  The source code for the Arduino is provided in appendix 













Figure 2.2.5 A. The original power supply housing for the incandescent bulb. B. The modified 
power supply housing with the 16x2 LCD display and the flash intensity up/down switch mounted 
below the power switch. C. The interior of the housing showing the BuckBlock LED driver 
(bottom left), DC power supply connections to the power switch (to the right of the BuckBlock) 
and Arduino with associated circuitry soldered to a stripboard. D. The LED/fan housing mounted 
to the modified bulb housing. E. The fan mounted to the LED/housing and its voltage regulator 
mounted to the illumination cover. F. The D3300 digital camera mounted to the beamsplitter with 
the hot shoe adapter and shutter release cable connected. G. The entire modified system showing 










































































































2.2.3 Results and Discussion 
The modified photographic slit-lamp has been running for approximately two years, 
captured over 5000 photographs without failure and can be used with the same ease and 
fluency as its original analog state.  The D3300 camera provides high resolution 
photographs (figure 2.2.7) and is also able to record high definition video.  Furthermore, 
its HDMI out connection can be connected to an external display to show a live image. 
While this slit-lamp was modified strictly for photography, the beamsplitter’s solenoid-
mirror was manually moved into the down position to verify these video capabilities.  A 
permanent fix for video capture would be to connect an additional switch to the Arduino 
and add the appropriate code that would, upon it being pressed, lower the solenoid to 




There are significant possibilities to customise the set-up described in this Chapter.  
Instead of the Pro Mini, Arduino microprocessors with an increased number of I/O pins 
can be used to add more functions to the slit-lamp system. For instance, Krohn & 
Kjersem (2012; 2013) described a method of photographing intraocular tumours with an 
Figure 2.2.7 Photographs of (A) an optic section and (B) retroillumination of the anterior 
crystalline lens taken with the modified slit lamp 
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expensive Haag-Streit slit lamp; an additional LED could be added to the system described 
in this chapter to perform the same function.  
 
As the use of an Arduino microprocessor allows all of the existing slit-lamp electronics to 
be bypassed, the methods that were used to modify this Nikon slit lamp can be easily 
adapted to microscopes produced by other manufacturers. Making things even simpler, 
slit-lamps that use optical beamsplitters for their camera attachments do not require the 
use of an H-Bridge and additional source code to control the mirror-solenoid 
combination.  Depending on their design, this system can be added to slit-lamps that do 
not have photographic attachments.  Additionally, as the method of remote shutter release 
and hot shoe control is fairly standardised across the photographic industry, the same 
principles described in this paper should be able to be applied to non-Nikon digital 
cameras.  It should also be noted that as the Nikon D3300 used in this project contains an 
APS-C sized sensor, the photographs are taken with a 1.5X crop factor compared to the 
original 35mm film camera. This can be avoided by using a digital camera with a full frame 
sensor in place of the D3300.       
 
The primary purpose of this project was to digitise a high-quality analog photographic slit-
lamp system for which replacement parts had become unavailable and that was required by 
the researcher for LOCS III grading. While this was achieved, the methods described 
above will be useful for other research laboratories and clinical settings to upgrade and 
utilise effectively obsolete instrumentation at a low cost; the entire spend for this project 
came in at under £450. The modifications described in this chapter can easily be 
replicated, customised and adapted by those with a basic knowledge of computer 





Chapter 3:  Assessment of Lens Opacity and Cataract using OCT 
 
3.1 Introduction 
As mentioned in Chapter 1, there are a lack of grading systems available to assess the 
severity and morphology of lens opacities and cataract that are not of the age-related type.  
Furthermore, the slit-lamp based systems that are most commonly used, such as LOCS III, 
are subjective and susceptible to variations in microscope settings.   This study sought to 
develop a method to objectively measure lens opacity and cataract using anterior segment 
OCT with the Visante AS-OCT (Carl Zeiss Meditec, Germany).  This chapter outlines the 
in-vivo imaging and analysis of crystalline lenses from a group of adults for opacification 
using AS-OCT and makes a comparison to LOCS III grading.  To investigate functional 
correlates of media opacities, measures of visual function were also evaluated including 
habitual visual acuity, contrast sensitivity and retinal straylight.  The following sections will 
outline the recruitment, data collection and analysis for these measures. 
 
3.2 Sample Size Determination and Recruitment 
3.2.1 Sample Size 
This study sought to recruit 90 typically developed adult participants aged 50 years and 
higher, both with and without cataract.  Participants were stratified by age providing a 
broad cross-section of natural age-related lens opacification.  The stratified age ranges 
were: 
• 30 Participants aged 50-60 years 
• 30 Participants aged 60-70 years 






Three avenues were taken to recruit participants for this study.  Participants were primarily 
recruited from the Ulster University Optometry Clinic and through emails circulated 
University-wide to staff and students.  Other participants were recruited from the local 
community via retirement organisations (including the University of the 3rd age (U3A), and 
through word-of-mouth from participants to their families and friends.   
 
Eligible clinic patients were approached after attending for their routine eye examinations 
about participation in the study.  They were given Participant Information Sheets (PIS) 
(see appendix A-2) outlining the study and time to consider participating.  If they decided 
to participate, an appointment was scheduled after a short series of screening questions 
were asked to ensure eligibility criteria were met.  Emails sent to university staff and 
students were approved by the Faculty of Life and Health Sciences and then distributed to 
staff- and student-wide email lists by Information Technology Services. Those who 
responded were provided with the PIS and questioned as to whether they met eligibility 
criteria.  The initial questioning to confirm eligibility consisted of open ended questions 
querying the presence of any eye disease or a history of any medical treatment or surgery 
to the eyes; appointments were made if appropriate.  PIS forms were also distributed to 
members via a confidential email list of the Causeway U3A and interested participants 
were screened and scheduled as described above.   
 
3.3. Ethical Approval  
Ethical approval was received from the Ulster University Research Ethics Committee 
(UUREC) prior to the start of the study.  Research was carried out in accordance with the 






The following procedures and assessments were conducted at the Vision Science Research 
Laboratory, Ulster University.  Participants were seen on one occasion for approximately 
one hour.  Upon attendance, participants were asked to complete and sign a consent form 
(See Appendix A-2), which was also signed by the researcher.  The study was carried out 
on both eyes of the participant unless they specifically requested only one eye to be 
assessed, or if an eye did not meet inclusion criteria such as the presence of a heterotropia, 
corneal opacity or coloboma.   
 
3.4.1 Ophthalmic and Systemic History 
A brief review of participants’ prior ophthalmic and systemic histories was undertaken to 
ensure that they met inclusion criteria and that there was no increased risk to 
pharmacologic pupil dilation.  Participants were questioned on past ocular pathology, 
medical and surgical treatment, and spectacle wear.  Questions were also asked about 
systemic health, medications and allergies including any past adverse reactions to eye 
drops.  Exclusion criteria included narrow anterior chamber angles or glaucoma, the 
presence of corneal or lenticular pathology (apart from cataract) that would affect imaging, 
and pseudophakia or aphakia.   
 
3.4.2 Anterior Chamber Angle and Intraocular Pressure Assessment 
As participants’ pupils were to be dilated with tropicamide 1% to enable crystalline lens 
imaging, the appropriate clinical checks were made prior to instillation.  These included 
Van Herick angle assessment and intraocular pressure (IOP) measurement.   
 
3.4.2.1 Van Herick Angle Assessment 
There is an increased risk of pharmacologic pupil dilation causing acute angle closure 
glaucoma in those with physiologically narrow angles.  Thus, the anterior chamber angle 
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was evaluated, using the Van Herick technique, prior to the installation of tropicamide 1%. 
Participants were seated at a slit-lamp biomicroscope.  The slit width was set to an optic 
section, and the illumination was angled at 60 degrees temporal to the objective lenses for 
temporal angle measurement, and nasally for nasal angle measurement.  Additionally, for 
nasal angle measurement, the entire objective and illumination system was rotated 
temporally by approximately 45 degrees and participants were asked to fixate between the 
objective lenses to enable an optic section of the cornea at the limbus.  For temporal angle 
measurement, participants were asked to fixate straight ahead at the researcher’s ear and 
the corneal optic section was focused at the limbus.  The Van Herick technique estimates 
anterior chamber angle depth by comparing the width of the shadow between the 
posterior cornea and iris to the width of the corneal optic section at the limbus.  Those 
with a grade 1 angle or less (width of shadow less than ¼ of cornea) were excluded from 
the study.  After the Van Herick assessment, participants’ anterior eyes were examined 
with the slit-lamp to ensure no contraindications to pupil dilation as well as to examine the 
cornea and lens for any pathology that would warrant exclusion from the study. 
 
3.4.2.2 Intraocular Pressure Measurement 
Again, to mitigate the risk of acute angle closure, pre- and one-hour-post-dilation IOPs 
were measured in each participant.  Either a Pulsair (Keeler Ltd., U.K.) or ICare (Icare, 
Finland) tonometer were used for this purpose.  Participants were asked to fixate on a 
target straight ahead and either three (Pulsair) or five (Icare) readings were taken of each 
eye as per manufacturer requirements to obtain accurate IOP measurements.  A sharp rise 
in IOP after pupil dilation would indicate angle closure and require medical treatment. 
Participants were given an information sheet outlining the signs and symptoms of angle 
closure with instructions on the appropriate course of action to be taken should it occur 




3.4.3 Visual Acuity 
Distance visual acuity (VA) was measured monocularly with participants’ habitual 
correction in place.  A logMAR visual acuity chart was used in opposition to traditional 
Snellen notation due to its ability to provide per letter scoring, constant logarithmic 
progression of letter size per line and equal number of optotypes per row (Bailey and 
Lovie-Kitchin 2013).  This system of measuring VA has been widely used across research 
and clinical trials due to its reliability and accuracy (Lovie-Kitchin 1989; Ferris and Bailey 
1996; Bailey and Lovie-Kitchin 2013).   
 
VA was measured under normal room illumination using a Bailey-Lovie logMAR chart 
(University of California, USA).  Participants were seated 3m from the chart and asked to 
read from the top line downwards until they could no longer read any letter on a line 
correctly; participants were also asked to guess at the letters on the line below this to 
ensure the limit of their VA was met.  When both eyes were included in the study, 
participants’ right eyes were always measured first. VA was calculated using by-letter 
scoring. A value of 0.02 log units was used for each letter read correctly and then a 0.3 log 
unit correction factor was added to the final VA to account for the 3m chart distance.  
Participants were asked to read lines backwards of out of order if memorisation of the 
letters was suspected.  Participants wore their habitual spectacle prescription and were 
questioned about the adequacy/age of correction. In the rare case that the researcher was 
not confident that the participant was wearing an up to date spectacle prescription, a 
pinhole test was carried out to ensure no drastic improvement in VA.   
 
3.4.4 Contrast Sensitivity  
To provide a further measure of participants’ functional vision, their contrast sensitivity 
(CS) was assessed.  Low spatial frequency CS has been shown to be largely unrelated to 
high spatial frequency VA, and often represents more of a real-world measurement of 
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visual function; it is considered to be a useful test in those symptomatically affected by 
cataract but who still achieve normal levels of VA (Elliott 1993; Richman et al. 2013).    
 
A Pelli-Robson chart was used to assess monocular CS in participants. Assessment was 
carried out at a 1m distance, under adequate illumination of 60 – 120 cd/m2 and ensuring 
no specular reflection from the chart (Elliott 2007).  Participants were asked to read the 
chart from the top down as far they could while occluding their fellow eye; in cases where 
both eyes were included in the study, the right eye was always measures first.  When the 
participant met their threshold, the next triplet of letters were pointed out and they were 
given 20 seconds to ensure nothing more could be seen.  A log value of 0.15 was awarded 
for each triplet where two letters were read correctly while ignoring the first triplet (as it 
has a value of 0.00 log units).          
 
3.4.5 C-Quant Retinal Straylight Assessment 
The Commission Internationale de l’Eclairage includes retinal straylight as a significant 
contributor in the definition of disability glare (Van den Berg et al. 2013). Retinal straylight 
is intraocular light scattering caused by the ocular media that results in a veiling luminance 
on the retina; this forward scatter reduces image contrast (Mainster and Turner 2012).  
Various studies have demonstrated that retinal straylight increases with age and also due to 
cataract (Van Den Berg et al. 2007; Van Der Meulen et al. 2012; Michael et al. 2009; Van 
den Berg et al. 2013).  Straylight measures have been shown to be unrelated to visual acuity 
(Van Den Berg et al. 2007; Van Der Meulen et al. 2012). In a study of 2422 people, retinal 
straylight was found to be more strongly related to LOCS III score than either contrast 
sensitivity or visual acuity (Michael et al. 2009).   
 
Retinal straylight was measured in participants using a C-Quant Straylight Meter (Oculus 
GmbH, Germany). The C-Quant measures retinal straylight using the psychophysical 
79 
 
method of compensation comparison, which was first described in 2003 (Franssen et al. 
2006; Van den Berg et al. 2013).  The instrument implements an annulus as a straylight 
source with an average angular value of 7 degrees, surrounding a central dark test field 
consisting of a circle divided vertically into two halves (see figure 3.4.1).  A flickering of 
the annulus will cause forward scatter and subsequent veiling luminance onto the retinal 
image of the central target.  Over a series of approximately 20 short duration trials, the 
randomly selected right or left test field is flickered with additional compensation light and 
exactly out of phase with the straylight source.  The test field without compensation will 
be seen by the observer to be flickering in phase with the straylight source during the test.  
By adjusting the compensation light added to the randomly chosen test field, it can appear 
to stop flickering or flicker less.  The C-Quant utilizes a two-alternative forced choice 
method where the participant must choose which test field appears to be flickering more 
strongly.  As a result, a straylight parameter known as log (s) can be calculated.  Two 
reliability measures are also calculated: the standard deviation of log (s) known as Esd and 
a quality factor known as Q; log (s) is considered to be reliable when Esd < 0.08 and Q > 
1.   
 
 
Figure 3.4.1 Image of the stimulus used by the C-Quant showing the straylight source and 
central test fields.  Image taken from Franssen et al. (2006) 
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The C-Quant apparatus sits on a desktop and consists of a tube-like body with an 
eyepiece.  The base of the instrument contains two buttons situated on the left- and right-
hand sides, that participants push to select which test field they observe to be flickering 
more strongly.  The instrument is connected to a computer that runs the stimulus control 
and analysis software. 
 
The test was conducted monocularly using an eyepatch to occlude the eye not being 
assessed.  Again, if both eyes were included in the study the right eye was measured first. 
The default range setting of E was used in all participants. To start, the participant was 
seated in front of the instrument and asked to place their eye close to the eyepiece but not 
firmly against it.  They were instructed to fixate only on the central test fields and ignore 
the outside flickering ring.  Participants were then told that a short series of flickering 
lights would be presented, and to use their first impulse to select which test field they 
observed to be flickering more strongly by pressing the corresponding button on the base 
of the instrument in a two-alternative forced choice paradigm.  They were informed that it 
was normal for the determination to become very difficult and to use intuition to decide 
when this occurred.   If the value of log (s) was determined not to be reliable based upon 
the Esd and Q metrics, the participant was given another chance to complete the test after 
increasing the range setting of the instrument to the highest level of F.  
 
3.4.6 Crystalline Lens Slit-lamp Imaging and LOCS III Grading 
After the above standard optometric and straylight measurements were completed, 
participants’ pupils were dilated with tropicamide 1%.  To ensure maximum pupil dilation, 
a period of at least 20 minutes elapsed before imaging was carried out.  The modified 
Nikon FS-3 slit-lamp described in Chapter 2 was used to image nuclear, cortical and 
posterior subcapsular opacities in all participants.  The following camera and slit-lamp 
settings were used for all images:  
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1. Camera Settings: 
a. ISO sensitivity: 6400 
b. Flash Intensity: Level #9 (1/60s of LED at full brightness) 
c. Shutter Speed: 1/60s  
2. Slit-Lamp Settings: 
a. For imaging the Nucleus: 
i. Slit width: 0.2mm 
ii. Slit height: Extended over pupillary margins 
iii. Angle of illumination: Exactly 45 degrees to objective lenses 
iv. Filter: None 
b. For Imaging Cortical and PSC opacities: 
i. Slit width: Variable, usually between 3-5mm 
ii. Slit height: Variable – enough to provide adequate retroillumination 
iii. Angle of illumination: 3-5 degrees to objective lenses 
iv. Filter: None 
As indicated by the above settings, optic sections of the lens focused at the nucleus centre 
were captured for nuclear grading and retroillumination images were captured for grading 
cortical and PSC opacities.  The slit-lamp was focused at the planes of the pupil and 
posterior capsule for retroillumination images.   
 
During imaging, the participant was seated at the slit-lamp with their chin and forehead 
placed against their respective rests.  The chin rest was adjusted vertically to align the 
participant’s lateral canthus against the corresponding marker on the slit-lamp.  The 
participant was asked to fixate straight ahead just past the researcher’s ear, and told they 
would experience very brief flashes of light as the photographs were taken.  The optic 
section and retroillumination images of the crystalline lenses were then captured.  All 
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images were captured with the room lights switched off. Multiple images were captured for 
each eye and the best quality image was then used for grading.  
 
LOCS III grading of all captured images was conducted at a single computer terminal with 
constant monitor settings for brightness, contrast and colour. A transparency of the 
standard LOCS III images was illuminated with a lightbox; any areas of the light box that 
were not covered by the transparency were masked off to prevent light leakage. The 
lightbox was placed beside the computer monitor, and for every photographed eye, grades 
were assigned for each measure of opacity in accordance with the LOCS III instructions 
(Chylack et al. 1993).   
 
Images were first graded for nuclear opalescence (NO) and nuclear colour (NC) by 
opening the nuclear optic section images on the computer workstation and making direct 
comparisons to the six standard LOCS III images.  A grade between 0.1 (representing 
complete nuclear transparency) and 6.9 was assigned for each of NO and NC.  Care was 
taken to grade NO based strictly by examining the hazy quality of the nucleus without 
respect to its brunescence.  For NC evaluation, the haziness of the nucleus was ignored 
and a grade was assigned based upon the brunescence reflected off of the posterior 
capsule. 
 
The retroillumination photographs were used to analyse cortical (C) opacification.  Again, 
these images were viewed on the computer workstation and grades were obtained by 
making a direct comparison to the set of standard LOCS III C images at the lightbox.  As 
per instructions, the researcher considered all areas of opacification solely as an aggregate 




For grading PSC opacities, only the retroillumination photographs that were captured with 
the slit-lamp focused at the posterior plane of the capsule were used.  In the same manner 
as above, grades ranging from 0.1 to 5.9 were assigned based upon direct comparison of 
the photograph to the P set of standard LOCS III images illuminated by the lightbox.  
Once more, care was taken to grade P by considering all areas of opacification as an 
aggregate.  As per the LOCS III instructions, the opacity was only considered to be a true 
PSC if it extended into the central 3mm of the pupil.    
 
3.4.7 Visante Anterior Segment Imaging 
Directly after slit-lamp imaging, AS-OCT scans of participants’ crystalline lenses were 
captured using the Visante instrument.  Participants were asked to sit at the instrument 
with their chin placed on the chin rest and forehead placed against the forehead rest.  They 
were then instructed to look at the centre of the instrument’s internal fixation target. Using 
the video monitor and chin/forehead rest controls of the Visante, the participant’s eye was 
aligned to perform a scan through the centre of the cornea/crystalline lens.  The presence 
of the corneal reflex, which is an optical artifact that causes a vertical line to appear 
through the image, was visualised to ensure central alignment (Zeiss Visante User Manual 
[no date]).  As this corneal reflex would make analysis of image opacification difficult, 
attempts were always made to save images just as it disappeared.   B-scans across the 90-
degree axis of the lenses were taken to mimic that of the slit-lamp optic section used 
during lens slit-lamp photography however, if sufficient quality scans were not attainable 
due to the participants’ eyelids or other factors, 180-degree B-scans were taken instead.  If 
there was the presence of non-nuclear cataract, the alignment of B-scans was adjusted to 
image through these opacities.  Attempts were made to acquire both high- and low-
resolution scans using the Raw Image mode of the Visante.  As previously mentioned, 
because the high-resolution mode consists of 512 A-scans but with only a 3mm imaging 
depth, separate images of the anterior and posterior half of the lens were taken.            
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3.4.7.1 Processing and Analysis of Visante Images   
Raw detector data were exported for all scans using the Visante Image Exporter software 
(Carl Zeiss Meditec, Germany).  This sensor data was then processed, segmented and 
analysed for opacity with MATLAB (MathWorks Inc., USA) using customised, bespoke 
software. These processes are outlined below. 
 
3.4.7.1.1 Image Processing of Visante Raw Sensor Data 
Although Carl Zeiss Meditec do not provide information about the format or encoding 
properties of the raw files, scans were successfully opened after a period of trial and error 
by the author. An estimation of the encoding was determined from the high-resolution 
raw file sizes of 1mb, meaning they contained 8388608 bits of information.  Knowing that 
the maximum resolution of the Visante was 512 A-scans, the vertical resolution of the 
detector was assumed to also be 512 pixels in size.  Therefore, the total number of pixels 
was assumed to be 262144 (512 x 512). Dividing 8388608 by 262144 results in 32, which 
suggests the bit depth of the detector.  The raw data was then successfully read into 
MATLAB in the form of a 512 x 512 matrix with 32-bit signed integer precision.  To 
convert the images to the original aspect ratio used by the Visante, the matrix was then 
resized to 512x1280 resolution using the imresize() function and bicubic interpolation as 
described by Kao et al. (2011).  The resized matrix was subsequently converted to a 
grayscale intensity image using the mat2gray function.  See Figure 3.4.2 to see the original 








Figure 3.4.2 Demonstration of the resizing of the processed original 512 x 512 raw detector 
data (A) to the 512 x 1280 aspect ratio (B).  The vertical line through the centre of the images 
is the ‘corneal’ reflex.  
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The newly formed grayscale images were processed to increase contrast, which facilitated 
manual segmentation.  The limits of contrast of each image were determined using the 
stretchlim() function.  The imadjust() function was used in conjunction with these limits of 
contrast to map the intensity values to the final version of the image that was to be 











3.4.7.1.2 Segmentation and Grading of Processed Visante Images 
Once the image had been processed as above, the software displayed it using the imshow() 
function in order for manual segmentation to be carried out.  The impoly() function was 
used so that the area to be graded, such as the nucleus or cortical opacity, could be 
manually outlined by the researcher; to do this, the mouse was used to control the cursor 
and click points along the border of the area to be graded.  By connecting the first and last 
points, a region of interest (ROI) object was created.  The createmask() function was then 
used on the ROI object to define a binary mask of the area of the lens to be graded.  The 
Figure 3.4.3 Demonstration of contrast adjustment of the processed images.  The top image 
represents the unadjusted state, and the bottom image shows the change after applying the 
imadjust() function with the limits of contrast as a constraint.  Histograms showing the pixel 
distributions are displayed to the right of each image.      
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binary mask object was of a logical class so zero values in areas outside of the ROI would 
not influence measurements taken inside of it.  The mean pixel intensity (PI) of the 
selected ROI was calculated by using the mean() function after finding the product of the 
grayscale image and binary mask.  As each pixel represents an intensity, the mean PI 
provides a measure of overall opacification in the region of interest. The value of pixels 
range between zero and one, with zero representing black (or zero intensity) and one 
representing white (or maximum intensity).   Figure 3.4.4 demonstrates the masking 





Figure 3.4.4 Demonstration of the masking process. The cortex was selected to be segmented 
by clicking the mouse along its border and connecting the first and last points(top image). The 
bottom image shows the segmented cortex.  
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Various techniques were used to calculate a grade of age-related opacity depending on its 
type.  For high resolution images, nuclear opacification was determined by segmenting the 
nucleus from the anterior and posterior images of each half of the lens.  A portion of the 
aqueous humor was also segmented from these same images respectively.  The mean PI 
values of the aqueous represented background intensity levels that were unrelated to 
lenticular opacification.  A mean nuclear pixel intensity ratio (PIR) was calculated by 
averaging the ratios taken between the anterior nucleus mean PI divided by anterior 
aqueous mean PI and the posterior nucleus mean PI divided by posterior aqueous mean 
PI.  This final PIR represented the grade for nuclear opacity.  The process of grading for 
low resolution images was easier as the entire crystalline lens was contained in the same 
image.  The entire nucleus was segmented and a PIR was calculated from the mean 
nucleus and anterior aqueous PIs.  Although, as mentioned previously, attempts were 
made to acquire AS-OCT scans of the lens just as the corneal reflex disappeared, this was 
not possible in all cases.  In these instances, the corneal reflex was not included in 
calculations by taking care to avoid it during image segmentation.   
 
Cortical lens opacities were graded in a similar way to the above.  As a baseline, the entire 
anterior or posterior cortex was segmented depending on the location of the opacity.  The 
software then provided the entire cortex mean PI.  Due to the focal aspect of cortical 
opacities, it was also useful to know the area of the cortex.  The software calculated this by 
applying the bwarea() function to the ROI mask of the cortex and providing a pixel area 
(PA).   Any cortical opacities were then segmented using the same process.  The cortical 
opacity PIR was calculated by dividing the opacity PI by the cortex PI.  A pixel area ratio 
(PAR) was also calculated by dividing the opacity PA by the cortex PA.  If multiple B-
scans had been taken to image through opacities at different locations, the opacity PIRs 




Posterior subcapsular cataract was analysed and graded in a similar way to cortical cataract.  
B-scans of the entire posterior cortex were segmented taking care not to include the areas 
of posterior subcapsular opacification.  The areas of PSC were then segmented separately 
from the original B-scans.  The PIR and PAR was calculated from these segmentations.  
Again, if the PSC was imaged with multiple B-scans, summed PIR and PAR values were 

























3.5.1 Recruited Participants 
Through the course of this study, 92 participants were recruited.  Two participants were 
excluded due to the presence of narrow anterior chamber angles contra-indicating dilation, 
leaving a total study cohort of 90 participants.  While attempts were made to include both 
eyes, this was not possible in all cases.  Thus, a total of 156 eyes were imaged and the 
excluded eyes were due to the presence of amblyopia, coloboma, pseudophakia, or 
participant request.  Participant ages ranged from 50 to 84 years with a mean of 64.06 ± 






N Eyes  



























Table 3.5.1 Stratified age ranges for all participants showing the number of eyes, percentage of 
total, number of males and females, and mean age.  
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3.5.2 Measures of Visual Function 
 
3.5.2.1 Visual Acuity 
Monocular habitual visual acuity (VA) was obtained in 100% of imaged eyes.  Mean VA 
for all eyes was 0.00 ± 0.14 (SD) logMAR with a range of -0.26 to 0.68 logMAR. VA for 
the entire group of eyes was not normally distributed (Shapiro-Wilk, p<0.001) with a 





For the stratified age ranges, VA was only normally distributed for the 60 to 70-year-old 








Wilk Skewness Kurtosis 
50-60 -0.05 (0.12) -0.20 to 0.38 p < 0.001 1.500 3.418 
60-70 -0.01 (0.11) -0.20 to 0.30 p > 0.001 0.340 0.524 




0.00 (0.14) -0.20 to 0.68 p < 0.001 1.236 3.446 
 
Figure 3.5.1 Histogram of VA frequencies from all 156 eyes showing positive skewness that still 
remains after removal of the outlier (0.68 logMAR).   
Table 3.5.2 Summary of the VA distributions’ mean, range and indicators of normality for all 
measured eyes.   
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Spearman rank order analysis was conducted comparing age and VA for all 85 left eyes to 
avoid any confounding from participants where both eyes were imaged. This showed a 
moderate correlation between decreasing VA and increasing age (rho=0.456, p<0.001).  
Linear regression also showed a significant association between VA and age (F(1,83)=17.662, 













Figure 3.5.2 Scatterplot showing the significant relation between VA and age (F(1, 83) = 17.662, p 
< 0.001, R2 = 0.175).   
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3.5.2.2 Contrast Sensitivity 
Contrast sensitivity (CS) measures were obtained in 100% of imaged eyes. Mean CS for all 
eyes was 1.85 ± 0.16 (SD) log units with values ranging from 1.20 to 1.95.  CS data was not 
normally distributed (Shapiro-Wilk, p < 0.001) and heavily skewed to the left (-1.703).  














Wilk Skewness Kurtosis 
50-60 1.93 (0.07) 1.65 to 1.95 p < 0.001 -3.264 10.344 
60-70 1.86 (0.13) 1.65 to 1.95 p < 0.001 -0.820 -1.181 








Figure 3.5.3 Histogram and Q-Q plot of CS frequencies from all 156 eyes showing negative 
skewness.   
Table 3.5.3 Summary of the CS distributions’ mean, range and indicators of normality for all 




Spearman’s rank-order analysis showed that CS was moderately correlated with both age 
(rho = -0.418, p < 0.001) and VA (rho = -0.493, p < 0.001).  Linear regression also 
showed significant associations between CS and both age (F(1, 154) = 38.996, p < 0.001, R2 = 
0.202) and VA (F(1, 154) = 48.054, p < 0.001, R2 = 0.238).  Figures 3.5.4 and 3.5.5 show the 







Figure 3.5.4 Scatterplot showing the significant relation between CS and age (F(1, 154) = 38.996, p 
































Figure 3.5.5 Scatterplot showing the significant relation between CS and VA (F(1, 154) = 48.054, p 
< 0.001, R2 = 0.238).   
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3.5.2.3 C-Quant Retinal Straylight 
Straylight values were obtained in 132 (85%) of imaged eyes.  Of the missing values for the 
48 eyes, a software fault was responsible for eight (17%) and in all other cases, participants 
were unable to achieve results with valid reliability markers (Q and eSD) for either of their 
two attempts. 
 
Mean log[s] values for the entire group of eyes were 1.20 ± 0.26 (SD) with a range of 0.68 
to 2.34.  Straylight values for all eyes were not normally distributed (Shapiro-Wilk, p < 
0.001) and positively skewed (1.133).  The histogram and Q-Q plots for log[s] are shown 





Log[s] data were normally distributed for both the 50 to 60-year-old and 70-year-old plus 
age groups (Shapiro-Wilk, p > 0.05) but not for those aged 60 to 70 years (Shapiro-Wilk, p 




Figure 3.5.6 Histogram and Q-Q plot of log[s] frequencies from all 132 eyes showing negative 











Wilk Skewness Kurtosis 
50-60 (n = 52) 1.06 (0.15) 0.68 to 1.40 p = 0.934 -0.097 -0.066 
60-70 (n = 41) 1.24 (0.24) 0.91 to 2.00 p = 0.043 0.866 1.302 




1.20 (0.26) 0.68 to 2.34 p < 0.001 1.133 2.523 
 
Spearman’s rank order analyses for all eyes showed correlation between log[s] and both 
age (rho = 0.465, p < 0.001) and CS (rho = -0.365, p < 0.001) but not VA.  Linear 
regression showed significant association between log[s] and CS (F(1, 130) = 26.398, p<0.001, 
R2=0.169), age (F(1, 130)=33.566, p<0.001, R2=0.205) and VA, although very weakly for the 
latter (F(1, 130) = 4.291, p = 0.04, R2 = 0.032). The p-value for VA was also bordering on the 
result being of no significance.  Figures 3.5.7, 3.5.8 and 3.5.9 show the scatterplots for 




Figure 3.5.7 Scatterplot showing the significant relation between log[s] and CS (F(1, 130) = 26.398, 
p < 0.001, R2 = 0.169).   
Table 3.5.4 Summary of the log[s] distributions’ mean, range and indicators of normality for all 













Figure 3.5.8 Scatterplot showing the significant relation between log[s] and age (F(1, 130) = 33.566, 
p < 0.001, R2 = 0.205).   
Figure 3.5.9 Scatterplot showing the significant relation between log[s] and CS (F(1, 130) = 4.291, p 
= 0.04, R2 = 0.032).   
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3.5.3 LOCS III Grading of Crystalline Lenses 
Adequate pupil dilation and subsequent slit-lamp photography, with sufficient image 
quality to perform LOCS III grading, was successful in 100% (n=156) of eyes included in 
the cohort.  The following subsections outline the results for nuclear, cortical and 
posterior subcapsular cataract.   
 
3.5.3.1 LOCS III Nuclear Opalescence and Colour 
Mean LOCS III NO for all eyes was 2.3 ± 0.8 (SD) with a range of 1.2 to 5.2.  NC values 
ranged from 0.5 to 5.1 with a mean of 2.3 ± 0.8 (SD).  Neither NO or NC were normally 
distributed (Shapiro-Wilk, p < 0.001).  Figures 3.5.10 and 3.5.11 show the histograms and 
Q-Q plots for these distributions. Figure 3.5.12 shows images of various stages of nuclear 





Figure 3.5.10 Histograms for total participant NO (left) and NC (right) with overlaid distribution 
curves. 
Figure 3.5.11 Q-Q plots of observed NO (left) and NC (right) values showing deviation from 







According to Spearman’s analyses for the entire group of participants, both NO and NC 
showed correlations with age and the three measures of visual function.  Rho values and 
significances were very similar between both measures with age showing the strongest 
association.   These data are summarised in table 3.5.5. 
 
 NO NC 
Rho Sig. Rho Sig. 
Age 0.674 p < 0.001 0.724 p < 0.001 
VA 0.417 p < 0.001 0.424 p < 0.001 
CS -0.366 p < 0.001 -0.479 p < 0.001 
log[s] 0.257 p = 0.003 0.386 p < 0.001 
 
 
Linear regression also showed similar results to the above with moderate associations 
between the LOCS III nuclear measures to those of age and visual function.  Again, values 
for the F-distributions, significances and R2 values were all very similar between NO and 
NC.  Table 3.5.6 shows this.  
 
Table 3.5.5 Summary of Spearman’s rank order correlation between NO, NC and age as well as 
measures of visual function.   
Figure 3.5.12 Optic section image of various stages of nuclear opacity.  Respective LOCS III NO 
and NC grades for each image: Left: NO 1.2, NC 1.5; Centre: NO 1.9, NC 0.5; Right: NO 5.2, 
NC 4.1   
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 NO NC 
F Sig. R2 F Sig. R2 
Age (1,154) = 129.364 p < 0.001 0.457 
(1, 154) = 
159.431 p < 0.001 0.509 
VA (1, 154) = 47.778 p < 0.001 0.237 
(1, 154) = 
49.939 p < 0.001 0.245 
CS (1, 154) = 64.363 p < 0.001 0.295 
(1, 154) = 
77.977 p < 0.001 0.336 
log[s] (1, 130) = 20.315 p < 0.001 0.135 
(1, 130) = 
35.897 p < 0.001 0.216 
 
 
Although they were similar, all indicators for regression and correlation showed a higher 
association between NC and compared variables than for NO and the same compared 
measures.   
 
Multiple linear regression was performed for both NO and NC with the three measures of 
visual function as predictors.  Both models were significant (NO: F(3, 128) = 16.824, p < 
0.001, R2 = 0.283; NC: F(3, 128) = 25.121, p < 0.001, R2 = 0.371).  All measures of visual 
function showed significance as predictors in each model; table 3.5.7 summarises this data.   
 
Model 
Measures of Visual Function 

































When the data was sorted into stratified age ranges, the Shapiro-Wilk test showed that the 
60 to 70-year-old group was normally distributed for both NO (p = 0.129) and NC (p = 
0.611), while the 50 to 60-year-old group was normally distributed for NC only (p = 
Table 3.5.6 Summary of linear regression between NO, NC and age as well as measures of visual 
function.   
Table 3.5.7 Multiple regression analyses of LOCS III Nuclear grades vs measures of visual 




0.442); the 70-years and older group was not normally distributed for either LOCS III 
nuclear measure.  Spearman correlation between the LOCS III nuclear measures and those 
of age and visual function varied between each stratified age group; these are summarised 










Rho p Rho p 







None N/A N/A 




0.343 =0.014 CS -0.336 =0.016 














Linear regression also showed mixed associations between LOCS III nuclear measures 
compared to those of age and visual function.  Associations grew stronger with each level 











Table 3.5.8 Significant Spearman correlations between NO and NC compared to age and 









Statistics Significant Linear Regression 
Mean 
(SD) Range Age VA CS log[s] 
NO 



























50 - 60 1.7 (0.45) 0.5 to 2.5 No No No No 





































Table 3.5.9 Summary data for NO and NC when stratified by age group.  Descriptive statistics 
show increasing means for increasing age groups and linear regression show a trend of increasing 
association to measures of visual function with age. 
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3.5.3.2 LOCS III Cortical Grading 
Mean LOCS III C grades were 0.6 ± 0.8 (SD) with a range from 0.1 to 3.5.  The vast 
majority of participants had no cortical cataract and therefore, were given grades of 0.1.  
Grades greater than 0.1 occurred in 49 (31%) of eyes; of these, 38 (24%) had grades above 
one and 18 (11%) had grades above 2.0.  The distribution of C was not normal (Shapiro-
Wilk, p < 0.001) and strongly skewed (1.663) due to the number of 0.1 grades assigned to 
participants with no cortical opacities. Figure 3.5.13 shows the histogram and Q-Q plots 









Figure 3.5.13 Histogram (left) and Q-Q (right) plots of the C distribution for all participants, 
showing a strong positive skewness.  
Figure 3.5.14 Retroillumination images showing a clear (left) lens with a LOCS III C grade of 0.1 
and significant cortical opacity (right) with LOCS III C grade of 3.5. 
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Spearman’s rank order analyses showed correlation between C and age as well as all 
measures of visual function as seen in table 3.5.10.  Age showed the strongest correlation 
to C whereas VA and CS were moderately correlated and log[s] showed a weak correlation.  
  
Measure Spearman’s Correlation to LOCS III C Rho Sig. 
Age 0.509 p < 0.001 
VA 0.256 p = 0.001 
CS 0.270 p = 0.001 
log[s] 0.179 p = 0.040 
 
 
Linear regression showed significant associations between C and age (F(1, 154) = 38.755, p < 
0.001, R2 = 0.201), as well as weakly to both CS (F(1, 154) = 10.216, p = 0.002, R2 = 0.062) 
and log[s] (F(1, 130) = 5.386, p = 0.022, R2 = 0.040).  A model of multiple regression 
comparing VA, CS and log[s] to C, showed no significance for any predictor.   
 
When stratified by age, each group was not normally distributed (Shapiro-Wilk, p < 0.001) 
and heavily skewed to the right due to the paucity of upped LOCS III grades for C.  
Descriptive statistics for stratified age groups are displayed in table 3.5.11.   
 
Age 
Range Median IQR Range Mean Std. Dev. 
Shapiro-
Wilk 
50 – 60 
(n = 56) 0.1 0.0 0.1 to 2.6 0.2 0.4 p < 0.001 
60 – 70 
(n = 51) 0.1 0.7 0.1 to 2.9 0.5 0.8 p < 0.001 
70+ 
(n = 49) 0.9 1.9 0.1 to 3.5 1.1 1.0 p < 0.001 
Total 




Table 3.5.10 Significant Spearman correlations for LOCS III C compared to age and measures of 
visual function.  
Table 3.5.11 Summary of descriptive statistics for LOCS III C when stratified by age. 
106 
 
Spearman’s rank order correlation showed an association between C and log[s] (rho = -
0.310, p = 0.03) in the 50 to 60-year old group and no other associations between the 
LOCS score and age or any measure of visual function in any other group.  Similarly, linear 
regression between C and age as well as measures of visual function showed no association 

























3.5.3.3 LOCS III Posterior Subcapsular Grading 
Very low levels of posterior subcapsular opacification were present in this sample of 
participants. Only five participants had any sort of grade for P ranging from 0.2 to 2.2.  
Naturally, this sample was not normally distributed (Shapiro-Wilk, p < 0.001) with a heavy 
positive skew.  Table 3.5.12 below outlines the descriptive statistics for LOCS III P grades. 
Figure 3.5.15 shows images of a clear lens and one with significant PSC. Due to the low 
presence of P grades, correlation and regression comparisons were not made between the 




Range Median IQR Range Mean Std. Dev. 
Shapiro-
Wilk 
50 – 60 
(n = 56) No levels of P – all values 0.1 
60 – 70 
(n = 51) 0.1 0.0 0.1 to 2.2 0.1 0.3 p < 0.001 
70+ 
(n = 49) 0.1 0.1 0.1 to 1.9 0.2 0.4 p < 0.001 
Total 






Table 3.5.12 Summary of descriptive statistics for LOCS III P when stratified by age. 
Figure 3.5.15 Retroillumination images showing a clear (left) lens with a LOCS III P grade of 0.1 
and significant PSC opacity (right) with LOCS III P grade of 1.9. 
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3.5.3.4 Inter-Observer Agreement of LOCS III Grading 
To verify the accuracy of LOCS III grading by the researcher (ASM), 23 eyes (15% of 
total) were chosen at random and graded by an experienced optometrist and researcher 
(JAL). Bland-Altman plots were made up for all four LOCS III measures which are shown 
in figures 3.5.16, 3.5.17, 3.5.18 and 3.5.19.  Agreement between ASM and JAL was very 
















Figure 3.5.17 Bland-Altman plot showing inter-observer agreement for LOCS III NC grades. 





















Figure 3.5.19 Bland-Altman plot showing inter-observer agreement for LOCS III P grades. 
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3.5.4 OCT Grading of Lens Opacity 
 
3.5.4.1 OCT Nuclear Grading 
Out of the 156 imaged eyes, both the anterior and posterior high-resolution OCT B-scans 
required for grading nuclear opacity were successfully captured in 129 (83%) eyes.  A 
slightly higher success rate was achieved in imaging the lens with low-resolution scans (149 
eyes, 96%) due to the easier participant alignment and faster acquisition times that resulted 
from the ability to image the entire crystalline lens at once in this mode.   
 
For the entire group, median high resolution PIR was 1.282 ± 0.090 (IQR), and these were 
not normally distributed (Shapiro-Wilk, p=0.037)).  Similarly, values for low resolution 
PIR measures were not normally distributed (Shapiro-Wilk, p < 0.001) with a median of 
1.102 ± 0.049 (IQR).  Figures 3.5.20 and 3.5.21 show the histograms and Q-Q plots for 
high- and low-resolution PIRs respectively. Figure 3.5.22 and 3.5.23 show B-scans of 
crystalline lenses with low and significant nuclear opacification along with their 
corresponding slit lamp images.   
 






Figure 3.5.20 Histogram with overlaid distribution curve and Q-Q plot for total participant 










Figure 3.5.21 Histogram with overlaid distribution curve and Q-Q plot for total participant Low-
Resolution Nuclear PIR. 
Figure 3.5.22 High-resolution OCT (left) with a Nuclear PIR grade of 1.185 and corresponding 
optic section (right) with LOCS III scores of 1.2 and 1.5 for NO and NC respectively. 
Figure 3.5.23 High-resolution OCT (left) with a Nuclear PIR grade of 1.457 and corresponding 
optic section (right) with LOCS III scores of 5.2 and 4.1 for NO and NC respectively. 
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Spearman’s rank order analysis showed significant correlations between PIR and age as 
well as all measures of visual function for high-resolution images.  Age showed the 
strongest correlation followed by log[s], CS and VA.  For low-resolution images, PIR was 
correlated with age, VA, and CS although this was weaker for most measures compared to 
high-resolution PIRs. Table 3.5.13 summarizes the correlations for the entire group. 
 High-resolution PIR Low-resolution PIR 
Rho Sig. Rho Sig. 
Age 0.621 p < 0.001 0.427 p < 0.001 
VA 0.218 p = 0.013 0.219 p = 0.007 
CS -0.231 p = 0.008 No Correlation n/a 




Linear regression showed significant relations between high-resolution PIR values and 
measures of visual function and age.  Again, age showed the strongest relation followed by 
CS, log[s], and VA.  Age and measures of visual function were also linearly associated with 
low-resolution PIRs albeit at weaker levels.  Table 3.5.14 outlines the regression analyses 
for both high- and low-resolution PIR values.  
 
 High-Resolution PIR Low-Resolution PIR 
F Sig. R2 F Sig. R2 
Age (1,127) = 81.946 p < 0.001 0.392 
(1, 147) = 
28.031 p < 0.001 0.160 
VA (1, 127) = 7.111 p = 0.009 0.053 
(1, 147) = 
27.840 p < 0.001 0.159 
CS (1, 127) = 16.574 p < 0.001 0.115 
(1, 147) = 
13.470 p < 0.001 0.084 
log[s] (1, 110) = 13.584 p < 0.001 0.110 
(1, 126) = 
8.941 p = 0.003 0.066 
 
 
Significant models of multiple linear regression occurred for all three measures of visual 
function as predictors of high- (F(3, 108) = 5.596, p = 0.001, R2 = 0.135) and low-resolution 
Table 3.5.13 Summary of Spearman correlations for both high and low-resolution nuclear PIR 
compared to age and measures of visual function.  
Table 3.5.14 Summary of linear regression analyses for both high and low-resolution PIR compared 
to age and measures of visual function.  
114 
 
(F(3, 124) = 4.026, p = 0.009, R2 = 0.089) PIRs.  For both high- and low-resolution PIR 
models, only log[s] was a significant predictor while VA and CS were not (see table 3.5.15).  
 
Model 
Measures of Visual Function 
Measure Coefficient t p 
High-

































When stratified by age, each group showed normal distributions for high-resolution PIRs. 
Capture rates in each group were good for high-resolution PIRs with 82.1% (n = 46), 
88.2% (n = 45) and 77.6% (n = 38) of eyes successfully imaged in the 50 to 60, 60 to 70 
and 70-years-and-older ranges respectively.  Capture rates were higher for low-resolution 
scans in each age bracket when compared to their corresponding high-resolution scans at 
92.9% (n = 52), 94.1% (n = 48) and 100% (n = 49) for 50 to 60, 60 to 70, and 70 years-
and-older age ranges respectively. In contrast to the stratified high-resolution PIRs, only 
the distribution for the 60 – 70-year-old group was normal (Shapiro-Wilk, p = 0.673) for 
the low-resolution groups. The descriptive data is summarised in tables 3.5.16 and 3.5.17. 
 
Age 
Range Median IQR Range Mean Std. Dev. 
Shapiro-
Wilk 
50 – 60 
(n = 46) 1.239 0.055 
1.178 to 
1.354 1.246 0.042 p = 0.140 
60 – 70 
(n = 45) 1.286 0.068 
1.180 to 
1.369 1.286 0.044 p = 0.748 
70+ 
(n = 38) 1.335 0.080 
1.217 to 
1.460 1.335 0.060 p = 0.882 
Total 
(n = 129) 1.282 0.090 
1.178 to 
1.460 1.286 0.060 p = 0.037 
 
Table 3.5.15 Multiple regression analyses of OCT Nuclear PIRs vs measures of visual function.   
 





Range Median IQR Range Mean Std. Dev. 
Shapiro-
Wilk 
50 – 60 
(n = 52) 1.089 0.040 
1.039 to 
1.174 1.094 0.029 p = 0.020 
60 – 70 
(n = 48) 1.098 0.050 
1.026 to 
1.167 1.101 0.032 p = 0.673 
70+ 
(n = 49) 1.123 0.040 
1.058 to 
1.432 1.131 0.057 p < 0.001 
Total 
(n = 149) 1.102 0.049 
1.026 to 
1.432 1.108 0.044 p < 0.001 
 
    
Spearman’s correlations for high- and low-resolution PIRs compared to measures of visual 
function when grouped by age brackets showed variable results with no significant 
associations for high-resolution PIRs and only some for low-resolution measures; the data 
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Table 3.5.17 Descriptive data for low-resolution nuclear PIR when stratified by age.   
 
Table 3.5.18 Summary of Spearman’s correlations for both high and low-resolution nuclear PIR 




Linear regression was performed comparing both high- and low-resolution PIRs to each 
measure of visual function and age.  Again, results were variable with certain measures of 
visual function across age brackets showing significance depending on resolution or 






Significant Linear Regression 
Age VA CS log[s] 
High-
resolution 




No No No 




70+ No No No No 
Low-
resolution 
50 - 60 No No No No 
















Multiple linear regressions with the three measures of visual function as predictors of 










Table 3.5.19 Summary of linear regression analyses for both high and low-resolution nuclear 




3.5.4.1.2 Comparison of LOCS III Nuclear Grades and OCT PIRs 
 
To determine the viability of OCT in grading nuclear cataract, comparisons were made 
between participants’ LOCS III nuclear grades and PIR values.  Spearman’s analyses 
determined that both high and low-resolution PIRs were moderately-to-highly associated 
with NO and NC with high resolution PIRs showing a stronger trend.  When stratified by 
age, the relationship still existed however, the overall association was weaker in all groups 
and in most cases, there were no associations between low resolution PIRs and NC.  Table 
3.5.20 summarises the correlations between PIRs and LOCS III nuclear grades.   
 
 Age Range High-resolution PIR Low-resolution PIR 
LOCS III NO 
50 - 60 Rho = 0.420 p = 0.004 
Rho = 0.325 
p = 0.019 
60 - 70 Rho = 0.568 p < 0.001 
Rho = 0.515 
p < 0.001 
70+ Rho = 0.550 p < 0.001 
Rho = 0.494 
p < 0.001 
All ages Rho = 0.671 p < 0.001 
Rho = 0.542 
p < 0.001 
LOCS III NC 
50 - 60 Rho = 0.429 p = 0.003 Not significant 
60 - 70 Rho = 0.296 p = 0.048 Not significant 
70+ Rho = 0.469 p = 0.003 
Rho = 0.403 
p = 0.004 
All ages Rho = 0.633 p < 0.001 
Rho = 0.409 








Table 3.5.20 Summary of Spearman’s correlations for high and low-resolution nuclear PIR 




Linear regression also showed moderate associations between PIR and LOCS III NO 
scores (high-resolution PIR: F(1, 127) = 128.54, p < 0.001, R2 = 0.503; low-resolution PIR: 
F(1, 127) = 104.263, p < 0.001, R2 = 0.451).  Slightly weaker significant associations occurred 
for NC scores (high-resolution PIR: F(1, 147) = 75.435, p < 0.001, R2 = 0.339; low-resolution 
PIR: F(1, 147) = 56.816, p < 0.001, R2 = 0.279).  Figures 3.5.24, 3.5.25, 3.5.26 and 3.5.27 
show the scatterplots for the above-mentioned regressions.  
 
 
 Figure 3.5.24 Scatterplot showing the significant relation between high-resolution nuclear PIR 










Figure 3.5.25 Scatterplot showing the significant relation between low-resolution nuclear PIR 
LOCS III NO (F(1, 127) = 104.263, p < 0.001, R2 = 0.451).   
Figure 3.5.26 Scatterplot showing the significant relation between high-resolution nuclear PIR 








The above linear regressions were also performed within each stratified age group.  
Associations were similar except NO showed no significant relation to low-resolution PIR 
for the 50 to 60-year-old group and NC was not related to low-resolution PIR in the 50 to 
60 and 60 to 70-year-old groups.  The significant associations were also weaker when 
stratified by age as compared to the entire group as a whole.  Table 3.5.21 summarises the 








Figure 3.5.27 Scatterplot showing the significant relation between low-resolution nuclear PIR 








PIR vs. NO 
High-
Resolution 
PIR vs. NC 
Low-
Resolution 
PIR vs. NO 
Low-
Resolution 
PIR vs NC 
50 - 60 
F(1,44) = 9.363 
p = 0.004 
R2 = 0.175 
F(1, 44) = 8.256 
p = 0.006 
R2 = 0.158 
Not significant Not significant 
60 - 70 
F(1,43) = 24.662 
p < 0.001 
R2 = 0.364 
F(1,43) = 5.804 
p = 0.020 
R2 = 0.119 
F(1,46) = 14.268 
p < 0.001 
R2 = 0.237 
Not significant 
70+ 
F(1,36) = 18.746 
p < 0.001 
R2 = 0.342 
F(1,36) = 14.559 
p = 0.001 
R2 = 0.288 
F(1,47) = 20.273 
p < 0.001 
R2 = 0.175 
F(1,47) = 26.589 
p < 0.001 
R2 = 0.348 
All ages 
F(1, 127) = 128.54 
p < 0.001  
R2 = 0.503 
F(1, 147) = 75.435 
p < 0.001 
R2 = 0.339 
F(1, 127) =104.263 
p < 0.001 
R2 = 0.451 
F(1, 147) = 56.816 
p < 0.001 




 A model of multiple linear regression with LOCS III NO and NC as predictors of PIR 
showed significant moderate relations for both high-resolution (F(2, 126) = 71.472, p < 
0.001, R2 = 0.532) and low-resolution (F(2, 146) = 38.630, p < 0.001, R2 = 0.346).  In contrast 
to the high-resolution model, NC was not significant as a coefficient for the low-resolution 
model.  Values for the multiple regression are summarised in table 3.5.22. 
 
Model 
LOCS III Nuclear Measures 
Measure Coefficient t p 
High-



















Table 3.5.21 Summary of linear regression analyses for both high and low-resolution nuclear PIR 
compared to LOCS III NO and NC grades.  Data is shown for each stratified age group and the 
total cohort.    
 
Table 3.5.22 Summary of multiple regression analyses for both high and low-resolution nuclear 




3.5.4.2 OCT Grading of Cortical Cataract 
As previously mentioned, the presence of cortical cataract in the study population was low; 
a total of 26 participants had grades above 0.000 for cortical PIR and PAR OCT measures.  
None of the participants aged 50 to 60 years old received a value greater than 0.000 for 
either cortical PIR or PAR due to the fact that OCT imaging of the only participant who 
had significant cortical cataract was unsuccessful.  Of those aged 60 to 70 years, only seven 
received cortical PIR and PAR scores greater than 0.000 and for those aged 70 years and 
older, 19 received grades above 0.000.  As a result, the distributions for both cortical PIR 
and PAR were heavily skewed and not normal (Shapiro-Wilk, p <0.001).  The median 
value for PIR was 0.000 ± 0.000 (IQR) with a range of 0.000 to 1.338 and for PAR was 
0.000 ± 0.000 (IQR) with a range of 0.000 to 0.808.  Figures 3.5.28 and 3.5.29 show the 
histograms and Q-Q plots for the cortical PIR and PAR distributions.  Figure 3.5.30 



























Spearman’s correlation analyses showed significant associations between age as well as 
visual acuity and contrast sensitivity to both cortical PIR and PAR.  Age was moderately 
correlated (PIR: Rho = 0.458, p < 0.001; PAR: Rho = 0.468, p < 0.001) followed by VA 
(PIR: Rho = 0.298, p = 0.001; PAR: Rho = 0.301, p < 0.001) and CS (PIR: Rho = -0.264, 
p = 0.002; PAR: Rho = -0.277, p = 0.001).  There was no significant correlation between 
either cortical measure and straylight. 
Figure 3.5.29 Histogram with overlaid distribution curve and Q-Q plot for total participant 
Cortical PAR. 
Figure 3.5.30 High-resolution OCT (left) with a cortical PIR grade of 1.156 and PAR of 0.808. 
The corresponding optic section is shown on the right with a LOCS III C grade of 3.5.  The OCT 




Linear regression was performed comparing both cortical PIR and PAR to age and 
measures of visual function.  Statistically weak significance was shown for certain 
measures; these are outlined in table 3.5.23.     
 
 Cortical PIR Cortical PAR 
F Sig. R2 F Sig. R2 
Age (1,128) = 31.661 p < 0.001 0.198 
(1, 128) = 
6.516 p = 0.012 0.048 
VA (1, 128) = 6.119 p = 0.015 0.046 
Not 
significant N/A N/A 
CS (1, 128) = 8,861 p < 0.003 0.065 
Not 
significant N/A N/A 
log[s] Not significant N/A N/A 
Not 




A Spearman correlation showed strong association between PIR and PAR values (Rho = 
0.983, p < 0.001) however the relationship between the two measures was much weaker 
when linear regression was performed (F(1, 128) = 50.609, p < 0.001 R2 = 0.283).  Figure 
3.5.30 shows the scatterplot for cortical PIR vs PAR.   
Table 3.5.23 Summary of linear regression analyses for both cortical PIR and PIR compared to 








A model of multiple regression with VA, CS and log[s] as predictors of PAR showed 
significance, although with a very weak association (F(3, 108) = 2.795, p = 0.044, R2 = 0.072).  
CS was the only predictor that showed significance in this model.  A significant but weak 
association was also shown with PIR as the dependent variable (F(3, 108)=3.260, p < 0.024, 
R2 = 0.083).  In contrast to PAR, CS was not a significant predictor.   The regression 
model is summarised in table 3.5.24.   
Model 
Measures of Visual Function 
Measure Coefficient t p 































Figure 3.5.30 Scatterplot showing the significant relation between cortical PIR and PAR (F(1, 128) 
= 50.609, p < 0.001 R2 = 0.283). Note: the point at (0.000, 0.000) represents all of the multiple 
data points from B-scans where there were no cortical opacities present.    
Table 3.5.24 Multiple regression analyses of OCT Cortical PIR and PAR vs measures of visual 




When stratified by age, there was no significant correlation or regression for age or any 




























3.5.4.2.1 Comparisons of LOCS III Cortical Grades and OCT Cortical Measures 
As with the nuclear PIR comparison to LOCS III N grades conducted in section 3.5.4.1.2, 
cortical PIR and PAR measures were compared to LOCS III C grades. Spearman 
correlation showed strong associations between LOCS III C grades and both cortical PIR 
(Rho = 0.799, p < 0.001) and PAR (Rho = 0.812, p < 0.001).  When stratified by age, 
strong correlations still existed in both the 60 to 70-year-old and 70-years-and-older age 
groups; correlation analyses were not possible in the 50 to 60-year-old group due to the 
cortical PAR and PIR grades being constant at 0.000.  Table 3.5.25 summarises the 
correlations for each age group. 
 
 Age Range Cortical PIR Cortical PAR 
LOCS III C 
50 - 60 N/A N/A 
60 - 70 Rho = 0.716 p < 0.001 
Rho = 0.726 
p < 0.001 
70+ Rho = 0.819 p < 0.001 
Rho = 0.910 
p < 0.001 
All ages Rho = 0.799 p < 0.001 
Rho = 0.812 
p < 0.001 
 
 
Linear regression showed moderate to strong relations of LOCS III C grades to cortical 
PAR (F(1, 128) = 99.384, p < 0.001, R2 = 0.437) and PIR (F(1, 128) = 358.740, p < 0.001, R2 = 
0.737) respectively.  Figures 3.5.31 and 3.5.32 show the scatterplots for the regressions. 
Table 3.5.25 Summary of Spearman’s correlations for both cortical PIR and PAR compared to 















Figure 3.5.31 Scatterplot showing the significant relation between cortical PIR and LOCS III C 
(F(1, 128) = 358.740, p < 0.001, R2 = 0.737).   
Figure 3.5.32 Scatterplot showing the significant relation between cortical PAR and LOCS III C 




The moderate to strong relation between LOCS III C and cortical OCT grades remained 
when stratified by age.  In both the 60 to 70-year-old and 70-years-and-older groups PIR 
showed a stronger relation to LOCS III C than PAR.  The data are summarised in table 
3.5.26.  Again, the regression was not performed for the group of those aged 50 to 60-




Cortical PIR vs LOCS III C Cortical PAR vs LOCS III C 
50 - 60 N/A N/A 
60 - 70 
F(1,43) = 70.124 
p < 0.001 
R2 = 0.620 
F(1,43) = 42.019 
p < 0.001 
R2 = 0.494 
70+ 
F(1,37) = 95.251 
p < 0.001 
R2 = 0.720 
F(1,36) = 28.579 
p < 0.001 
R2 = 0.436 
All ages 
F(1, 128) = 358.740 
 p < 0.001  
R2 = 0.737 
F(1, 128) = 99.384 
p < 0.001 















Table 3.5.26 Summary of Linear regression for both cortical PIR and PAR compared to LOCS III 




3.5.4.3 OCT Grading of Posterior Subcapsular Cataract  
Successful OCT imaging and grading of posterior-subcapsular opacification was only 
successful for one of the five participants who received LOCS III P scores over 0.1.  The 
OCT image was graded for both PIR and PAR.  The values for the left eye of participant 
number 51 were 1.267 and 0.132 for PIR and PAR respectively.  Participant number 51’s 
LOCS III P score was 1.2.  Figure 3.5.33 shows the participant’s SL retro-illumination and 
posterior high-resolution OCT images.  Statistical analyses were not performed on OCT 







Figure 3.5.33 Retroillumination of a PSC is seen (top) with a LOCS III P grade of 1.2. The 
corresponding high-resolution OCT is shown below with a PSC PIR grade of 1.267 and PAR of 
0.132; the orange arrows show the extent of the PSC.   
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3.5.4.4 Repeatability of OCT Grading 
To assess the performance of OCT grading of lens opacity, 19 randomly chosen high-
resolution B-scans (15% of imaged eyes) were regraded for PIR by the researcher (ASM). 
Figure 3.5.34 shows the Bland Altman plot for the original and regraded images.  It can be 
seen that there was very high repeatability for OCT grading of opacification.  Bias between 
the original and regraded B-scans was -0.00005.   
 
   
 
 
         













3.6.1 Participants and Success Rates 
This study effectively recruited the desired sample size of 90 participants however, as 
mentioned in section 3.5.1, the stratified age groups did not contain 30 participants each.    
The numbers of participants were slightly higher in the lower age groups simply due to the 
demographics of the University Eye Clinic where most of the recruiting was conducted. 
The exclusion criteria also played a detrimental role due to the higher presence of ocular 
disease and pseudophakia with increasing age.  Although this skewness occurred, the 
sample sizes were very similar across age groups when taking into account the numbers of 
eyes imaged with 36%, 33% and 31% of total eyes imaged in the 50 to 60, 60 to 70 and 70-
years-and-older age groups respectively.  This worked nicely for statistical analyses.   
 
Success rates for obtaining measures of visual function were excellent across all 
participants apart from retinal straylight. Visual acuity and contrast sensitivity were 
measured in 100% of eyes.  This was not the case for log[s], with only an 85% success rate.  
While VA and CS are easily and quickly performed clinical measures for which all 
participants were familiar, the C-Quant instrument was a new experience for all.  Some 
participants found the C-Quant device and its requirement for multiple trial responses 
tedious and difficult to complete.  
 
Slit-lamp imaging and LOCS III grading was also very successful in the study group with 
100% of eyes imaged at the slit-lamp and graded.  Imaging using the modified slit-lamp 
was quick to perform with photographs only taking slightly over 500ms to capture (from 
the press of the trigger). Multiple photographs could be taken in rapid succession to ensure 
gradable images were captured.  Participants also found the process easy as imaging 
required minimal cooperation only requiring positioning into the head and chinrests with 
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fixation straight ahead.  The slit-lamp objective and illumination systems also did not come 
into close contact with participants which added to their comfort.     
 
 The excellent capture rates that occurred in slit-lamp photography became slightly 
reduced upon imaging with the Visante AS-OCT.  More specifically, while low-resolution 
OCT B-scan capture rate was high at 96%, this dropped to 83% with high-resolution 
scans.  The ergonomics required during OCT imaging were much more awkward 
compared to SL imaging.  Participants were required to place their chin and forehead on 
rests which continually moved in order to achieve correct alignment and focussing of the 
crystalline lens.  The OCT instrument’s exterior and lens system were also very close to 
each participant’s face and eye respectively causing discomfort in some cases.  Finally, 
participants were required to keep their body positioning still and eye fixated on the 
internal target without blinking while images were captured.   
 
As the Visante AS-OCT is of the time-domain modality, image capture was much slower 
and therefore, more susceptible to image artefacts compared to more modern Fourier-
domain technologies.  Low-resolution B-Scan capture was more successful than high-
resolution imaging due to the faster acquisition time (256 vs 512 A-Scans) and facility to 
image the entire lens at once.  A major problem during high-resolution capture was 
acquiring adequate quality scans of the posterior lens; the limits of the focusing and 
penetration capabilities of the Visante AS-OCT were straddled to achieve this and 
therefore, caused difficulty in obtaining images.  Also, difficulty in maintaining accurate 
alignment of the eye added to the lower success rate in capturing high-resolution images of 
the posterior lens.  Due to this, any eye where a posterior high-resolution scan was not 
possible could not be graded.  It should be noted that over 750 OCT images were taken 
through the study and as it progressed, the researcher’s skill in obtaining gradable images 
increased greatly.  In one case, successful imaging of a participant with cortical cataract 
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occurred however, a power failure caused the image files to become corrupted upon 
saving.   
 
3.6.2 Visual Acuity 
Participants’ visual acuity measures corresponded well with those in the normal 
population. Elliot et al.’s (1995) data of logMAR VAs of those without ocular disease and 
stratified by age showed mean values of -0.10 (CI: 0.00 to -0.20) for those aged 50-59 
years, -0.06 (CI: 0.04 to -0.16) for those aged 60 to 69 years and -0.02 (CI: 0.08 to -0.12) 
for those aged 70 and older.  All of this study’s median and mean values for each stratified 
age group fit within the appropriate range of the above-mentioned figures.  As Elliott et 
al.’s study cohort consisted of those with optimal correction and the absence of ocular 
disease, this suggests that the participants in this study were of similar characteristics in 
regard to their refractive correction and ocular health status.  As mentioned in Chapter 3, 
while habitual correction was used to determine VA and most participants had undergone 
recent eye exams based upon their histories, the researcher used a pinhole to determine 
whether an improvement occurred in the few cases where participants were unsure of their 
last refraction; there was no improvement of VA in any of these cases.  The VA levels of 
participants suggests that most did not have a level of lens opacity that would affect high 
contrast vision.   
 
3.6.3 Contrast Sensitivity 
Most participants had good levels of contrast sensitivity across all age ranges as evidenced 
by the heavily skewed distribution.  All median CS levels for each stratified age group were 
higher than 1.80 – a normal value for those aged 20 to 50 years of age (Elliott 2007).  This 
suggests the low presence of significant cataract in the study cohort as it has been shown 
that large letter CS, like that of the Pelli-Robson chart, is often not affected by early 
cataract (Elliott and Situ 1998).  It has also been shown that early nuclear cataract only 
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begins to affect CS at spatial frequencies above 12 CPD and early cortical/PSC have a 
greater effect on CS but only at spatial frequencies above 6 CPD (Chua et al. 2004);  Pelli-
Robson CS would not be effective in this participant group as its spatial frequency is 1 
CPD and the majority of cataract in participants was nuclear, with only five having PSC.   
When stratified by age, mean and median CS levels remained within the normal range for 
each group.  As expected, lower CS was correlated and related with increasing age (Elliott 
2007; Mäntyjärvi and Laitinen 2001; Chua et al. 2004).   
 
3.6.4 Retinal Straylight 
As mentioned previously, the success rate with the C-Quant was not 100% as opposed to 
the other measures of visual function.  This may have played a major factor in its statistical 
analysis relating to cataract, as many participants with the worst levels of LOCS III NO 
and NC did not obtain a reliable log[s] value.  In fact, the eye with the highest NO and NC 
scores of 5.2 and 4.1 respectively (#41 LE) was unsuccessful in obtaining a log[s] value. 
Out of the 29 eyes with moderate NO levels of 3.0 and above, 7 (24%) were missing C-
Quant data.  The missing log[s] values for LOCS III C data were not as dramatic however, 
and as most cortical cataract was in the periphery of the lens, log[s] would most like not 
have been affected. 
   
Log[s] and VA were quite independent from one another and this has been confirmed by 
previous work comparing the two measures (Gholami et al. 2017; Michael et al. 2009; Van 
Den Berg et al. 2007).  Age was found to be related to log[s] thorough both correlation and 
linear regression analyses; this coincides with other studies comparing the two measures 
(Gholami et al. 2017; Van den Berg et al. 2013; Van Den Berg et al. 2007).  Linear 
regression and correlation also showed that participants’ log[s] increased with worsening 
CS, with very similar strengths of association between the measures as those found by 
Michael et al. (2009).        
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3.6.5 LOCS III Grading and its Interaction with Measures of Visual Function     
The results and trends were interesting when comparing measures of visual function 
against LOCS III scores.  Many of the results aligned with previous research comparing 
VA, CS and log[s] against LOCS III grades of cataract. Gholami et al. (2017) reviewed and 
performed statistical analysis on the combined results of five studies that compared log[s] 
to LOCS III grading as well as VA and CS in cataract populations.  While the various 
definitions of cataract in each interpreted study differed from one another, early cataract 
LOCS values were defined as approximately 2.0 while more moderate cataract included 
levels of 3.0 or more (Gholami et al. 2017).  The authors found increasing levels of log[s] 
with each of the age-related cataract types with PSC followed by cortical and then nuclear 
having the greatest to lowest effect respectively.     In this study, nuclear cataract had the 
strongest relation to log[s] however, the presence of cortical and PSC opacities were very 
low. All three cataract types were very early in their stages in this study with NO and NC 
median values at just over 2.0 and both C and P median values being the lowest possible 
grade of 0.1. This is in contrast to the above study that selected participants specifically for 
cataract.  Also, it should be noted that some of the studies reviewed by Gholami et al. 
(2017) did not dilate the pupil to perform LOCS III grading and so should be considered 
with caution as LOCS III requires adequate dilation in order to effectively grade opacity 
(Chylack et al. 1993).   
 
A study included in the above mentioned review article conducted by Filgueira et al. 
(2016), looked at early nuclear (14 eyes with LOCS III NO1 and NO2) and PSC (20 eyes 
LOCS III P1 and P2) grades in a population aged 50 to 70 years, and compared the 
measures to VA, contrast threshold and log[s].  The authors found a much stronger 
correlation of log[s] to LOCS III NO scores compared to this study, but this is likely due 
to the selection of participants only with cataract by Filguiera et al.  In contrast, the 
correlation between LOCS III grades and VA in Filgueira et al.’s paper was very similar to 
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this study.  Although this study and the one conducted by Filgueira et al. confirm the link 
between increasing log[s] and decreasing VA with worsening LOCS III scores, the data 
from this study may provide a more reasonable account of the relation between the 
measures as the sample size is much larger. 
 
Studies on a group of over 2000 European drivers have reported and compared the 
measurements of VA, CS, log[s] and grading of cataract using LOCS III in various ways 
(Michael et al. 2009; Nischler et al. 2010; Van Den Berg et al. 2007).  As with this study, the 
above research on European drivers showed statistically significant relations between 
increasing LOCS score and increasing log[s] as well as worsening Pelli-Robson CS and VA 
(Michael et al. 2009; Nischler et al. 2010).  These relations are all similar to this study’s NO 
and NC relations to visual function however, they were not as strong in this study.  
Michael et al. (2009) also carried out multiple linear regression with VA, CS and log[s] as 
predictors of LOCS III scores and, like the results of this study for nuclear grades, found 
them all to be significant.  It should be noted that, although the presence of cataract was 
low in this study, its results may be a better reflection of the real word for a few important 
reasons:  the above research studies in Europe did not dilate participants’ pupils prior to 
LOCS grading and the grading was also carried out by non-medical staff; the LOCS III N, 
C and P measures for each eye in these studies were also averaged together into a single 
number – a highly unorthodox practice (Van Den Berg et al. 2007; Michael et al. 2009).  
These discrepancies with LOCS III grading most likely caused an over-estimation of the 
severity of cataract and therefore, showed stronger relations to visual measures as 
compared to those in this study.    
 
While the LOCS III scores for C in this study did correlate with all measures of visual 
function, they only showed significant relations to CS and log[s] upon linear regression, 
albeit very weakly; as the presence of cortical and PSC were very low in this study it seems 
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logical, based on the limited data available, that their LOCS III measures would be related 
in the same way to measures of visual function outlined in the above reviewed studies. 
 
This study is unique in that it did not single out only LOCS III grades for eyes confirmed 
to have cataract and then compare them to measures of visual function.  The results 
showed similarity to previous research but the more fastidious attention to the correct 
LOCS III protocol, coupled with the very good inter-observer repeatability in the grading 
of cataract by clinicians, may provide a more realistic view of the interaction between 
visual function and LOCS grading of cataract.   
 
3.6.6 Comparison of OCT and LOCS III Grading of Cataract 
Overall, this study demonstrates that OCT grading of cataract was very comparable to 
LOCS III grading.  The correlations between nuclear PIR and age as well as measures of 
visual function were very similar to those between LOCS III nuclear grades and the 
measures, especially for high-resolution nuclear PIR.  Linear regression again showed 
similarities between LOCS III nuclear grades and OCT nuclear PIRs and their relation to 
age, VA, CS and log[s].  The regressions showed a slightly weaker relation between PIR 
values and all variables compared to LOCS III nuclear grades however, this may be due to 
the missing data from the poorer imaging success rates that occurred with OCT.  Things 
were different when comparing the multiple regression models of measures of visual 
function as predictors of nuclear opacity grades; while all predictors were significant for 
LOCS III NO and NC, only log[s] showed significance for high- and low-resolution PIRs; 
again this may be due to the missing data for PIR from those with higher levels of cataract 
but also could reflect the relationship between the scatter of light by the lens in disability 





There were very good agreements between the measures of opacity when nuclear PIRs 
were directly compared to LOCS III nuclear grades.  Moderate to borderline-strong 
correlations occurred between high-resolution and low-resolution PIRs when compared to 
LOCS III NO.  The correlations were similar between high-resolution PIR and NC but 
this was not the case with low-resolution PIR and NC where overall, there was a moderate 
correlation but significance disappeared in the 50 to 60 and 60 to 70-year-old groups.  In 
all cases high-resolution PIR showed a stronger correlation than low-resolution PIR to 
both NO and NC even though there were fewer images that were graded.  This suggests 
that high-resolution imaging is more effective for cataract grading.   
 
Linear regression showed a stronger trend between high-resolution PIR and LOCS III NO 
and NC grades compared to low-resolution PIR.  This was even the case although there 
was less data in the high-resolution sample.  The stronger relation between high-resolution 
PIR and LOCS III nuclear grades became more evident when data was stratified by age.  
Significant relations between high-resolution PIR and NO and NC remained for all age 
groups whereas low-resolution PIR lost significance compared to NO and NC for the 50 
to 60-year-old age group and to NC for the 60 to 70-year-old group.  To further confirm 
the stronger relationship between high-resolution PIR and LOCS III nuclear values, the 
models of multiple regression with NO and NC as predictors of either high-resolution or 
low-resolution PIRs showed a stronger relation to high-resolution scans with both NO 
and NC holding statistical significance as opposed to just NO for low-resolution scans.    
 
This study found good agreement between nuclear PIR and LOCS III measures.  There 
are many strengths compared to the previous two studies that have attempted to grade 
nuclear cataract with AS-OCT.  In Wong et al.’s (2009) study, the 55 eyes were selected 
from a population of participants with known moderate to severe cataract; this will have 
biased the slightly stronger relation they found comparing PIR to NO and NC compared 
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to this study, where the severity of cataract was low.  Wong et al. (2009) also seemed to 
have used an incorrect protocol for LOCS III assessment as their grades were on a 0.5 
rather than 0.1 interval scale; this could exaggerate the correlations between PIR and 
LOCS III.  Furthermore, unlike this study, raw sensor data was not used to determine 
pixel intensity by Wong et al (2009); the authors used commercial software to analyse the 
B-scans that were pre-processed by the Visante AS-OCT and captured using the 
instrument’s corneal imaging mode.  This study utilised a much more robust method by 
processing and analysing the Visante AS-OCT’s raw sensor data using custom software to 
ensure as little as possible information was lost.  An example of this is the lack of a 
correlation between VA and either OCT or LOCS III grades by Wong et al. (2009).  This 
study had much lower LOCS III NO and NC grades compared to Wong et al. but 
correlation and regression found significant associations between VA and both PIR and 
LOCS III nuclear measures.  It is most likely that the incorrect LOCS III grading scale was 
not sensitive enough to find any correlation by Wong et al (2009).  Also, the possible loss 
of information in the methods used by Wong et al. for processing and analysis of the B-
scans may have also contributed to the lack of correlation.   
 
The methods in relation to LOCS III grading used by Kim et al. (2016) in their study 
assessing nuclear cataract with a surgical OCT system have also shown weakness 
compared to this study.  Kim et al. (2016) graded cataract in 47 eyes with LOCS III NO 
scores above 3.0 however the researchers, similarly to Wong et al. (2009), erroneously used 
a 0.5 interval to assign grades, rather than the correct scale of 0.1.  In their analysis of OCT 
images for nuclear opacification, the researchers did not appear to grade the anterior 
chamber to determine a background pixel intensity; this will most likely have affected their 
nuclear OCT grades as there is certain to be, at least slight, variation in background 
intensity between different images.  Kim et al. (2016) did still find a significant correlation 
between their OCT measure of nuclear cataract and LOCS III NO scores.  As described 
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above in relation to the study by Wong et al. (2009), the methods developed and utilized in 
this study also provide a much more convincing association between LOCS III and OCT 
based assessment of cataract as compared to those by Kim et al. (2016). 
 
This study is the first to assess cortical cataract using OCT. While there was a low presence 
of cortical cataract in the study cohort, an effective and objective grading system through 
the use of PIR and PAR was developed. Both PIR and PAR were useful measures of 
cortical opacification based upon the morphology of cortical opacity; in some cases, the 
size of cortical opacity was large but low in intensity while in others, the exact opposite 
occurred.  This is reflected in the correlation and regression analysis comparing cortical 
PIR and PAR; the measures were strongly correlated but moderately related under 
regression precisely because of this discrepancy between size and intensity of opacification 
in some cases.   
 
Cortical PIR and PAR measures were very comparable to LOCS III C grades showing a 
moderate to strong association in both correlation and regression analyses. This is 
reinforced by the similar correlation and regression strengths between each measure of 
opacification and age, as well as measures of visual function; although PIR and PAR were 
not associated with straylight while LOCS III C was, this is most likely due to inadequate 
data obtained resulting from the lower success rates of OCT capture and acquisition of 
log[s] values. The two variations of measuring opacity with OCT also present a great 
strength compared to LOCS III grading as the latter technique requires the observer’s 
subjective opinion of cortical area with specific disregard to darkness or colour when 
grading cortical or PSC opacities.  There is a limitation to the OCT analysis of cortical 
opacity in this study as only single B-scans through the greatest position of cortical cataract 
could be imaged; this can be corrected in the future through the use of the much faster 
and higher-resolution SS-OCT technology in the form of rasterised volumetric scans of 
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the entire crystalline lens.  
 
There are only two other studies examining non-nuclear cataract with OCT.  Chan et al. 
(2014) imaged 37 eyes with significant posterior polar cataract requiring surgery and 
developed a grading system based upon the position of the opacity in regard to the 
posterior capsule.  This was a rudimentary grading system that did not involve any 
objective analysis using software, but simply relied on the observer to estimate the position 
of the opacity when viewing the B-scan (Chan et al. 2014).  In a small report, Kymionis et 
al. (2014) also imaged posterior polar cataract in three patients using a Visante OCT as a 
means of assessing capsule integrity. While Chan et al.’s and Kymionis et al.’s work 
focused on assessing posterior polar cataract in order to identify risk of capsule rupture 
during surgery, this study presents a much more robust method of assessing the 
morphology and severity of lens opacity objectively and could be used for this purpose as 
well. The fact that PSC, which is much subtler in appearance to polar cataract, was 
successfully imaged and graded with OCT in this study further supports this method as an 
















This study set out to develop a robust and objective method of assessing lens opacity using 
AS-OCT.  Through the development of customised software for processing, segmenting, 
and grading raw OCT sensor data, and a protocol for acquiring high quality B-scans of the 
crystalline lens, this has been achieved.  OCT measures of PIR and PAR were comparable 
to LOCS grades for nuclear, cortical, and posterior-subcapsular opacity but the developed 
method of OCT analysis allows any area of the lens to be graded, enabling the assessment 
of non-age-related opacification.  Furthermore, the high repeatability of this method 
reinforces its objectivity.   
 
The major limitation of this study is the use of the time-domain modality of OCT 
acquisition.  Even in its high-resolution mode, the Visante AS-OCT captures at a slow rate 
and inferior resolution compared to more modern Fourier-domain modalities.  In High-
resolution mode, the Visante AS-OCT only allowed capture of a single B-scan along one 
meridian of one-half of the crystalline lens at a time.  As mentioned previously, more 
modern SS-OCT technology would allow high-speed rasterised volumetric scans of the 
entire lens; this would enable opacities to be segmented and graded in entirety as opposed 
to through one section of the lens containing the greatest level of opacity.   
 
Overall, this study has demonstrated a method of imaging and grading lens opacity that is 
superior to the commonly used subjective methods.  The Visante’s high-resolution 
imaging of the crystalline lens and the subsequent analysis using the custom software, gives 
the ability to objectively assess opacity at any location within the crystalline lens.  Further 
work is warranted in applying this modality using more modern OCT technology, and 
developing the software to shift from manual to automated segmentation and analysis.  
This will provide a complete tool for screening and monitoring the progression of cataract.  
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Finally, OCT imaging and analysis is applicable to both age-related and all other forms of 
lens opacity and, therefore, presents an ideal solution of monitoring the condition in 
































The following section will outline studies involving assessment of cataract in a Down 
Syndrome population and, as a corollary, the assessment of retinal structure in this same 
cohort using OCT.  As mentioned in Chapter 1, there is a paucity of information 
surrounding the severity and morphology of cataract that exists in DS.  Also, the disputed 
link between cataract and beta-amyloid requires the determination of the typical 
characteristics of lens opacity in DS.  The method developed in Chapter 3 was used to 
assess lens opacity while the retina was imaged using the Spectralis OCT described in 
section 2.1.5.2.  The imaging and assessment of these two structures will be discussed in 
chapters 5 and 6 while the methods are outlined below. 
 
4.2 Sample Size Determination and Recruitment 
4.2.1 Sample Size 
The sample size was determined through a power calculation based on 90% power and 5% 
significance.  A 59% prevalence of cataract in a DS population aged 40 years and over 
(Castane et al. 2004) against a 33% prevalence in a typically developed population aged 70 
to 79 years (Reidy et al. 1998) was used in the calculation.  Based on this, the sample size 
was determined to be 30 participants.  The participant age range was selected to be from 





















Participants were recruited from the paediatric and special needs clinic at Ulster 
University’s optometry department which contains a cohort of children with DS.  Those 
within the specified age range and who met eligibility criteria were identified through 
patient records; their parents or guardians were contacted via telephone to determine 
interest in participation.  Appointments were set for participants to attend a one-hour 
appointment at the eye clinic at Ulster University; all parents and guardians were given a 
PIS and consent form to sign (see appendix A-3).  Parents and guardians of participants 
with DS who were attending the eye clinic were also solicited for participation.  In this 
case, PIS and consent forms were given directly to parents and guardians; is some cases 
they elected to participate in the study directly after the eye exam and in others, 
appointments were made for them to return at a later date.   
 
Young adults and children with DS were also recruited from the Down’s Syndrome Vision 
Research Unit at Cardiff University.  This centre is the UK’s largest research unit 
examining vision and the eye in DS.  Potential participants who fit the eligibility criteria 
were identified from the cohort of over 250 and an information package was mailed to 
their parents and guardians inviting them to take part in the research.  The information 
package consisted of a PIS and consent form (Appendix A-4) with contact details.  
Interested participants contacted the Eye Clinic at the Cardiff University School of 
Optometry and Vision Sciences to set up an appointment.  The researcher attended the 
clinic at Cardiff University for a two-week period to carry out the study on participants. 
 
Two other avenues were undertaken to recruit potential participants directly from the 
community.  Firstly, the researcher along with his supervisor (JAL) attended a meeting at 
the Up and Downs: a community group of parents caring for children with DS. A general 
presentation on DS and vision was given to parents and then they were solicited for 
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participation in this study.  PIS as well as consent forms were given out and any queries by 
parents were answered.  Parents were then asked to book in for their children to attend an 
appointment at Ulster University’s Eye Clinic.   
 
Finally, adult participants were recruited from two Health and Social Care Northern 
Ireland (HSCNI) Northern Trust Day Centres:  Millbrook in Ballymoney and Mountfern 
in Coleraine.  The researcher liaised with the manager of each centre for an information 
package containing the various PISs and consent forms (Appendix A-3) to be sent out to 
the parents, guardians or participants directly, if they were able to consent for themselves.   
Participants were then booked via the day centre managers to visit the university Eye 
Clinic for participation in the study.  Transportation to and from the clinic was arranged 
by the day centre.  
 
4.3 Ethical Approval 
Ethical approval was received from the UUREC, the Northern Health and Social Care 
Trust (NHSCT) and the Office for Research Ethics Committee Northern Ireland 
(ORECNI) (Appendix A-3).  These approvals were for the recruiting of participants from 
Northern Ireland and with the Ulster University Vision Research Laboratory as the 
research site.  For those participants seen at Cardiff University, an amendment was made 
for the blanket research ethics approval in place for the Down’s Syndrome Research Unit 




The following section will outline the procedures and assessments that were carried out on 
participants in Northern Ireland at the Vision Science Research Laboratory, Ulster 
University and in Wales at the Cardiff University School of Optometry and Vision 
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Sciences.  Participants were seen on one occasion for approximately one hour.  If 
participants were children, their parents or guardians were asked to sign a consent form on 
their behalf (Appendix A-3).  If participants were adults who were unable to consent, an 
assent form was signed on their behalf by their parent or guardian (Appendix A-3); if they 
were adults able to consent, they were asked to sign a simplified consent form themselves 
(Appendix A-3).  The researcher also signed all consent and assent forms.  The study was 
conducted on both eyes unless either met any exclusion criteria:  
• Undergone cataract surgery 
• Nystagmus 
• Ocular albinism 
• Significant corneal or lenticular (apart from cataract) pathology adversely affecting 
imaging of the crystalline lens and retina 
 
4.4.1 Ophthalmic and Systemic History 
Parents or carers were questioned in regard to participants’ ophthalmic and systemic 
histories on initial attendance for their appointment.  This was to confirm adherence to the 
inclusion criteria and to ensure no increased risk to pharmacologic pupil dilation.  
Ophthalmic history included questions on spectacle wear, presence of pathology and any 
previous or current surgical or medical treatment to the eyes.  Systemic history included 
questions on the presence of any general medical conditions, current medications and the 
presence of any allergies.  The exclusion criteria for the study are mentioned above.  
Finally, the previous occurrence of any adverse reaction to pharmacologic pupil dilation 






4.4.2 Visual Acuity 
Following the assessment of participant history, an evaluation of visual acuity was 
undertaken.  Distance VA was measured monocularly with participants’ habitual 
correction in place.  For those capable of reading letters and with sufficient intellectual 
capacity, VA was recorded in logMAR using the Keeler Crowded logMAR test; if this was 
not possible, the Crowded Kay Picture test was used.  Both tests were carried out under 
normal room illumination at a distance of 3m.  To determine the initial point of testing, 
the Keeler Crowded logMAR test uses a series of screening cards where four letters are 
presented in decreasing size in accordance with the logarithmic scale. The test was 
conducted using the crowded series of four letters at the smallest screening letter size 
identified by the participant.  The Kay picture test consists of a booklet with each page 
containing a series of four pictures subtending a specific degree of visual angle; the 
pictures decrease in size logarithmically on each page.  For either test, a habitual VA for 
each eye was determined using individual letter scoring. If participants were non-verbal, a 
matching card was provided enabling them to indicate pictures or letters using their 
fingers.       
 
4.4.3 External Eye, Anterior Chamber and Intraocular Pressure Assessment 
In order to determine the presence of any pathology that would preclude imaging and to 
assess the anterior chamber to ensure that it was safe to dilate the pupil with tropicamide 
1%, the anterior eye was examined with a slit-lamp.  Additionally, IOP was measured as 
another means of determining safe conditions for pupil dilation. 
 
4.4.3.1 External Eye Assessment 
The external eye of all participants was examined using a slit-lamp biomicroscope.  
Participants were asked to place their chin and head on the slit-lamp’s rests and asked to 
fixate straight ahead.  If participants’ intellectual disability interfered with fixation, the 
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researcher used hand movements and verbal encouragement to capture their attention and 
obtain momentary views of the eye; this allowed a thorough assessment of the eye within a 
few minutes time.  White light was used to examine the eye. The angle and width of the 
microscope’s illumination was varied to accurately assess the external eye, with an 
emphasis on the cornea, iris and crystalline lens.  If any pathology such as severe 
keratoconus or corneal opacities that would impair imaging were discovered, the eye was 
excluded from the study. 
 
4.4.3.2 Anterior Chamber Angle Assessment 
As described in Chapter 3, pharmacologic pupil dilation carries a risk of inducing acute 
angle closure glaucoma in those who are anatomically predisposed.  The Van Herrick 
technique was used to determine whether the irido-corneal angle was sufficiently open to 
proceed with the instillation of tropicamide 1% eye drops. This was conducted during the 
external eye assessment and the technique used is described in Chapter 3.  Any participant 
whose grade was 1 or less was excluded from the study.  Angle estimation using the Van 
Herick technique requires accurate fixation for reliability and repeatability however, as this 
group consisted of members with intellectual disability where accurate fixation would not 
always be possible, the researcher used his judgement as a clinician as to whether the angle 
was sufficiently open to warrant pupil dilation.  
 
4.4.3.3 Intraocular Pressure Measurement 
To mitigate and detect any angle closure as an adverse reaction to tropicamide 1%, pre- 
and post-dilation IOPs were measured in all participants using the ICare (ICare, Finland) 
tonometer.  The ICare tonometer did not require the use of any anaesthetic to numb the 
cornea and, in contrast to pneumatic non-contact tonometry, provided a nearly sensation 
free method of measuring IOP; this was ideal for participants with intellectual disability.  
As per manufacturer instructions, a total of five measurements were taken of each eye to 
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obtain an accurate estimation of IOP.  A comparison between pre- and post-dilation IOPs 
was made to ensure a sharp rise had not occurred.  Post-dilation IOPs were measured at 
the end of participants’ one-hour appointment.  
 
4.4.4 Posterior-Segment Optical Coherence Tomography 
After IOP assessment, tropicamide 1% was instilled in each imaged eye to induce pupil 
dilation and thereby facilitate imaging of the crystalline lens.  As tropicamide takes 
approximately 20 minutes to reach its full effect on the pupil, OCT scans of participants’ 
retinae were taken at this time.  PS-OCT does not require pupil dilation to obtain adequate 
quality images and the Spectralis OCT described in Chapter 2 was used for retinal imaging.  
Attempts were made to image the macula, including fovea, and peripapillary retinal nerve 
fibre layer (RNFL).   
 
Participants were seated and asked to place their chin and forehead on the Spectralis’ 
respective rests.  Their head was aligned correctly by adjusting the chin rest vertically and 
they were asked to look at the internal fixation target consisting of a blinking blue spot of 
light.  To focus the instrument, its joystick was maneuvered by the researcher to view the 
retinal cSLO image; this was then brought into sharp focus by adjusting the appropriate 
knob on the Spectralis.  When focus was achieved and the appropriate cross-section of the 
retina to be imaged was correctly aligned, the automated retinal tracking system of the 
Spectralis OCT was initiated.  Initially, line scans were taken of the macula ensuring 
centration on the fovea.  Line scans were followed by macular cube scans.  Following the 
macular scans, peripapillary RNFL scans were obtained.  For this, participants were 
required to shift their gaze nasally; the internal fixation light of the Spectralis moves for 
this purpose.  If participants had difficulty fixating on the internal blue light, the external 
fixation target was used.   
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Macular scans were analysed using the Early Treatment of Diabetic Retinopathy Study 
(ETDRS) grid (see figure 4.4.1); the Spectralis’ viewing software defined macular thickness 
as the distance between Bruch’s membrane and the internal limiting membrane.  The 
peripapillary RNFL scan consisted of a circle scan surrounding the optic nerve head as 
shown in figure 4.4.2.  The Spectralis’ software automatically segmented the RNFL and 
calculated thickness globally as well as for six peripapillary sectors.  Line scans were 
analysed for minimum foveal thickness as shown in figure 4.4.3 and also for foveal pit 
depth by averaging the thickest nasal and temporal measurements of the line scan and 
subtracting the minimum foveal thickness.   
 





Figure 4.4.1 The ETDRS grid analysis conducted by the Spectralis OCT.  Average thickness 
values are shown in black text while volumes are shown in red.  The ETDRS grid consists of a 
central 1mm ring surrounded by 3 and 6mm rings which are further subdivided into superior, 












Figure 4.4.2 The RNFL analysis conducted by the Spectralis OCT.  The circular grid in the 
bottom right hand corner of the image shows the mean thickness in each subfield (in black text) 
with the values from the normalised database in green.      
Figure 4.4.3 A Spectralis line scan through the macula. The area of minimum thickness has been 
selected with the green reference line showing a value of 224 µm.      
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4.4.5 Crystalline Lens Slit-Lamp Imaging and LOCS III Grading 
After imaging with the Spectralis OCT, participants were given a short break to ensure 
maximum pupil dilation and to avoid fatigue.  Following this, crystalline lens imaging was 
undertaken using the modified Nikon FS-3 slit-lamp described in Chapter 2.  The same 
camera and slit lamp settings described in Chapter 3 were used: 
3. Camera Settings: 
a. ISO sensitivity: 6400 
b. Flash Intensity: Level #9 (1/60s of LED at full brightness) 
c. Shutter Speed: 1/60s  
4. Slit-Lamp Settings: 
a. For imaging the Nucleus: 
i. Slit width: 0.2mm 
ii. Slit height: Extended over pupillary margins 
iii. Angle of illumination: Exactly 45 degrees to objective lenses 
iv. Filter: None 
b. For Imaging Cortical and PSC opacities: 
i. Slit width: Variable, usually between 3-5mm 
ii. Slit height: Variable – enough to provide adequate retroillumination 
iii. Angle of illumination: 3-5 degrees to objective lenses 
iv. Filter: None 
Both optic sections and retroillumination images were taken of all crystalline lenses.  
Participants were seated at the slit-lamp and asked to place their chin and head on the 
appropriate rests.  The chinrest was adjusted vertically to correctly align the participant’s 
head in the microscope.  The participant was asked to look straight ahead but if they 
experienced difficulty doing this, the researcher used hand movements and verbal 
communication to keep their attention.  Participants were told they would see a flashing 
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light when the photographs were taken.  All images were captured with the room lights 
switched off.  Multiple photographs were taken so that the best quality image could be 
used for grading.  
 
LOCS III grading was attempted for all photographs.  Images were graded at the same 
computer terminal and monitor with the settings described in Chapter 3.  The 
transparency of LOCS III standard images was illuminated by the lightbox described in 
Chapter 3 and set directly beside the monitor for grading.  Grades were assigned for the 
three types of cataract LOCS III is capable of characterising (Chylack et al. 1993).  A 
detailed outline of the LOCS III grading process has been described in Chapter 3.  It 
should be noted that if any dot or flake like opacity that has been reported in DS was seen 
on retroillumination, it was graded as a cortical opacity in line with the LOCS III protocol. 
 
4.4.6 Visante Anterior Segment Imaging and Grading 
Once slit-lamp photography was conducted, participants’ crystalline lenses were imaged 
with the Visante AS-OCT.  Again, participants were seated at the instrument with their 
head and chin placed on the Visante’s respective rests and asked to look at the internal 
fixation target.  Their eyes were then aligned by adjusting chin and forehead position using 
the Visante’s controls.  The crystalline lens was brought into focus for imaging; to ensure 
correct alignment, the corneal reflex was visualised.  Images were captured when the 
corneal reflex just disappeared in order to facilitate subsequent grading of the images for 
opacity.  B-scans of the lens at a 90-degree orientation were taken to coincide with slit-
lamp images however, if participants’ lids interfered with imaging due to narrow palpebral 
aperture, 180-degree B-scans were also acquired.  B-scan orientation was also adjusted to 
image any other opacities seen in the lens during slit-lamp imaging.  As seen in chapter 3, 
because of the superior imaging quality, crystalline lenses were captured in the Visante’s 
high-resolution mode. As opposed to the 6mm imaging depth possible with low-resolution 
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B-scans, high-resolution scans are only capable of a 3mm imaging depth; therefore, 
separate B-scans of the anterior and posterior lens were acquired.  B-Scans were graded for 
opacity using the custom software described in Section 3.4.7.1.  In anticipation of dot-like 
opacities that have been reported in DS, these would be graded in a similar manner to 
cortical and PSC morphologies.  In addition to PIR and PAR the total number of dot 
opacities would be counted as well.  
 
Chapter 5 outlines the results and discussion for lens opacity in DS while Chapter 6 does 
the same for PS-OCT imaging.  
                         



















Chapter 5: Cataract in Down Syndrome 
5.1 Introduction 
This chapter discusses the results and interpretation of the assessment of the Down 
Syndrome crystalline lens as outlined in the Chapter 4.  Imaging of the lenses obtained 
using the slit-lamp and Visante AS-OCT and their grading are discussed.  Comparisons are 
made to the crystalline lens opacities in the 50 to 60-year-old group of typically developed 
individuals studied in Chapter 3.  Firstly, the recruitment and success rates are outlined 
below followed by descriptions of participants’ visual acuities and measures of lens opacity 
with slit-lamp grading and anterior segment OCT imaging. 
 
5.2 Results 
5.2.1 Recruited Participants 
In total 30 participants were recruited from the various agencies stated in section 4.2.2.  
Two participants were excluded from the study leaving a total cohort of 28. The first 
excluded participant was diagnosed with a brain tumour and the second was a wheelchair 
user and therefore, unable to complete any assessment or imaging.  Attempts were made 
to image both eyes of all included participants however in two participants one eye was 
excluded due to the presence of pathology (corneal degenerative disease with 
neovascularisation and esotropia respectively).   This meant that attempts were made to 
image 54 eyes from the 28 participants.  The mean age of participants was 24.10 ± 14.20 
(SD) years with a range of 6.05 to 55.36.  The cohort consisted of 17 males and 11 








5.2.2 Visual Acuity Assessment 
Monocular habitual VA was successfully measured in 51 of 54 eyes (94%).  Habitual 
refractive correction was worn for all participants, though in a few cases, it was not 
possible to determine whether spectacles were worn typically.  The missing measurements 
were from two participants: in one case, VA could not be obtained from either eye of the 
participant due to lack of cooperation and in the second, the participant was only able to 
complete VA measurement in the right eye.  The distribution of VA for all measured eyes 
was not normal (Shapiro-Wilk, p<0.001) with a median value of 0.300 ± 0.275 (IQR) 
logMAR.  VA in measured eyes ranged from 0.050 to 0.800 logMAR.  When grouped by 
whether VA was measured using letter or picture optotypes, the distribution containing 
letter VA was not normally distributed (Shapiro-Wilk, p=0.002) but picture acuity was 
normally distributed (Shapiro-Wilk, p=0.219).  Participants’ VA levels were compared to 
the typical adults aged 50 to 60-years described in chapter 3; a Mann-Whitney U test 
showed a significant difference between both groups (U = 80.00, p < 0.001) with worse 
VA in those with DS.  Table 5.2.1 outlines the descriptive statistics for the DS and typical 
adults acting as control groups.  Figures 5.2.1, 5.2.2 and 5.2.3 show the histograms and Q-
Q plots for VA in the DS group.  









DS Letter  




0.800  0.275 (0.250) p < 0.001 22.25 (9.92) 
DS Picture 




0.800 0.400 (0.381)  p = 0.219 25.08 (17.67) 
Total DS  




0.800 0.300 (0.275) p < 0.001 23.25 (13.08) 
Controls  






(0.155) p < 0.001 54.11 (3.25) 
 Table 5.2.1 Summary of VA distributions’ mean, median, range and indicators of 










Figure 5.2.1 Histogram and Q-Q Plot of VA frequencies from all 18 DS eyes measured with 
letter optotypes.   
Figure 5.2.2 Histogram and Q-Q Plot of VA frequencies from all 33 DS eyes measured with 
picture optotypes.   
Figure 5.2.3 Histogram and Q-Q Plot of combined VA frequencies from all DS eyes measured.   
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Spearman rank order analysis showed a moderate correlation between habitual VA and age 
for all 26 DS left eyes (rho = 0.640, p < 0.001).  Linear regression also showed a relation 
between VA and age albeit less than the correlation between the two measures (F(1, 24) = 













Figure 5.2.4 Scatterplot showing the significant relation between VA and age for 
the left eye only (F(1, 24) = 17.135, p < 0.001, R2 = 0.417).   
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5.2.3 LOCS III Grading of Crystalline Lenses in Down Syndrome 
Slit-lamp imaging and subsequent LOCS III grading for at least one measure of opacity 
was successful in 39 of the 54 imaged eyes.  The below sections outline the results for 
nuclear, cortical and posterior subcapsular measures of opacity.   
 
5.2.3.1 LOCS III Nuclear Opalescence and Colour 
LOCS III NO and NC scores were obtained for all 39 imaged eyes.  The scores for NO 
were not normally distributed (Shapiro-Wilk, p < 0.001) and scores ranged from 0.1 to 2.2 
with a median of 0.4 ± 0.4 (IQR).  NC scores ranged from 0.1 to 2.5 with a median value 
of 0.3 ± 0.4 (IQR) and the distribution was, again, not normal (Shapiro-Wilk, p < 0.001).  
When compared, Mann-Whitney U tests showed significant differences between both DS 
NO and NC scores and those of the control group.  NO and NC grades of opacity were 
higher in controls (NO: U = 112.00, p < 0.001; NC: U = 158.00, p < 0.001).  Figures 5.2.5 
and 5.2.6 show the histograms and Q-Q plots for NO and NC scores in the DS group. 
Figure 5.2.7 shows pictures of lenses with no and significant opacity.  Table 5.2.2 describes 
the distribution of NO and NC in the DS and control groups.   




n = 39 
NO 0.5 (0.5) 0.4 (0.4) 0.1 to 2.2 p < 0.001 
NC 0.5 (0.6) 0.3 (0.4) 0.1 to 2.5 p < 0.001 
Controls 
n = 56 
NO 1.8 (0.3) 1.8 (0.4) 1.2 to 2.7 p = 0.040 
NC 1.7 (0.5) 1.8 (0.8) 0.5 to 2.5 p = 0.442 
   
 
 









For the DS group, Spearman’s rank order analysis showed significant correlations between 
both LOCS III nuclear measures and age as well as VA.  Age was very strongly correlated 
and VA was moderately correlated; the data are summarised in table 5.2.3.   
 
NO NC 
Rho Sig. Rho Sig. 
DS Age 0.794 p < 0.001 0.858 p < 0.001 
DS VA 0.332 p = 0.039 0.455 p = 0.004 
 
 
Table 5.2.3 Summary of Spearman’s rank order correlation between NO, NC and age as well as 
VA for participants with DS.   
Figure 5.2.5 Histograms for total participant NO (left) and NC (right) with overlaid distribution 
curves. 
Figure 5.2.6 Q-Q plots of participant NO (left) and NC (right) values showing deviation 
from normalcy in both cases. 
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Linear regression was performed to compare both LOCS III nuclear measures to age and 
VA.  Similar significant relations were found as in the above correlations however, VA was 
not as strongly related to either NO or NC.  Table 5.2.4 summarises this data. 
 
NO NC 
F Sig. R2 F Sig. R2 
DS Age (1, 37) = 117.531 p < 0.001 0.761 
(1, 37) = 
135.566 p < 0.001 0.786 
DS VA (1, 37) = 6.075 p = 0.018 0.141 
(1, 37) = 




Figures 5.2.7 and 5.2.8 show the scatterplots for the above linear relationships between 
NO, NC compared to Age and VA.   
Table 5.2.4 Summary of linear regression between NO, NC and age as well as VA for 






Figure 5.2.7 Scatterplots showing the significant relation between NO and Age (top) and 








Figure 5.2.8 Scatterplots showing the significant relation between NC and Age (top) and 





















Figure 5.2.9 Optic sections of crystalline lenses showing no opacity (Left) (Participant 16 




5.2.3.2 LOCS III Cortical Grading 
A total of 15 DS eyes (28%) were successfully imaged and scored for LOCS III C grades.  
The distribution of C values was not normal (Shapiro-Wilk, p = 0.009) and grades ranged 
from 0.1 to 2.4 with a median of 0.5 ± 0.7 (IQR).  Grades above 0.1 occurred in 12 (80%) 
of the imaged eyes.  A Mann-Whitney U test showed that C grades were significantly 
greater in the DS group when compared to controls (U = 115.500, p < 0.001).  Spearman’s 
correlation analysis showed no association between C and either Age or VA.  The same 
held true for linear regression, with no relation between C and the variables.   Figure 5.2.10 
shows the histogram and Q-Q plot for the distribution of LOCS III C grades and table 
5.2.5 summarises the distribution and above-mentioned correlation and regression 
analyses. Figure 5.2.11 demonstrates a clear lens and one with opacity. 
 
 




Age VA Age VA 
C 














Figure 5.2.10 Histogram (left) and Q-Q (right) plots of the C distribution for all gradable 
images, showing skewness.  
Table 5.2.5 Summary of descriptive statistics of C grades and analyses of correlations 














Figure 5.2.11 Retroillumination images (top) and corresponding optic sections of 
crystalline lenses showing no opacity (Left) (LOCS III C: 0.1) and cortical dot opacities 




5.2.3.3 LOCS III Posterior Subcapsular Grading 
As with the above cortical grading of lens opacity, only 15 eyes (28%) were gradable for 
LOCS III P opacities.  P grades above 0.1 were only present in two eyes from two separate 
participants.  Naturally, the distribution of P grades was not normal (Shapiro-Wilk, 
p<0.001).  The P grades above 0.1 were in the eyes of the eldest and third-eldest 
participants aged 55.36 and 53.92 years respectively.  These two eyes also had poor VAs of 
0.800 and 0.650 logMAR respectively.  The presence of posterior subcapsular opacification 
differed from controls as there was no presence of the opacities in the latter population. 
Figure 5.2.12 shows the histogram and Q-Q plots and table 5.2.6 summarises the 
distribution of LOCS P values in DS. 
 
 
 Median IQR Range Mean Std. Dev. Shapiro-Wilk 
P 
(n = 15) 0.1 0.0 0.1 to 2.3 0.4 0.7 p < 0.001 
 
 
Spearman’s analyses showed a correlation between P and Age (Rho = 0.587, p = 0.022) 
but not VA.  Linear regression analyses also showed a relation between P and Age (F(1, 13) = 
21.919, R2 = 0.628 p < 0.001) and VA (F(1, 13) = 6.153, R2 = 0.321, p = 0.028).  Figure 
5.2.13 shows the scatterplots for the comparisons showing the outliers; once these were 
Figure 5.2.12 Histogram (left) and Q-Q (right) plots of the P distribution for all gradable 
images, showing skewness.  
Table 5.2.6 Summary of descriptive statistics of P grades and analysis of normality 
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removed the correlations and regressions became, expectedly, insignificant. Figure 5.2.14 














Figure 5.2.13 Scatterplots showing the relation between P and Age (left) and VA (right) and 
the effect of the outliers. 
. 
Figure 5.2.14 Retroillumination images of crystalline lenses showing PSC in the only two 




5.2.4 OCT Grading of Lens Opacity in Down Syndrome 
5.2.4.1 OCT Nuclear Grading 
High resolution anterior and posterior B-scans of the crystalline lens were captured in 33 
(61.11%) of the 54 imaged eyes in DS.  The images were graded to determine nuclear PIR.  
PIR values were not normally distributed (Shapiro-Wilk, p < 0.001) with a median of 1.188 
± 0.70 (IQR); values ranged from 1.102 to 1.454.  Figure 5.2.15 shows the histogram and 




When compared to controls, a Mann-Whitney U test showed that nuclear PIR was 
significantly lower in those with DS (U = 277.500, p < 0.001).  Spearman’s correlation 
analyses showed significant associations between nuclear PIR and both age and VA.  
Linear regression also showed moderate relations between nuclear PIR and both age and 




Correlation Linear Regression  Rho Sig. 
Age 0.666 p < 0.001 F(1, 31)=34.110, R2 =0.524, p<0.001 
VA 0.578 p < 0.001 F(1, 31)=9.238, R2=0.230, p=0.005 
 
  
Figure 5.2.15 Histogram and Q-Q plot describing the distribution of Nuclear PIR in the DS 
group. 
. 
Table 5.2.7 The statistics correlation and regression analyses performed between Nuclear PIR 














5.2.4.1.2 Comparison of Nuclear PIR to LOCS III Nuclear Grades 
As with controls, LOCS III nuclear grades were compared to nuclear PIR values.  
Spearman’s analysis showed significant correlations between PIR and both NO and NC, 
with moderate strength of association for both measures.  The strength of correlations 
between the measures was very similar to those in the control group; the correlations for 
both groups are summarised in table 5.2.8. 
 
 Group High-Resolution PIR 
LOCS III NO 
DS Rho = 0.360 p = 0.047 
Controls Rho = 0.420 p = 0.004 
LOCS III NC 
DS Rho = 0.437 p = 0.014 




Linear regression analyses were performed to compare nuclear PIR values to LOCS III 
NO and NC grades.  Significant relations of moderate strength were found.  These 
relations were much stronger than those found in controls and are shown in Table 5.2.9.  
Figure 5.2.17 shows the scatterplots for the regressions in the DS group. 
 Group High-Resolution PIR 
LOCS III NO 
DS 
F(1, 29) = 25.932 
R2 = 0.467 
p < 0.001 
Controls 
F(1,44) = 9.363 
p = 0.004 
R2 = 0.175 
LOCS III NC 
DS 
F(1, 29) = 22.715 
R2 = 0.460 
p < 0.001 
Controls 
F(1, 44) = 8.256 
p = 0.006 
R2 = 0.158 
 
 
Table 5.2.8 Summary of the correlations between Nuclear PIR and LOCS III grades for both 
DS and control groups. 
. 
Table 5.2.9 Summary of the regression analyses between Nuclear PIR and LOCS III grades 











Figure 5.2.17 Scatterplots showing the relation between Nuclear PIR and LOCS III NO 




5.2.4.2 OCT Cortical Grading in DS 
As mentioned previously, the presence of cortical lens opacities was high in the DS group.  
A total of 33 high-resolution AS-OCT B-scans were graded for cortical opacity.  One 
participant showed traditional cortical cataract in both eyes and successful grading was 
performed for cortical dot opacities in 16 other eyes. 
 
The participant with traditional cortical cataract was 26.67 years-old with PIRs of 1.383 
and 1.456, and PARs of 0.049 and 0.148 in right and left eyes respectively.  All other 
participants received a grade of 0.000 for cortical PIR and PAR. Naturally, there was no 
correlation between the presence of age-related cortical cataract and either age or VA.  
Comparisons were not made between this type of cataract in the DS group and that in 
controls as none of the control participants with cortical opacities were successfully 
imaged with AS-OCT.  
 
Cortical dot opacities were graded for PIR, PAR, and number of opacities present in the 
cortex.  Those lenses without the presence of any dot opacities were given a score of 0.000 
for each measure.  The distributions of dot PIR, PAR, and number of dots were not 
normal in any case (Shapiro-Wilk). Table 5.2.10 summarises the distribution for each 
measure of dot opacity and figures 5.2.18, 5.2.19 and 5.2.20 show their histograms and Q-
Q plots.  
Measure Median IQR Range Mean Std. Dev. Shapiro-Wilk 
Dot PIR 
(n = 16) 0.000 1.299 
0.000 to 
1.1680 0.643 0.678 p < 0.001 
Dot PAR 
(n = 16) 0.000 0.017 
0.000 to 
0.138 0.021 0.040 p < 0.001 
Number 
of Dots 
(n = 16) 
0.00 9.00 0 to 50 7.58 13.45 p < 0.001 
 
 














Figure 5.2.18 Histogram and Q-Q plot describing the distribution of Cortical Dot PIR in the 
DS group. 
. 
Figure 5.2.19 Histogram and Q-Q plot describing the distribution of Cortical Dot PAR in 
the DS group. 
. 
Figure 5.2.20 Histogram and Q-Q plot describing the distribution of number of cortical dots 




Spearman’s rank order analyses showed that dot PIR, PAR and total number were not 
associated to either participant age or VA.  Naturally, linear regression analyses also did 
not show any relations between the measures of dot opacity and VA or age.  Again, 
comparisons for the above analyses could not be made to controls because of the lack of 
any non-age-related cortical cataract in that population.  Figure 5.2.21 shows OCT B-scans 






Figure 5.2.21 AS-OCT B-Scans showing age-related cortical cataract (top) and dot opacities 




5.2.4.2.1 Comparisons of Cortical PIR Measures to LOCS III C Grades 
Comparisons were made between OCT age-related and dot opacity measures of cataract, 
and LOCS III C scores for the DS group.  Spearman’s rank order analyses only showed a 
significant correlation between dot PAR and total number of dot opacities with LOCS III 
C. Linear regression analyses showed both dot PAR and total number of dots were 
significantly related to LOCS III C.  Table 5.2.11 summarises these analyses. Scatterplots 
for the two significant regressions are shown in figure 5.2.22.  No comparisons of the 
above analyses were made to cortical PIR or PAR as this was only present in one 
participant. Comparisons were not made in controls due to the lack of dot like cortical 
opacities in the distribution.   
OCT Measure 
LOCS III C 
Correlation Linear Regression 
 Rho Sig. 
Dot PIR 0.409 p = 0.146 Not Significant 
Dot PAR 0.665 p = 0.009 F(1, 12)=23.652, R2=0.663, p<0.001 
Number of 






Table 5.2.11 Summary of Spearman’s correlation and linear regression analyses between OCT 












Figure 5.2.22 Scatterplots showing the relation between Cortical Dot PIR and LOCS C (top) 




5.2.4.3 OCT Posterior Subcapsular Grading in DS 
The presence of posterior-subcapsular opacification detected with OCT in the study 
cohort was low.  Only the same two eyes that had a LOCS III P grade over 0.1 also 
obtained scores above 0.000 for OCT PSC PIR and PAR.  For participant 27 (RE: female 
53.92 years of age), PSC PIR was 1.557 and PAR was 0.175, and for participant 23 (LE: 
male aged 55.36 years) PIR was 1.338 and PAR was 0.242.  Figure 5.2.23 shows the OCT 
B-scans for both participants. Contrary to that found in the DS cohort, there was no 
presence of PSC in controls. Statistical analysis was not performed comparing LOCS III to 
OCT PSC due to the distribution of data containing outliers that influence the results as 





Figure 5.2.23 AS-OCT B-scans of the posterior crystalline lens showing PSC in the only 





5.3.1 Recruitment of Participants 
This study successfully recruited its goal of 30 participants with DS however, two were 
excluded as explained in section 5.2.1.  Overall, recruitment was difficult with over 200 
potential participants directly solicited over the course of the study.  Many parents and 
carers were initially interested in the study but became reluctant when they were informed 
of the need for pharmacologic pupil dilation.  The study also successfully recruited 
subjects across a wide age range, including those at the higher end of life expectancy 
(Glasson et al. 2002; Bittles et al. 2007; Zigman 2013). 
 
5.3.2 Visual Acuity 
Monocular habitual VA measurement was obtained in 95% of eyes.  Accounting for the 
intellectual disability in those with DS as summarised in chapter one, this is an excellent 
success rate.  The VA levels of this study’s cohort agree with previous research conducted 
in those with DS (Courage et al. 1994; Woodhouse et al. 1996; Tsiaras et al. 1999).  
Therefore, the statistically significant difference in VA found between this study’s DS and 
control groups is acceptable.  In the DS cohort, VA measures from both picture and letter 
optotypes were combined as research has shown that both crowded Kay picture and 
logMAR letter acuity is comparable (Elliott and Firth 2009).  A small caveat lies in the fact 
that DS participants’ habitual VAs were assessed in this study; while all parents and carers 
were asked to bring current spectacles and be aware of the participants’ medical history, 
when participants arrived with a carer, in all but one case, they were unaware of any past 
medical or ophthalmic history, or if the participant was wearing current spectacles.  Saying 
this, participants who attended day centres were seen regularly by a hospital optometrist 





5.3.3 Morphology of Lens Opacity in DS 
5.3.3.1 Success Rates of Imaging the Lens in DS 
There were mixed results regarding the successful capture of both slit lamp and AS-OCT 
images of the crystalline lens in those participants with DS.  Slit lamp imaging of optic 
sections to enable nuclear LOCS III grading was quite successful, with 72.2% of eyes 
imaged.  The success rate of retroillumination imaging for LOCS III C and P grading 
dropped significantly to 27.8%.  This reduction is due to the careful alignment of the slit 
lamp illumination and axial position of the eye required to attain adequate 
retroillumination of the crystalline lens from the fundus.  As participants with DS often 
did not sit still or were not able to maintain steady fixation for an adequate amount of 
time, the red reflex was either lost upon initiating capture of the photograph or never 
obtained in the first place.  Imaging of the nucleus was easier in this instance because the 
slit lamp could be manipulated to ensure an optic section was maintained along with the 
movements of the participant’s eyes.  The discrepancy between gradable areas of the lens 
disappeared when acquiring AS-OCT B-scans.  While the success rate of obtaining high-
resolution B-scans was slightly lower than that of slit lamp imaging for LOCS III nuclear 
measures at 61.1%, these same images were also useable for grading every area of the 
crystalline lens. The lower capture rate of high-resolution OCT images compared to slit 
lamp optic sections was most likely a result of three factors: 1) AS-OCT imaging was 
conducted towards the end of the participants’ appointments causing them to become 
tired and restless; 2) the Visante OCT was intimidating for participants as it required their 
eyes and face to be positioned just centimetres from the face of the instrument, with its 
chin and headrests in constant movement during imaging; 3) participants were required to 
main steady fixation for a few seconds while B-scans were acquired; as they had a natural 
tendency to look around, imaging artifacts were introduced, or central alignment of the 




5.3.3.2 General Morphology of Lens Opacity in DS 
In terms of age-related cataract that occurs in typically developed adults, the comparison 
between lens opacity found in DS and controls is interesting.   When examining nuclear 
opacification, those with DS had much lower levels than their older controls. When 
comparing LOCS III nuclear measures between the groups, mean NO and NC values 
were very low in DS and the only three DS participants with grades over 1.0 were 55.4, 
53.9 and 54.7 years of age; these participants were all in the same age bracket as controls 
and their LOCS III nuclear grades fit within the normal range of the control’s 
distributions.  Differences between DS and control groups were also seen in the 
correlation and regression analyses comparing LOCS III nuclear grades to age and VA.  
Regarding correlation, NO and NC were strongly associated with age and moderately with 
VA in DS, while in controls the only significant association was between NO and VA.  
Similarly, regression showed relations between LOCS III nuclear grades and both age and 
VA in DS but only between NO and VA in controls.  These discrepancies are likely due to 
the large age spread in the DS cohort, especially with the very clear nuclei in children and 
young adults.  Although the entire cohort of typically developed adults studied in Chapter 
4 were not used as controls, the above-mentioned inconsistencies concerning correlation 
and regression are eliminated for VA when the entire cohort of typically developed adult 
participants is considered; this reinforces the idea that correlation and regression analyses 
were weak in controls due to their age range only spanning 10 years.  
 
When comparing AS-OCT nuclear PIR values between DS and controls, the results were 
similar to those described above. Again, those with DS had significantly lower PIRs when 
compared to controls. The range of PIR values in DS was much greater than in controls.   
While correlation and regression analyses were significant between PIR and age as well as 
VA in DS again, as with LOCS III NO and NC, there was no relationship between these 
in controls.   Again, this is likely due to the large spread of age in the DS cohort compared 
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to controls.  While there was this difference between PIR, age and VA between groups the 
similarity between LOCS III nuclear measures and PIR correlations was very good.  Also, 
the regression between NO, NC and PIR was slightly stronger in DS but this, again, may 
be due to the wide-ranging ages in the DS group.  In summary, looking at both LOCS III 
and OCT measures of cataract, age-related nuclear lens opacification does not seem to 
occur at a younger age in DS. 
 
The starkest difference between DS and controls occurred with the presence of cortical 
lens opacities.  There were age-related cortical opacities present in three eyes from three 
control participants.  In the DS group one participant presented with an age-related 
morphology of cortical cataract but many had multiple dot opacities within the cortex.  As 
mentioned previously, the success rate of slit-lamp imaging to assess cortical opacity in DS 
by LOCS III analysis was very low, with gradable images in only 15 eyes.  Of the graded 
eyes for C, 12 (80.0%) of them had scores above 0.1 and out of these, solely dot like 
opacities were present in 11 (73.3%) eyes.  In the eye with age-related cortical cataract, 
there were no dot opacities visible in the retroillumination image.  Interestingly, the 
participant with age-related cortical cataract was 26.67 years old and this explains the 
correlation and regression analyses showing no relation between LOCS III C and age.  
 
Of the 33 eyes imaged with AS-OCT 18 (54.5%) had the presence of cortical opacities and 
of these, dot opacities were present in 16 (48.5%) eyes. The two eyes where dot opacities 
were not detected but cortical cataract was, belonged to participant number 5; this is the 
same participant who’s RE was successfully graded for LOCS III C but where slit lamp 
retroillumination imaging was not successful in the LE.  It should be noted that not all 
eyes imaged and graded for LOCS III C at the slit lamp were successfully imaged with AS-
OCT.  Despite this, the much higher image acquisition success rate in OCT highlights its 
potential effectiveness over the slit lamp retroillumination technique required for LOCS 
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III grading of non-nuclear opacities in populations of those with intellectual disability. 
Although there were mismatches where eyes were graded for LOCS III C but not OCT 
cortical measures and vice versa, based on the similar lack of correlation or regression seen 
in LOCS III C and OCT cortical grading, it is certain that the cortical opacities present in 
DS did not influence VA and were not related to age.   
 
Through the course of acquiring images of the crystalline lens in DS, it was noted that 
occasionally, dot opacities were visible when viewing an optic section of the lens and 
sometimes, these were not visible on retroillumination.  Also, due to the sparse number of 
dot opacities present in some participants, in some cases, the Visante OCT was not able to 
image them because a correctly aligned B-Scan could not be acquired while the participant 
maintained adequate fixation.  The difference in the presence of dot opacities between 
LOCS III and AS-OCT images in this study could create confusion as to the actual 
prevalence of this specific morphology in DS however, when the researcher was 
photographing participants at the slit lamp, any opacities seen were noted.  Therefore, a 
more reliable prevalence of these opacities can be determined by accounting for the eyes 
with dot opacities that were graded either solely with LOCS III or OCT (n = 12), and both 
LOCS III and OCT (n = 7).  Of the eyes that were not successfully imaged with either 
modality, the researcher noted the presence of at least one dot opacity in seven additional 
eyes.  Finally, accounting for the lack of cortical opacity noted in 10 eyes, it can be 
surmised that 26 out of 36 (72.2%) eyes showed the presence of cortical dot opacities in 
DS.  In summary, the presence of age-related cortical cataract may occur at a younger age 
in DS (although this was identified in only one participant), but the presence of dot 
opacities in the cortex occurs at a very high rate.  Furthermore, these cortical dot opacities 




Participants with DS showed a greater presence of age-related PSC compared to controls.  
Although LOCS III P grading was only possible in 15 eyes, in the 33 eyes that were 
successfully imaged with OCT, no other PSC opacities were found.  While the correlation 
and regression analyses showed a relation to VA and Age, this is a result of the two eyes 
with PSC acting as outliers.  It should be noted that OCT provides benefits of imaging 
opacities for intensity and area; while LOCS III P grading requires a subjective 
interpretation of area only while disregarding darkness of the opacity, OCT imaging 
showed the exact location of PSC in the lens and allowed the discernment that the PSC in 
participant 27 was smaller in area but greater in intensity than that in participant 23.  
Saying this, the PSC opacities in the two participants were quite large and most likely 
would have had a significant effect on vision.  
 
5.3.3.3 Morphology of Cataract in DS Compared to Previous Studies 
In general, nuclear lens opacity does not seem to occur at a younger age or greater rate in 
those with DS but this cannot be said for age-related cortical and PSC opacification. The 
age-related cortical opacity occurred in a participant who was very young and while the 
posterior-subcapsular opacities occurred in the eldest individuals, this was in stark contrast 
to the absence of this type in any of the control eyes.   
 
When compared to studies of lens opacity in DS, this study presents interesting results. 
The presence of lenticular opacity was seen in 77.8% of the 36 eyes that were either 
imaged by or seen at the slit lamp by the researcher.  Previous studies have reported 
prevalence ranging from 4-72% (Jaeger 1980; Catalano 1990; Hestnes et al. 1991; Berk et al. 
1996; daCunha and Moreira 1996; Woodhouse, Griffiths, et al. 2000; Kim et al. 2002; Liza-
Sharmini et al. 2006; Fimiani et al. 2007; Krinsky-McHale et al. 2012; Fong et al. 2013; Wong 
and Ho 1997). Many of the studies reporting low rates of lens opacity were conducted in 
children and adolescents; this may account for the lower rates as some studies have 
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detected little cataract in those less than approximately 12 years of age (daCunha and 
Moreira 1996; Kim et al. 2002; Liza-Sharmini et al. 2006); the results from this study match 
very well with this as the lenses were clear in all imaged eyes of participants under the age 
of 12 years (n=5). Of the previous studies examining cataract in adults with DS, similarities 
do show between them and this study.  Jaeger (1980) examined the eyes of 74 participants 
with DS aged 15 to 64 years and found 55.4% to have the presence of lens opacities. Of 
these opacities, the vast majority (65.8%) were describe as ‘flake-like’ opacities (Jaeger 
1980); the author’s description of these matched those of the dot opacities that appeared 
in this study.  Jaeger (1980) also found that 18.9% of the study group presented with age-
related cataract at an average age of 48 years. Again, this matches well with the ages of 
participants in this study for age-related nuclear and PSC opacities.  A study conducted by 
Woodhouse et al. (2000) on 31 DS adults with a mean age of 36.7 years, found a cataract 
prevalence of 22.6% however, there was no mention of morphology beyond either 
developmental or congenital.  Woodhouse et al.’s (2000) study was done as part of a large 
ophthalmic screening where pupils were not dilated, and lens opacity was assessed with a 
direct ophthalmoscope; it is reasonable to assume that if these participants were examined 
under dilation using a slit lamp, the detection of cataract would be much higher.  Another 
study examining the presence of lens opacity in adults with DS looked at past medical 
records to determine the occurrence of ophthalmic disorders in the group (Krinsky-
McHale et al. 2012).  The authors analysed 455 medical records from participants 30 to 81 
years of age and found that cataract was the most common ophthalmic condition, with a 
prevalence of 42% (Krinsky-McHale et al. 2012).  Krinsky-McHale et al. (2012) found the 
average age of cataract diagnosis to be 48.43 years; the authors did not make any mention 
of cataract morphology but based upon the fact that they were reviewing past medical 
records, these may have been age-related.  There was an increasing prevalence of cataract 
with age noted by Krinsky-McHale et al. (2012) and, assuming these were age related 
opacities, this aligns with that of the nuclear opacification found in this study.  Fong et at. 
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(2013) have recently conducted a study with one of the most descriptive analyses of 
cataract morphology in adults with DS.  When examining 91 adults aged from 30 to 56 
years, Fong et al. (2013) found that 72% of participants had the presence of opacities in 
the lens.  Of those lens opacities, 50.6% were described as blue dot cataract and 45% were 
age-related and further broken down into 38% nuclear, 13.6% cortical and 8.5% PSC 
(Fong et al. 2013).  These prevalence rates align quite well with those found in this study.  
 
The flake-like and blue dot opacities that occur at a high prevalence in studies by Jaeger 
(1980), Fong et al. (2013) and others Catalano (1990), appear to be of the same 
morphology as the dot opacities seen in this study.  Blue dot, or more appropriately 
cerulean, cataract is an acquired early onset lens opacity that often is first noticed in 
adolescence and consists of blue or white coloured opacities scattered primarily in the 
cortex but also in the nucleus of the crystalline lens (Armitage et al. 1995; Kanski and 
Bowling 2011).  Of those whose lenses contained these opacities in this study, a few dot 
opacities were occasionally seen in the nucleus; this was also noticed by Jaeger (1980) in his 
description.  In the 16 AS-OCT images that contained dot opacities, their presence in the 
central area of the lens was estimated by measuring the pupil margin with a calliper tool in 
MATLAB and then dividing this value by two.  The resulting value estimated a size of 
approximately 4 to 4.5mm representing an undilated pupil.  A box with this estimated 
undilated pupil size was then drawn centrally on the crystalline lens and spanning its entire 
anterior to posterior length; the number of dot opacities that lay inside the box were then 
counted.  81.3% of eyes contained centrally located dot opacities and of these, 43.5% of 
total dot opacities within the lens were located centrally, on average.        
 
5.3.3.4 Morphology of Cataract in DS Compared to Beta-Amyloid Studies 
As mentioned in Chapter 1, due to the close relationship between AD and DS, cataract in 
this population has been studied as a potential biomarker site for Aβ.  Goldstein et al. 
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(2003) initially claimed that, through post-mortem immunohistochemical analysis, Aβ was 
present in lenses with a specific type of cataract located in the supranuclear area and, 
compared to controls, this cataract type was only present in typically developed 
participants with AD.  The group then extended this research into lenses from those with 
DS (Moncaster et al. 2010). The authors showed that the blue dot cerulean cataract 
suggested to be characteristic of DS, was the same as the supranuclear cataract found in 
their previous study and related to Aβ deposition (Moncaster et al. 2010).  The authors 
stated in both studies that this cerulean cataract was supranuclear and present annularly in 
the deep cortex (Goldstein et al. 2003; Moncaster et al. 2010). Supranuclear cataract is 
defined as a narrow band of opacity found at the interface between the deep cortex and 
nuclear interface, and may be sometimes known as lamellar or zonular (Chylack et al. 






The cerulean cataract found in those with DS from this study did not fit within the 
constraints of the supranuclear area.  It was plainly visible in the OCT images that the dot 
opacities often progressed into the mid- and even peripheral cortex. In some cases, a few 
dot opacities were also present in the nucleus.  While Moncaster et al. (2010) also claimed 
that the cerulean supranuclear cataract increased with age in DS, this study found no 
Figure 5.3.1 Cross-sectional diagrams of the crystalline lens showing the location of 




relation between dot opacity and age in its analysis; this finding is counterintuitive in a 
population where prevalence and risk of AD greatly increase with age. Taking into 
consideration these differences, it may be possible that the relation between cerulean 
cataract and Aβ found by Goldstein et al. (2003) and Moncaster et al. (2010) may have 
been coincidental and a result of their very small sample sizes. This last statement is 
supported by subsequent studies using similar techniques as Goldstein et al. (2003) and 
Moncaster et al. (2010) but not finding any presence of Aβ in the human crystalline lens 
(Michael et al. 2014; Michael et al. 2013; Ho et al. 2014).  Finally, the in-vivo analysis of 
cataract in participants with AD by Bei et al. (2015) showing no supranuclear cataract also 
reinforces the findings in this study.           
 
5.4 Conclusion                           
This study provides a more detailed analysis of lens opacity than those that have come 
before. Previous studies in DS have only examined cataract qualitatively and this study, for 
the first time, has quantitatively graded the severity of cataract.  The data produced in this 
study can provide a springboard for further work, but it is logical to conclude that lens 
opacity occurs at a very high rate in DS.  Furthermore, the OCT images of lens opacity in 
DS have provided a unique insight into the typical location of cerulean opacity within the 
crystalline lens. As a result, this study has shown that cerulean cataract occurs commonly 
in DS, but its morphology does not appear to coincide with the description by studies 
linking it with Aβ and AD.   
 
This study is limited by a small sample size that resulted from the reduced success rates in 
acquiring adequate quality images of the crystalline lens.  This, coupled with the large age 
range present in the cohort, may have slightly weakened the undertaken statistical analyses.  
Saying this, the success rate of grading lens opacity was much better in AS-OCT than 
LOCS III; this is an exciting finding as the time domain technology of the Visante OCT 
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has been far surpassed by more modern Fourier domain modalities.  This latter 
technology, especially with the newest swept-source whole eye imaging capability, will 
provide an excellent platform for studying opacity in the entire lens through volumetric 
cube scans rather than the B-scans performed in this study.  Using this technology, 
longitudinal studies of cataract in DS are more than warranted.                  
























Chapter 6: Posterior Segment OCT in Down Syndrome 
6.1 Introduction 
The following section outlines the study of retinal structure in DS using posterior segment 
optical coherence tomography.  The same participants with DS from chapter 5 were 
imaged with the Spectralis PS-OCT.  Imaging of the macula was performed using line and 
volume scans; peripapillary RNFL scans of the optic nerve head were also acquired. The 
methods for scan acquisition and analysis were described in Chapter 4.    
 
6.2 B-Scans of the Macula in DS 
Of the 54 eyes on which imaging was attempted, B-scans of the macula that traversed the 
fovea were successfully obtained in 17 eyes from 14 participants.  Successful participant 
ages ranged from 7.75 to 54.68 years with a median of 24.68 ± 23.31 (IQR).  Mean VA was 
0.370 ± 0.198 (SD) logMAR with a range of 0.050 to 0.800.  The age distribution was not 
normal while that of VA was (Shapiro-Wilk).  Table 6.2.1 outlines the descriptive statistics 
for age and VA while figures 6.2.1 and 6.2.2 show the histograms and Q-Q plots for the 
measures.  
 
Measure Mean (SD) Median (IQR) Range Shapiro-Wilk 
Age (Years) 
(n=17) 24.86 (15.17) 24.68 (23.31) 7.75 to 54.68 p = 0.024 
VA (logMAR) 
(n=17) 0.370 (0.198) 0.325 (0.300) 0.050 to 0.800 p = 0.503 
 
 
Table 6.2.1 Descriptive statistics for age and VA in participants with DS whose eyes were 









Data were also grouped into stratified age ranges consisting of those under 18 years and 
those aged 18 years and above.  The distributions for VA and age are summarised for each 
group in tables 6.2.2 and 6.2.3. 
 
Age Range Mean (SD) Median (IQR) Range Shapiro-Wilk 
Under 18 
(n=8) 12.25 (2.56) 12.45 (3.51) 7.75 to 16.07 p = 0.990 
18 and Over 
(n=9) 36.08 (12.39) 30.11 (22.91) 24.68 to 54.68 p = 0.040 
 
 
Figure 6.2.1 Histogram and Q-Q plot describing the distribution of age for those DS 
participants imaged with line scans. 
. 
Figure 6.2.2 Histogram and Q-Q plot describing the distribution of VA for those DS 
participants imaged with line scans. 
. 
Table 6.2.2 Descriptive statistics for age in participants with DS whose eyes were successfully 





Age Range Mean (SD) Median (IQR) Range Shapiro-Wilk 
Under 18 
(n=8) 0.289 (0.222) 0.230 (0.125) 0.050 to 0.800 p = 0.010 
18 and Over 
(n=9) 0.442 (0.152) 0.400 (0.250) 0.200 to 0.675 p = 0.970 
 
 
Macular B-scans were measured for minimum foveal thickness and foveal pit depth.  
Shapiro-Wilk analysis showed that both minimum thickness (p = 0.253) and depth (p = 
0.088) were normally distributed.  Mean minimum foveal thickness was 259 ± 20 (SD)µm 
with a range from 224µm to 306µm.  Foveal pit depth ranged from 57µm to 146µm with 
a mean of 106 ± 25µm.  Data for foveal thickness and pit depth were also stratified by age 
into groups consisting of those up to the age of 18 years and those aged 18 years and 
above.  The descriptive data for all groups is summarised in tables 6.2.4 and 6.2.5.   
 
Age Group 
(Years) Mean (SD) Median (IQR) Range Shapiro-Wilk 
Under 18 
(n=8) 270 (25) µm 264 (29) µm 224 to 306 µm p = 0.489 
18 and Over 
(n=9) 250 (8) µm 248 (9) µm 239 to 267 µm p = 0.384 
All ages 




(Years) Mean (SD) Median (IQR) Range Shapiro-Wilk 
Under 18 
(n=8) 93 (29) µm 100 (55) µm 57 to 134 µm p = 0.414 
18 and Over 
(n=9) 117 (15) µm 113 (21) µm 105 to 146 µm p = 0.009 
All ages 
(n=17) 106 (25) µm 108 (20) µm 57 to 146 µm p = 0.088 
 
Table 6.2.3 Descriptive statistics for VA in participants with DS whose eyes were successfully 
imaged with line scans when stratified by age. 
 
Table 6.2.4 Descriptive statistics for minimum foveal thickness in participants with DS 
whose eyes were successfully imaged with line scans. 
 
Table 6.2.5 Descriptive statistics for foveal pit depth in participants with DS whose eyes 




Correlation analyses were performed to compare both minimum foveal thickness and pit 
depth to age and VA.  For the comparisons between the measures and VA, where the 
distributions were all normal, Pearson analyses showed no association for the entire group 
of participants.  As age was not normally distributed for all 17 eyes, a Spearman correlation 
was performed.  A moderate association was found between age and foveal pit depth (Rho 
= 0.549, p < 0.022) but not minimum foveal thickness.   
 
Linear regression was performed for the above comparisons and, again, the only 
significant relation was between age and foveal pit depth (F(1, 15) = 4.738, p = 0.046, R2 = 






Figure 6.2.3 Scatterplot of the relationship between foveal pit depth and age. 
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When stratified by age, Mann-Whitney U tests showed that those aged under 18 years had 
significantly greater minimum foveal thickness (U = 13.00, p = 0.027) however, there was 
no statistically significant difference between the two groups for foveal pit depth.  
Correlation analyses showed no significant association for either age or VA when 
compared to minimum foveal thickness of foveal pit depth in those aged under 18 years.    
In those aged 18 years and older, VA showed a strong correlation with foveal pit depth 
(Rho = 0.678, p = 0.045) but not minimum foveal thickness; age was not correlated with 
either measure in this group.  Linear regression showed a moderately strong and significant 
relation between VA and foveal pit depth (F(1, 7) = 10.079, p = 0.016, R2 = 0.590); the 
scatterplot is shown in figure 6.2.4.   
 





Figure 6.2.4 Scatterplot of the relationship between foveal pit depth and VA for those aged 
18 years and older.    
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6.3 Volume Scans of the Macula in DS 
Macular volume scans were successfully acquired in 6 eyes from four participants.  Mean 
age for the group was 21.85 ± 11.52 (SD) years with a range from 10.33 to 41.40 years.  
VA ranged from 0.235 to 0.600 logMAR with a mean of 0.370 ± 0.143 (SD).  The 
distributions of average macular thickness for each region of the ETDRS grid for all 
imaged eyes are outlined in table 6.3.1.  Shapiro-Wilk testing showed that all measures of 
macular thickness as well as VA and age were normally distributed.   
 
ETDRS Region Mean (SD) Median (IQR) Range Shapiro-Wilk 
Central 1mm 303 (20) µm 298 (32) µm 285 to 339 µm p = 0.273 
Superior 3mm 371 (17) µm 369 (28) µm 353 to 400 µm p = 0.680 
Inferior 3mm 366 (20) µm 362 (32) µm 343 to 397 µm p = 0.814 
Nasal 3mm 371 (22) µm 367 (39) µm 349 to 404 µm p = 0.415 
Temporal 3mm 352 (20) µm 345 (29) µm 335 to 389 µm p = 0.117 
Superior 6mm 327 (10) µm 328 (17) µm 314 to 341 µm p = 0.771 
Inferior 6mm 314 (17) µm 311 (30) µm 293 to 339 µm p = 0.887 
Nasal 6mm 349 (13) µm 347 (24) µm 333 to 368 µm p = 0.847 





Pearson correlation analyses showed no association between any ETDRS thickness 
measure and participant age or VA.  Naturally, linear regression showed there was no 
significant relation between any ETDRS measure and either age or VA.  Mann-Whitney U 
tests showed no significant difference between any measure when grouped by those under 
the age of 18 years (n=3) and those aged 18 years and older (n=3). 
 
Table 6.3.1 Summary of average retinal thickness values for each region of the macular ETDRS 
grid for all 6 imaged eyes. 
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6.4 Retinal Nerve Fibre Layer Thickness in DS 
Peripapillary RNFL scans were successfully obtained in 10 eyes from seven participants.  
The groups’ ages ranged from 12.13 to 41.40 years with a mean of 21.27 ± 9.73 (SD) years.  
Mean VA was 0.292 ± 0.182 logMAR with a range from 0.050 to 0.675.  Table 6.4.1 
displays the descriptive statistics for all regions of RNFL thickness including tests of 
normality (Shapiro-Wilk); not all regions were normally distributed.   
 
Peripapillary 
Region Mean (SD) Median (IQR) Range Shapiro-Wilk 
Global 132 (14) µm 124 (22) µm 118 to 156 µm p = 0.025 
Temporal 98 (10) µm 98 (12) µm 85 to 120 µm p = 0.462 
Temporal-
Superior 210 (30) µm 211 (49) µm 160 to 259 µm p = 0.988 
Temporal-
Inferior 188 (16) µm 186 (23) µm 169 to 220 µm p = 0.354 
Nasal 87 (18) µm 81 (25) µm 65 to 120 µm p = 0.035 
Nasal-Superior 146 (24) µm 146 (41) µm 102 to 181 µm p = 0.906 
Nasal-Inferior 144 (49) µm 124 (86) µm 101 to 230 µm p = 0.015 




Depending on normalcy of the distribution, either Pearson or Spearman correlation 
analyses did not show any significant association between any RFNL thickness region and 
either age or VA. When stratified by age, there was no significant difference in RFNL 
thickness in any peripapillary region between those under the age of 18 years (n=5) and 





Table 6.4.1 Summary of average RNFL thickness values for each peripapillary region for all 10 




6.5.1 Success Rates 
Successful acquisition of adequate quality PS-OCT images was very low for all three 
scanning modalities with only 31%, 19% and 11% of macular line, macular volume and 
peripapillary RNFL tomographs captured.  These poor rates are most likely due to the PS-
OCT imaging being conducted just after the installation of tropicamide, in a small window 
of time before imaging of the crystalline lens was undertaken.  As crystalline lens imaging 
was a priority of this thesis, less emphasis was placed on acquiring PS-OCTs.  The time 
limitation for PS-OCT is demonstrated by the decreasing success rates from line scans 
through to macular volume scans.  While line scans could be captured very quickly if 
participants were able to fixate on the Spectralis’ internal target, much more time was 
required for RNFL and especially macular cube scans, which required very steady fixation 
while multiple B-scans were captured.   
 
6.5.2 Macular Thickness in DS 
To date, the only published in vivo data examining the macula using OCT has been 
conducted by Laguna et al. (2013) and O’Brien et al. (2015).  In the first study, the authors 
performed macular volume scans on five eyes from three participants with DS.  Laguna et 
al. (2013) reported that retinal thickness was greater in DS when compared to age matched 
controls particularly at the central 1mm ETDRS subfield.  The authors also reported that 
the gross appearance of the retinal layers of macular OCT B-scans did not appear different 
to a typically developed retina (Laguna et al., 2013); the macular scans from this study also 
support this as all images of adequate quality showed a regular appearance and order of 
retinal layers. O’Brien et al. (2015) performed macular volume scans in 17 children with DS 
aged 6-16 years and compared thickness to age-matched controls.  Macular thickness was 
determined to be significantly greater in all areas of the ETDRS grid apart from the 
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temporal areas (O’Brien et al. 2015). Similarly to this study, O’Brien et al. (2015) also found 
no association between macular thickness and VA in DS.   
 
Although this study did not include age-matched controls, previous work has been 
conducted to determine normative values.  A study conducted by Grover et al. (2009) 
performed macular volume scans on 50 adults with no retinal pathology aging in range 
from 20 to 84 years.  The authors went on to determine normative values for each ETDRS 
subfield and also found no association between retinal thickness and age.  Table 6.5.1 
summarises the normative data collected by Grover et al. (2009) as well as the data from 
this study for retinal thickness in DS.  
 
ETDRS Region This Study’s Mean (SD) for participants with DS 
Normative Data for Mean 
(SD) Retinal Thickness 
Determined by Grover et al.  
Central 1mm 303 (20) µm 270.2 (22.5) µm 
Superior 3mm 371 (17) µm 336.0 (20.6) µm 
Inferior 3mm 366 (20) µm 334.9 (16.7) µm 
Nasal 3mm 371 (22) µm 335.0 (19.3) µm 
Temporal 3mm 352 (20) µm 322.6 (16.5) µm 
Superior 6mm 327 (10) µm 329.6 (16.4) µm 
Inferior 6mm 314 (17) µm 325.4 (16.6)µm 
Nasal 6mm 349 (13) µm 339.5 (16.9) µm 




While the data from this study show no association between retinal thickness and age, 
which agrees with the findings by Grover et al. (2009), retinal thickness in DS appears to 
be significantly thicker in the central and 3mm ETDRS subfields when compared to 
Table 6.5.1 Summary of average retinal thickness values for each region of the macular ETDRS 
grid for all 6 imaged eyes in this study (left column) and normative data obtained by Grover et al. 
(2009) (right column). 
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normative values.  Hence, the data from this study supports that found by Laguna et al. 
(2013) and O’Brien et al. (2015).    
 
As foveal hypoplasia has been mentioned to occur in DS (Stirn Kranjc 2012), minimum 
foveal thickness and foveal pit depth were measured from macular B-scans through the 
fovea.  While regression and correlation analyses showed an association between 
increasing foveal pit depth and worsening VA in those aged 18 years and older, which is 
counterintuitive, this was most likely influenced by the two outliers (see figure 6.2.4) and 
the small sample size.  The association between foveal pit depth and increasing age was 
also very weak and bordering on statistical insignificance.  A larger sample size is required 
to determine whether these relations remain with greater statistical power.   
 
Again, because controls were not included in this study, it is difficult to determine the 
exact morphology of the fovea in DS and whether this is differed from that in a typically 
developed eye.  Normative data for foveal thickness and have been determined using 
similar methods of measurement.  Tick et al. (2011) measured minimum foveal thickness 
and foveal pit depth in 110 eyes of 57 healthy adults aged 18 to 45 years using a Spectralis 
PS-OCT.  Using custom software, the authors determined mean foveal thickness to be 230 
± 21 (SD) µm and mean foveal pit depth to be 131 ± 22 (SD) µm (Tick et al. 2011).  In this 
study, mean minimum foveal thickness was 259 ± 20 (SD) µm and mean foveal pit depth 
was 106 ± 25µm.  Therefore, this study, even when stratified by age to account for the 
absence of those under 18 years in Tick et al.’s (2011) sample, gives evidence that those 
with DS appear to have thicker foveae and decreased foveal depth compared to their 
typically developed counterparts.  Although minimum foveal thickness was significantly 
greater in those with DS under 18 years of age compared to participants 18 and older, the 
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fact that this difference disappeared between the stratified age ranges for foveal pit depth 
reinforces the previously mentioned point. 
  
6.5.3 Retinal Nerve Fibre Layer Thickness in DS 
There are no reports in the literature quantifying retinal thickness in a sample of those with 
DS.  While controls were not present in this study, a normative database for RNFL 
thickness derived from 201 subjects of ‘Caucasian ethnicity’ aged from 18 to 78 years 
exists within the Spectralis’ analysis software (Heidelberg Engineering 2013).  When 
compared to this normative database the RNFL appeared to be significantly thicker in 
certain quadrants.  While the figures from the Spectralis’ normative database are not 
available, there have been studies deriving these figures in adults and children. Leung et al. 
(2010) determined normal peripapillary RNFL thickness using the Spectralis PS-OCT in  
76 adults with a mean age of 48.76 ± 13.54 years while, in a separate study, Yanni et al. 
(2013) used a Spectralis PS-OCT to determine normative values in 83 children aged from 
five to 15 years; the data from these studies along with those from this study are outlined 



























Global 132 (14)  129 (10) 135 (19) 104.5(10.1) 107.6(1.2) 
Temporal 98 (10)  101 (12) 96 (8) 86.3(15.8) 76.5(1.9) 
Temporal-
Superior 210 (30)  207 (31) 212 (31) 144.4(18.6) 145.1(2.2) 
Temporal-
Inferior 188 (16)  181 (8) 196 (20) 158.7(19.1) 147.0(2.1) 
Nasal 87 (18)  83 (20)  91 (18) 68.6(16.5) 84.5(1.9) 
Nasal-
Superior 146 (24)  153 (22) 139 (26) 110.2(22.9) 116.2(2.8) 
Nasal-
Inferior 144 (49)  125 (35)  162 (57) 111.7(24.1) 125.4(3.0) 
 Table 6.5.2 Summary of average RNFL values in µm for each peripapillary region for all 
participants and bracketed by age along with and normative data obtained by Leung et al. (2010) 
and Yanni et al. (2013).   
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Comparing the results from this study to those from Leung et al. (2010) and Yanni et al. 
(2013), strongly suggests that the RFNL layer is thicker globally and especially in the 
temporal-superior and nasal-superior regions in those with DS.   As it has also been 
reported that RNFL thickness decreases with age it is interesting to note the absence of 
this occurrence in this study although this may be a result of the low sample size.  
 
6.5.4 Retinal Structure in DS Compared to Studies in AD 
As explained in Chapter 1, the prevalence of AD in DS is high with all individuals showing 
neuropathological signs by the age of 40 years.  Studies of retinal structure in typically 
developed adults with AD using OCT have demonstrated characteristic changes that 
correspond with neurodegeneration (Cunha, Almeida, et al. 2016; Doustar et al. 2017; den 
Haan et al. 2017).  Specifically, studies have shown strong evidence for peripapillary RNFL 
thinning in AD compared to aged matched controls (Paquet et al. 2007; Marziani et al. 
2013; Kirbas et al. 2013; Cunha, Lopes, et al. 2016; Cunha, Almeida, et al. 2016; Doustar et 
al. 2017; den Haan et al. 2017).  In a recent meta-analysis, den Haan et al. (2017) determined 
that while RNFL thinning occurred in all four peripapillary quadrants in AD, the superior 
and inferior quadrants were thinner than the nasal and temporal quadrants.  The results 
from this study suggest the complete opposite occurs in the retina in DS when compared 
to the above-mentioned studies in AD, with a thicker RNFL compared to typically 
developed adults and children.  A similar discrepancy is seen between the macular 
thickness results in this study when compared to studies of macular thickness of typically 
developed adults with AD.  Studies have shown that macular thickness is thinner in each 
ETDRS subfield in typical adults with AD when compared to age-matched controls 
(Marziani et al. 2013; Cunha, Almeida, et al. 2016; den Haan et al. 2017).  A meta-analysis by 
den Haan et al. (2017) determined thinning to be the highest in the outer ring, followed by 
the inner ring and then fovea in those with AD. Again, the results from this study suggest 




While this study is small in sample size and limited by the lack of controls, it has added 
valuable data to the assessment of retinal structure in DS.  The results from this study 
mirror those of Laguna et al. (2013) and O’Brien et al. (2015) suggesting a thickened 
macular structure in those with DS.  Also, the decreased foveal pit depth typical of the 
participants in this study, lends support to the presence of foveal hypoplasia occurring in 
this population.  Finally, this is the first study to examine peripapillary RNFL thickness in 
DS and the data show that the features of this structure in DS does not seem related to 
those found in AD.  Further large-scale longitudinal study of the above parameters should 




















Chapter 7: Thesis Summary and Future Work 
7.1 Primary Outcomes 
The primary aim of this thesis was to profile the structure of cataract that occurs in the 
down syndrome eye in detail. A number of steps were taken in order to accomplish this. 
Firstly, the modification and digitisation of a slit-lamp biomicroscope to capture high-
resolution images of the eye was carried out as described in Chapter 2.  The method 
developed in this thesis can be applied to various models of slit-lamp biomicroscopes as an 
inexpensive means of updating or adding features to older equipment.  This is useful for, 
not only research labs and clinics alike, but perhaps in developing nations as well. 
 
The second outcome of this thesis was the production of custom software to process raw 
OCT sensor data and subsequently segment it as a means of analysing crystalline lens 
opacity.  A method to process .bin files from the Visante OCT has been described in 
Chapter 3, providing a solution for other researchers who may encounter difficulty with 
this. Furthermore, the application of the software to study a population of typically 
developed adults has demonstrated its utility in accurately analysing age-related crystalline 
lens opacity and shown the potential of OCT to determine the location and quantify the 
severity of any lens opacity; in line with this, the novel use of PIR and PAR provide an 
approach that will be useful in future studies of lens opacity. The agreement to LOCS III 
analysis and previous studies of visual function in relation to cataract further cement the 
use of OCT as an objective and repeatable method of assessing lens opacity.   
 
Following on from the above outcomes, the primary aim of this thesis was achieved using 
the newly developed and validated method of OCT analysis to perform a detailed study of 
lens opacity in a population of individuals with Down syndrome.  This is the first study to 
perform such an analysis of cataract in DS including the provision of quantitative data.  
Punctate dot opacities appear to be characteristic in DS and their morphology does not 
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coincide with previous studies linking supranuclear cataract to Alzheimer’s disease. This 
study has also shown the superiority of OCT imaging, when compared to slit-lamp 
assessment, in determining location of lens opacity; it enabled the observation that dot 
opacities were often present centrally in the anterior and posterior cortex and, occasionally, 
nucleus of the crystalline lens.   
 
As an adjunct, this thesis also examined macular and peripapillary retinal structure in DS 
using OCT.  Findings show increased macular thickness and evidence for foveal 
underdevelopment, which express agreement with the few brief studies examining retinal 
structure in DS.  The RNFL results from this study are the first to be reported in DS and 
do not coincide with the thinning that has been reported by previous work in typically 
developed adults with Alzheimer’s disease. 
 
7.2 Limitations 
In terms of OCT imaging and grading of cataract, there are a few limitations of this study.  
The use of time-domain technology resulted in a slow acquisition time of B-scans and the 
requirement to capture separate anterior and posterior images of the crystalline lens at a 
lower resolution compared to more modern Fourier-domain technology.  Furthermore, 
the capability of the Visante OCT to only acquire single line scans meant that only B-scans 
through the most significant portion of lens opacity could be captured.  This means that 
the complete assessment of all lens opacity within the crystalline lens could not be 
measured. Saying this, the current methods of assessing lens opacity are limited by this 
same two-dimensional analysis.  Finally, the manual segmentation required by the custom 
software opens the analysis of lens opacity to human error; although care was taken by the 
researcher in segmenting the images which resulted in good repeatability, this is not 
practical for clinical application in large cohorts. 
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The above limitations also affect the results for the assessment of lens opacity in Down 
syndrome.  Contrasting with typically developed adults, the intellectual disability present in 
those with DS contributed to a lower success rate in image acquisition and therefore, 
reduced statistical power. The two-dimensional B-scans were also not able to provide 
exhaustive data on the severity and location of lens opacity in this population because of 
the limitations in OCT imaging mentioned above.   Further, as this study of lens opacity in 
DS was cross-sectional and over a wide age range, it cannot be determined conclusively as 
to how lens opacity changes over time individually in those with DS.   
 
As it was conducted as an addendum, the assessment of retinal structure in this thesis is 
limited by its small sample size.  Due to the poor imaging success rate and lack of controls, 
the data only provide a preliminary view of retinal morphology in DS.  Less of an 
emphasis was placed on successfully acquiring useable images as a countermeasure to 
reduce fatigue in participants and thereby increase the chances of acquiring images of the 
crystalline lens.  The data from this portion of the study can be used to provide a small 
insight into the morphology of retinal structure in DS but are useful for power calculations 
and future study design.   
 
7.3 Future Work 
As OCT has been shown to provide a robust method of imaging and assessing lens 
opacity, further application and development towards this are warranted.  Modern Fourier-
domain modalities of OCT can be used to image the crystalline lens volumetrically; this 
will enable very high-resolution images showing the status of opacity throughout the entire 
lens.  Through the continued improvement of the software, algorithms can be developed 
to automate the segmentation of these three-dimensional tomographs; applying this to 




The above-mentioned improvements can then be applied to further assess the status of 
lens opacity in DS.  By performing a longitudinal study, a detailed understanding of how 
the crystalline lens changes in DS can be attained.  This will be useful in understanding 
whether the punctate lenticular opacities seen in DS occur randomly or are associated with 
other cognitive or disease processes.  These longitudinal studies would ideally be 
conducted in cohorts of those with DS who are seen regularly within the Hospital Eye 
Service; this would significantly increase imaging success rates, as participants would not 
have to undergo a battery of assessments in one sitting. Also, as this thesis was concerned 
with the morphological assessment of cataract in DS, an emphasis was not placed on the 
functional assessment of vision.  Further studies examining cataract in DS with OCT 
imaging along with the assessment of contrast sensitivity would be useful. 
 
Finally, the results of this thesis show that a detailed assessment of retinal structure using 
OCT is warranted in DS.  A larger study with the inclusion of typically developed controls 
and those with diagnosed AD would provide valuable information as to whether the retina 
exhibits similar changes to those in AD, or if this is not the case as suggested by the data in 
this study.   
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LiquidCrystal lcd( 9, 8, 4, 5, 6, 7 ); 
 
const int ledPin = 3;     // set output pin for the LED 
const int upButton = 12; // input for up button to increase flash intensity 
const int downButton = 11; //input for down button to decrease flash intensity 
const int eN1 = 14; // set output pin for EN1 of H-bridge 
const int eN2 = 15; // set output pin for EN2 of H-bridge 
const int shutterRel = 2; // set pin to connect to second optocoupler in order for camera 
shutter release  
const int pMos = 13; // set pin 13 as the output for photoMOS - this will set the 
buckblock LED to zero brightness if the arduino fails and control the post-flash 
brightness 
int channel = 1; 
int buttonUpState = 0; 
int buttonDownState = 0; 
int prevBtnUp = LOW; 
int prevBtnDwn = LOW; 
unsigned long lastBtnUp = 0; 
unsigned long lastBtnDwn = 0; 
int transInt = 5; 
int flashIntensity = 1; 
int flashState = 0; 
int prevFlash = HIGH; 
int shutState = 0; 
int prevShut = HIGH; 
unsigned long lastFlash = 0; 
unsigned long lastShut = 0; 
boolean hShoeSignal = false; // this is  for the DoWhile loop. This will wait for the 
hotshoe signal from the DSLR 
 
void setup() { 
  // the following portion of the code runs once when the Arduino is powered on or 
reset: 
  // declare the ledPin as an OUTPUT: 
     pinMode(ledPin, OUTPUT); 
     digitalWrite(ledPin, HIGH); 
  // declare eN1 and eN2 as outputs  
     pinMode(eN1, OUTPUT); 
     digitalWrite(eN1, LOW); 
     pinMode(eN2, OUTPUT); 
     digitalWrite(eN2, HIGH); 
     delay(100); 
     digitalWrite(eN2, LOW);   
  // declare pin 10 as an INPUT with internal pullup resistor on to connect to flash hot 
shoe 
     pinMode(10, INPUT_PULLUP);   
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  // declare the buttonPin as an input 
     pinMode(upButton, INPUT); 
     digitalWrite(upButton, LOW);  
     pinMode(downButton, INPUT); 
     digitalWrite(downButton, LOW); 
  // declare A2 as a digital input with internal pullup resistor on to connect to joystick 
button on slit lamp 
     pinMode(16, INPUT_PULLUP); 
  // declare shutterRel as an output and set to low 
     pinMode(shutterRel, OUTPUT); 
     digitalWrite(shutterRel, LOW);  
  // declare pMos as an output and set to high 
     pinMode(pMos, OUTPUT); 
     digitalWrite(pMos, HIGH);   
  // Display text on LCD 
  lcd.begin(16, 2); 
  lcd.clear(); 
  lcd.setCursor(0, 0); 
  lcd.print("Set Flash Level"); 
  lcd.setCursor(0, 1); 
  lcd.print("Press Up/Down:"); 
} 
 
void loop() { 
  // The following is the main code that runs repeatedly: 
      
  // The below is the settings for the buttons to set the desired level of flash intensity 
which will be the channel variable 
     buttonUpState = digitalRead(upButton); 
     buttonDownState = digitalRead(downButton); 
  
     if (buttonUpState == HIGH && prevBtnUp == LOW) 
     { 
       if (millis() - lastBtnUp > transInt) 
       { 
       channel++; 
       if (channel > 9) 
       { 
       channel = 9; 
       } 
       lastBtnUp = millis(); 
       } 
     } 
    prevBtnUp = buttonUpState; 
  
    if (buttonDownState == HIGH && prevBtnDwn == LOW) 
    { 
      if(millis() - lastBtnDwn > transInt) 
      { 
      channel--; 
      if (channel < 1) 
      { 
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       channel = 1; 
      } 
      lastBtnDwn = millis(); 
      } 
    } 
  prevBtnDwn = buttonDownState;  
   
  // Below will display the current 'Flash Level' on the LCD and assign a value for 
flashIntensity based on channel level 
  lcd.setCursor(15,1); 
  lcd.print(channel); 
  switch (channel) { 
    case 1:    // if channel is 1 
      flashIntensity = 1335; 
      break; 
    case 2:    
      flashIntensity = 1779; 
      break; 
    case 3:    
      flashIntensity = 2373; 
      break; 
    case 4:     
      flashIntensity = 3164; 
      break; 
    case 5:     
      flashIntensity = 4219; 
      break; 
    case 6:     
      flashIntensity = 5265; 
      break; 
    case 7:     
      flashIntensity = 7500; 
      break; 
    case 8:     
      flashIntensity = 10000; 
      break;   
    case 9: 
      flashIntensity = 16000; 
      break;   
  } 
  delay(10);  
 
//The below will wait for the trigger signal from the slit lamp joystick and then trigger 
the camera shutter. The do/while statement will wait for the hot shoe signal and then 
trigger the solenoid/flash  
  
 shutState = digitalRead(16); 
 if (shutState == LOW && prevShut == HIGH) 
     { 
       if (millis() - lastShut > transInt) 
       { 
         digitalWrite(eN1, HIGH); 
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         delay(100); 
         digitalWrite(eN1, LOW); 
         delay(500); 
         digitalWrite(shutterRel, HIGH); 
         do 
         { 
           flashState = digitalRead(10); 
             if (flashState == LOW && prevFlash == HIGH) 
               { 
                 if (millis() - lastFlash > transInt) 
                 { 
                 digitalWrite(ledPin, LOW); 
                 delayMicroseconds(flashIntensity); 
                 digitalWrite(pMos, LOW); 
                 delayMicroseconds((16000 - (flashIntensity)));  
      digitalWrite(ledPin, HIGH); 
                 digitalWrite(pMos, HIGH);  
                 lastFlash = millis(); 
                 hShoeSignal = true; 
                 }  
               } 
              prevFlash = flashState; 
         } while (hShoeSignal == false);      
         delay(500); 
         digitalWrite(shutterRel, LOW);     
         digitalWrite(eN2, HIGH); 
         delay(100); 
         digitalWrite(eN2, LOW); 
         lastShut = millis(); 
       } 
     } 
   prevShut = shutState; 
   hShoeSignal = false;   
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